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ABSTRACT

The prevalence of alcohol and drug abuse or dependence among Americans ages
12 and over is thought to be about 9.4% of the total population, or 22 million Americans
(Karpiak & Norcross, 2005; Substance Abuse and Mental Health Services Association
[SAMHSA], 2003). According to Vuchinich (2002), substance use disorders (SUD) are
the most common mental health problem in our society today. Additionally, estimates
are that anywhere from half to 84% of all substance use disorder patients also experience
a co-occurring disorder (Johnson, Brems, & Burke, 2002).
Traditional treatment facilities usually are focused primarily on either substance
abuse treatment or psychiatric treatment, and rarely take into account how personal and
interpersonal factors associated with one’s mental health occur in conjunction with
substance use disorders (Clement, Williams, & Waters, 1993). This confined focus o f
treatment to either substance use or psychiatric issues results in treatment that does not
address the totality of the person, even though there has been a recent push to address the
unique treatment needs of the substance abusing population (Straussner, 2004). The lack
of integrated treatment for both substance and psychiatric problems may explain the high
rates of relapse following treatment (Polivy & Herman, 2002).
The current study examined how personality and interpersonal variables are
related to behaviors exhibited during treatment in an intensive inpatient substance abuse
treatment program. Personality and interpersonal variables were assessed using the

Personality Assessment Inventory (Morey, 1991). Substance abuse treatment behaviors
were assessed using the Treatment Process Measure (TPM), which is a brief rating scale
for examining various aspects o f counselor-rated treatment participation (Joe, Simpson,
Greener, & Rowan-Szal, 2004). The TPM for this study was completed weekly by each
participant’s individual therapist, and these scores were used to assess treatment
participation. Pearson Correlations, Analysis o f Variance, and a Stepwise Multiple
Regression Analysis were the statistical tests used to analyze the data. Results indicated
that the Stress Scale, Treatment Rejection Scale, Antisocial Scale and Borderline Scale
on the PAI are predictive of treatment participation. In-depth results and implications for
future practice and research are discussed.
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CHAPTER ONE

INTRODUCTION
Psychoactive drug use and abuse has been deeply ingrained in American society
since the founding of our nation (Buchanan, 1992). Buchanan (1992) provides a
historical review of landmark events of the United States, in conjunction with an
illustration of the evolving yet ubiquitous role of substance use over the course of time.
Overall, the frequency of use and type of psychoactive drugs used in the United
States can be linked to particular landmark periods of political, social, and economic
development (Buchanan, 1992). Specifically, the availability of certain substances
during particular time periods, coupled with the acceptance o f usage within the
population at that time, appears to be linked to an increase in usage and abuse. For
example, during the American Revolution a dramatic shift in the role of alcohol occurred
when the consumption of alcohol became associated with ideas of independence,
equality, democracy, and loyalty to country. Also, com, American’s most abundant crop
during this time was distilled into whiskey, and often used to pay worker wages. Years
later, another shift in attitudes toward the use of drugs was seen during the Civil War,
when cigarette, opiate, and morphine addictions rose rapidly. In modem times, substance
use has been associated with ideas from self-realization and political radicalism.
Examples of this include marijuana and psychedelics used in the sixties, to the more

1

current substance use of methamphetamines and prescription drugs, all of which are used
as aids in achieving a desired personal experience of invigoration, relaxation, or
socialization (Buchanan, 1992).
The abuse of substances has led to the vast problem of addiction. In fact,
according to Vuchinich (2002), substance use disorders are the most common mental
health problem in our society today. Prevalence reports are inconsistent as to how many
individuals have a substance use disorder, because many estimates include both substance
abuse and dependence. However, the scope of the problem is enormous, with the most
recent estimates for alcohol and drug abuse or dependence among Americans ages 12 and
over thought to be about 9.4% of the total population, or 22 million Americans (Karpiak
& Norcross, 2005; SAMHSA, 2003). This estimate represents 5-10% of the population
as having an alcohol dependency and 1-2% with a drug dependency (Strong Medicine,
1995).
Although substance use disorders exist within all types of individuals, pervading
lines of gender, age, ethnicity, race, social class, and socioeconomic status, there is some
evidence suggesting certain groups and subgroups are more vulnerable than others. In
regard to gender, men are affected at higher rates than women. Estimates indicate that
prevalence rates for males are 35%, while for females, rates are only 18% (Rhee et al.,
2003). In regard to age, the Diagnostic and Statistical Manual of Mental Disorders (4th
ed., text rev; DSM-TV-TR; American Psychiatric Association, 2000) indicates that
individuals aged 18-24 have the highest prevalence rates for all substances, including
alcohol. Additionally, 10-15% of the elderly population is estimated to have a substance
use disorder (Zisserson & Oslin, 2004). Within the 18-24 year old age group, race also

appears to be a differentiating factor with Hispanic and Caucasians having higher rates of
substance problems than African American or Asian American individuals (McCabe et
al., 2007). Other special populations such as the homeless, the disabled, individuals with
mental illness, and gay, lesbian, bisexual, and transgender individuals also have higher
rates of addiction, and are even classified sometimes as overlooked or “hidden” faces of
addiction (Doweiko, 2006).
Although over the years the types of substances used have varied depending on
the times, the problem of addiction is chronic. The scope of the problem is illustrated by
a large body of research which outlines problems either caused by or associated with
addiction. Overall, the problem of substance use disorders is large, affecting all aspects
of the population.

Substance Use Disorders
Understanding the Terminology
Alcohol and drug use lies on a continuum ranging from use, to abuse, and to
addiction. The term “use” simply refers to the ingestion of a substance of some sort used
to alter physical or mental functioning (Doweiko, 2006). Use of alcohol and drugs can be
illegal, such as with crack cocaine or underage drinking, or legal, as with a prescription of
Xanax or of-age drinking. The term “use” also can refer to a one-time experimentation
with the substance or daily use of the substance. Use of a substance does not necessarily
mean that an individual will abuse or become addicted to it.
Terminology and Clinical Definitions of Substance Use Disorders
The American Psychiatric Association DSM-IV-TR (2000) outlines two groups of
substance use disorders. The first disorder is substance dependence. Substance

dependence disorders are characterized by, “a cluster of cognitive, behavioral, and
physiological symptoms” in which “the individual continues use of the substance despite
significant substance-related problems” and demonstrates “a pattern of repeated self
administration that can result in tolerance, withdrawal, and compulsive drug-taking
behavior” (p. 192). Substance dependence also is commonly referred to as “addiction,”
meaning that an individual has developed a dependence on the substance, and will
continue use despite social, occupational, and interpersonal problems. The repeated use
can result in the development of a tolerance to the substance, meaning that the individuals
will need an increased amount each time to attain the desired outcome, withdrawal
symptoms if the substance is not ingested, and compulsive drug taking behavior {DSMIV-TR, 2000).
The second group of substance use disorders according to the Diagnostic and
Statistical Manual of Mental Disorders-IV-TR {DSM-IV-TR, 2000) is substance abuse.
Although less severe than dependence, abuse is characterized by “a maladaptive pattern
o f substance use manifested by recurrent and significant adverse consequences related to
the repeated use of substances” and “must have occurred repeatedly during the same 12month period” (p. 198). The term “abuse” of a substance means that the person is using a
substance for a role that it was not intended, for example, taking another person’s
prescription drugs or taking medication in ways other than how it was prescribed.
Substance abuse can be a one-time event, as in the college student who binge drinks one
evening, or can occur over the course of many times, such as regular occurrences of
binge drinking, ingesting greater dosages than those prescribed or shortening the intervals
between dosages of medicine taken.

Although for diagnostic purposes particular distinctions are made between use,
abuse, and dependence, the psychological literature is not as clear on distinguishing these
groups of individuals. In fact, in much of the literature reviewed, the terms use, abuse,
and addiction or dependence often are used interchangeably, rather than to show
differences on the continuum. In an effort to be consistent with and inclusive of all o f the
current psychological literature on substance use, abuse, and dependence, the term
substance use disorder (SUD) will be used to describe any o f the categories.
The word “substance” or “chemical” is most often used to reference both drugs
and alcohol. The DSM-IV-TR (2000), uses the word “substance” to refer to “a drug of
abuse, a medication, or a toxin” (p. 191). This encompassing reference is used in the
psychological literature as well as the DSM-IV-TR (2000) for ease of description and
because it is common for individuals to present with more than one substance problem
concurrently.

In an effort to be consistent with previous studies’ terminology, this paper

also will use the word “substance” to include both alcohol and psychoactive drugs.
Understanding Substance Use Disorders’ Im pact on Individuals and Society
Substance use disorders are associated with health and social problems that
impact all aspects of our society (Straussner, 2004). The abuse of substances is
associated with more deaths, accidents, disabilities, and illnesses than any other avoidable
health problem today (Robert Wood Johnson Foundation, 2001). In the United States
alone, it is estimated that 110-170 million dollars each year are associated with substance
use disorders, such as accidents, time off from work, and hospitalizations (Taylor, 2005).
Medical problems are among the most common resulting from substance use
disorders. In fact, recent estimates are that 25% of all primary care patients have a

substance abuse problem, while 20-50% of all patients admitted to a hospital are being
treated for an illness related to the effects of alcohol or drugs (Greenfield & Hennessy,
2004; Jones, Knutson, & Haines, 2003; McKay, Koranda, & Axen, 2004). Medical
problems that develop after sustained substance abuse, for example cirrhosis of the liver,
or acute short-term medical problems, such as heart-attack or stroke, are common reasons
for seeking medical attention (Doweiko, 2006; Martin, Enevoldson, & Humphrey, 1997).
Other medical complications associated with alcohol and drug use include higher rates of
arthritis, headache, back pain, cancers, cardiovascular diseases, infectious diseases such
as sexually transmitted diseases, HIV/AIDS, tuberculosis, hepatitis, and bacterial
infections such as pneumonia, endocarditis, and skin abscesses (Doweiko, 2006).
Mental health problems also are associated with substance use disorders. Though
substance-use disorders comprise the most common mental health problem in the United
States, substance use disorders also can exacerbate previous mental health conditions
which were experienced prior to abuse, or can contribute to the formation o f new mental
health symptoms or disorders (Vuchinich, 2002). In fact, Doweiko (2006) cites that six
out of ten individuals with a substance use disorder also have at least one mental illness,
and substance use disordered individuals are twice as likely as the general population to
have an anxiety or mood disorder. Psychosis in young adults also is linked to alcohol and
drug abuse (Cohen, 1995). Still, other problems such as cognitive impairment and
insomnia also are related to substance use disorders (Brower, Aldrich, Robinson, Zucker,
& Greden, 2001; Vik, Cellucci, Jarchow, & Hedt, 2004).
Suicide is more common among alcohol and drug users than the general
population. Estimates suggest that alcoholics are 30 times more likely to commit suicide

than the general population (Mosier, 1999) and of all completed suicides, 20-35% are
carried out by alcoholics (Lester, 2000; Preuss et al., 2003). Overall, 5% of alcohol
dependent persons (Preuss, et al., 2003) and 35% of drug dependent persons will die from
suicide (Neeleman & Farrell, 1997).
Alcohol and drug use also are associated with social problems, including
increased involvement with crimes such as theft, robbery, homicide, and assault; and is a
consistent factor in reports of physical and sexual abuse of children, domestic violence,
incest, and rape. According to the Butler Center for Research (Substance Abuse and
Crime, 2000), an estimated 80% of all offenses resulting in incarceration in the United
States are related to alcohol or drugs, with crimes such as theft and robbery estimated to
be committed by individuals under the influence of drugs in about 38-40% of all cases,
and half of all homicides being alcohol related (National Foundation for Brain Research,
1992 as cited in Doweiko, 2006). A relationship also exists between homicide and illicit
drug use. Women are 28 times more likely to be the victim of intimate partner homicide
when drugs are used by one or both partners (Rivara et al., 1997). In addition, 56% o f all
assaults are alcohol-related (Dyehouse & Sommers, 1998). Moreover, alcohol and drug
disordered adults are 2.7 times more likely to physically abuse and 4.2 times more likely
to neglect a child (Ireland, 2001).

Statement of the Problem
Years of research and practice have guided clinicians and researchers toward a
better understanding of the magnitude of the problems associated with substance use
disorders and have laid a solid framework for treating substance abuse. A review o f the
literature uncovers several specific areas of research of substance abuse topics. In an

article written by Heinrich and Lynn Jr. (2002), the specific areas of research were
summarized into the following categories: 1. The external policy environment (such as
legal issues, managed care, access to treatment) 2. Treatment and service systems
(inpatient, outpatient, private, public, prison, volunteer versus mandated treatment) 3.
Structural and operational features o f treatment programs (individual therapy, group
therapy, other activities such as completion of high school education requirements) 4.
Interventions (12-step, cognitive-behavioral, combined treatments for dual diagnosis) 5.
Therapist variables (such as age, ethnicity, matched with patient) 6. Patient
characteristics (gender, race, ethnicity, sexual orientation, personality disorders, history
of criminal activity, trauma) 7. Social environment of patient (support, family system)
and 8. Patient outcomes (retention, completion of treatment program, relapse rates)
One of the largest portions of the literature is devoted to understanding patient
characteristics. Previous researchers (e.g., Conley, 1981; Mayer, 2005) have profiled an
addict. As a result, some characteristics that have been shown to occur more often for
addicts include personality disorders, history of past traumas, family history of addiction,
and co-occurring addictive and mental disorders. There has been a push to address these
unique treatment needs of special substance abusing populations, calling for treatments
that are both inclusive and sensitive to age, gender, race, ethnicity, sexual orientation,
patients with disabilities, and patients with co-occurring mental disorders (Straussner,
2004). Although the idea of using empirically validated treatments based on the best
match of what works for whom is widely accepted in theory, there still appears to be a
large gap in our understanding of exactly how to implement research results to practice
for the substance use disordered population. This gap is linked to the limited ability

within the current body of literature to generalize the findings, due to problems associated
with conflicting results, differing operational definitions of constructs studied, and
methodological limitations.
Problems in generalizing results, and conflicting results, are partially due to the
variation between treatment programs. The different theoretical orientations, treatment
approaches, services provided, and the varying levels of skilled practitioners make it
methodologically challenging to tease out which of the factors contribute to successful
treatment. Additionally, traditional treatment facilities usually are focused primarily on
either substance abuse treatment or psychiatric treatment, and rarely take into account
how personal and interpersonal factors associated with one’s mental health occur in
conjunction with substance use disorders (Clement, Williams, & Waters, 1993). This
confined focus of treatment to either substance use or psychiatric issues results in
treatment that does not address the totality of the person. The lack of integrated treatment
for both substance and psychiatric problems may explain the high rates of relapse
following treatment, with for example, 90% o f individuals treated for alcohol dependence
relapsing within the first 90 days after discharge from treatment (Polivy & Herman,
2002).
Another problem within the body of literature involves the differing definitions of
constructs examined, because, as previously discussed, the literature often confuses and
intermingles terms along the continuum of substance abuse, either combining or
excluding participants based on differing use o f substances or comorbid disorders. As a
result, although the inclusion or exclusion of such factors makes for tidier research
studies, the outcomes are likely not representative of the population in general.
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Additionally, outcome research can be difficult to understand, because the reference to
outcomes often refers to different things, such as completion of treatment, treatment
retention, treatment participation, progression in stages of change, or long-term outcome
research.
Methodological issues with previous research also pose problems. Specifically,
studies examining personality or interpersonal variables associated with treatment
outcomes are limited because most of these studies use the Minnesota Multiphasic
Personality Inventory, Second Edition (MMPI-2). As a result, other measures of
personality, particularly those which may be better suited for the SUD population or
provide different information, have been ignored. As a result of all of these factors,
individual patient characteristics within the substance use disordered population are still
largely ignored.

Justification
As a result of the large number of individuals With substance abuse and addiction
problems, as well as the secondary issues such as medical, social, or psychological
problems, most mental health clinicians will at some point be faced with the task of
treating substance use disorders. Accordingly, it is important to fill in the holes in the
existing psychological literature regarding the best treatment approaches for substance
use disordered individuals, so that treatment is efficient and efficacious.
Historically, research about interpersonal and personality factors among substance
abusers has been focused on identifying the typology of an addict, specifically attempting
to identify those individuals predisposed to developing a substance use disorder;
however, there have not been solid answers regarding a pre-addict personality (Doweiko,

2006). That said, although it would be informative to understand personality traits which
predispose to addiction, for prevention purposes, clinicians on the front lines of treating
addictions would benefit more from a better understanding of how individuals with
different types of personal and interpersonal traits respond to substance abuse treatment.
With this understanding, substance abuse treatments could be restructured to become
more integrative, targeting substance use disorders within the context o f specific
personality and interpersonal characteristics. For example, treatment programs could
integrate empirically validated treatments for personal and interpersonal problems, such
as interpersonal process therapy for depressed individuals (e.g., Teyber, 2000; Teyber &
McClure, 2011), while also targeting the substance use disorder. In this way, the
individual would address both the depression and substance disorder and identify the
likely relationship between the two disorders. Overall, this knowledge could provide
practical suggestions for better treatment, less relapse, and more successful long-term
treatment outcomes.
This study examined how personality and interpersonal variables are related to
behaviors exhibited during treatment and subsequent treatment participation in an
intensive inpatient substance abuse treatment program. This study is relevant because
previous research indicates support for identifying treatments based on sensitivity to pre
treatment client characteristics (Roth & Fonagy, 2005). Additionally, this study is
particularly relevant based on its uniqueness from the bulk of research in this area in that
it focuses on the immediate responsiveness o f patients throughout treatment and
examines participation, rather than solely relying on a long-term follow up measure to
evaluate treatment outcomes. The results of this study are intended to add to the

literature examining pretreatment characteristics and the process of substance abuse
treatment. The purpose of this study was to identify specific types of variables, such as
symptoms of a personality disorder, and understand how these are associated with
treatment participation, retention or completion, or overall rejection of treatment. For
those variables which seem to determine treatment related behaviors or participation, it is
possible that initial assessment before treatment begins could be useful in identifying “at
risk” patients for poor treatment participation. These patients can then be targeted at the
beginning of treatment with a modified supplemental treatment engaging them in
treatment while addressing some other related issues, such as interpersonal relations, the
ability to give constructive feedback as well as receive it from others, and other areas
such as boundaries and emotional regulation, rather than sending the patient off to a “one
size fits all” treatment. This approach fits very well with the widely accepted stages of
change model put forth by Prochasca and DiClemente (Conners, Donovan, &
DiClemente, 2001).
There are other potential benefits o f this line of research: In addition to patients
receiving the benefit of treatment better tailored to meet their unique needs, treatment
programs also could benefit in terms of patients’ more rapid response to treatment, which
could contribute to less overall cost investment for each treatment program. More
specifically, by targeting interventions related to “at-risk” patients, patients might
respond more positively to treatment, potentially lowering the incidence of treatment
dropout and treatment repetition due to relapse, thus lowering costs invested in non
completion of treatment. From an empirical perspective, this study contributes to the
larger body of literature by examining characteristics of patients related to treatment
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participation in state-funded, intensive, inpatient, substance abuse treatment centers for
civilly committed individuals.
The following research questions are addressed with this study:
1) How do personality variables predict how a patient behaves interpersonally
with staff and peers, willingness to discuss difficult material, accept feedback,
and give feedback?
2) How do interpersonal variables predict how a patient behaves interpersonally
with staff and peers, willingness to discuss difficult material, accept feedback,
and give feedback?
3) What pre-treatment patient characteristics are associated with
positive/negative participation?
Literature Review
Characteristics of Substance Abusers
Personality traits. For years, researchers have attempted to profile the substance
abuser according to personality traits, as well as other psychosocial characteristics. A
review of this research points to characteristic personality traits which are more likely to
be present in substance abusers than in the general population. For example, alcoholabusing individuals tend to be more impulsive, neurotic, independent, active, dominant,
aggressive, antisocial, under-controlled, and non-conforming than the general population
(Barnes, 1983; Martin & Sher, 1994). Similar findings also have been noted in alcoholicdependent persons. For example, several studies indicate that alcoholics are more likely
to exhibit passive, dependent, anxious, immature, irresponsible, impulsive, depressed or
manic depressive psychosis, socially deviant, and psychopathological characteristics

(Barnes, 1983; Barry III, 1974; Cox, 1979; Mustanski, Viken, Kaprio, & Rose, 2003).
Although studies aimed at profiling the substance abuser/user are relatively consistent in
terms of a global characteristic snapshot o f this population, thorough evaluation o f these
studies also indicates that there are great differences within this population on a
microscopic level. For example, individuals with polysubstance dependence, versus
monosubstance dependence, tend to be younger, unemployed, less likely to have a
significant other, as well as have higher rates of childhood physical and emotional
neglect, aggression, self-mutilation, and impulsivity, while the monosubstance users
tended to have higher rates of depression and Axis I disorders (Martinotti, et al., 2009).
Moreover, different combinations of these personality and interpersonal traits found in
this population result in enormous disparity in the treatment needs of each patient within
a clinical setting, as well as in the overall outcomes of treatment. In summary, although
the original goals of many studies were to show similarities, there were substantially
more differences revealed, especially in treatment outcomes, ultimately indicating that
there is no way to unilaterally profile drug and alcohol users. These differences will be
discussed further in the future subsections.
Comorbidity. Because a monolithic profile of substance Use disordered
individuals almost certainly does not exist, another strategy for categorizing this
population is to separate individuals into subgroups based on co-occurring disorders.
Comorbidity among individuals with substance use disorders is very common. Estimates
are that almost half of all substance use disorders (SUD) patients also experience a co
occurring disorder, and some estimates are even as high as 84%, depending on the type of
mental health setting (Johnson, Brems, & Burke, 2002). In terms of Axis I versus Axis II
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disorders, it is estimated that half of all individuals with a SUD also have another Axis I
disorder, while one-third to one-half of individuals with a SUD also have an Axis II
disorder (Haaga, McCrady, & Lebow, 2006; Taylor, 2005).
The most common Axis I disorders co-occurring with SUD are mood and anxiety
disorders (Skinstad, & Swain, 2001). Estimates indicate comorbidity of SUD with
affective disorders, such as depression, to be around 32%, bipolar disorders around 64%,
anxiety disorders about 36%, eating disorders around 28%, and attention deficit
hyperactivity disorder around 23% (Ziedonis & Brady, 1997). Schizophrenia has a
comorbid rate with SUD of around 40-50% (Kavanagh, McGrath, Saunders, Dore, &
Clark, 2002). Additionally, high rates of trauma also are associated with SUD, with
recent estimates indicating that 20-33% of SUD individuals also qualify for a PTSD
diagnosis (Back et al., 2000; Brown, Recupero, & Stout, 1995; Najavitis, et al., 1998;
Triffleman, Marmar, Delucchi, & Ronfeldt, 1995).
Axis II disorders occur in high rates within the SUD population. The most
common Axis II disorders co-occurring with SUD are Cluster B personality disorders
(Fieldman, Woolfolk, & Allen, 1995; Straussner & Nemenzik, 2007). Cluster B
personality disorders in the SUD population are much higher than in the general
population. In fact, estimates of the general population with any personality disorder is
14.8%, while for alcohol use disordered individuals, it is estimated that 28.6% have a
personality disorder, and for drug disorders, estimates are that 47.7% have a personality
disorder (Grant et al., 2004). Although most practitioners agree that these estimates are
an accurate reflection of this population, others disagree, stating that the symptoms of
personality disorder result from the dynamics of the addiction resulting from the
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substance use disorder, rather than the personality (Straussner & Nemenzik, 2007). This
debate has yet to be settled, but there is some evidence that the personality disorder
precedes the addiction (Compton, Cottier, Phelps, Abdallah, & Spitznagel, 2000; Trull,
Sher, Minks-Brown, Durbin, & Burr, 2000).
The cluster B personality disorders include antisocial, borderline, histrionic, and
narcissistic personality disorders. Individuals so diagnosed have “dramatic, emotional,
and erratic” qualities (Sadock & Sadock, 2003). O f the cluster B disorders, the most
common personality disorders which co-occur with substance use disorders are
borderline and antisocial personality disorders (Straussner & Nemenzik, 2007). The rate
of borderline personality disorder in the general populations is about 1-2%, but for SUD
individuals, estimates indicate that as high as 27.4% meet the criteria for borderline
personality disorder with even higher rates among drug addicts (Trull et al., 2000). Even
higher rates of comorbidity have been found when examining individuals with a
borderline personality disorder (BPD) diagnosis prior to the co-occurring SUD, with 57%
of BPD patients having a SUD (Trull et al., 2000). In addition to borderline personality
disorder, antisocial personality disorder also is more common in SUD individuals. In the
general population, antisocial personality disorder is estimated to occur in only 1% of
women and 3% of m en, but in the SUD population, estimates are about 5 times greater
(Brooner, King, Kidorf, Schmidt, & Bigelow 1997; Grant et al., 2004; Sadock & Sadock,
2003; Stefansson & Hesse, 2007).
Examinations of past research indicate commonalities among individuals with all
types of personality disorders, such as greater rates of unemployment and homelessness,
poorer physical health, little if any previous mental health treatment, more severe

symptoms connected to drug usage, and overall poorer functioning in personal and
interpersonal areas, which are also characteristic o f SUD patients; in regard to these
characteristics, SUD individuals in general rate their mental and physical health, day-today functioning, and interpersonal relationships, as more impaired than their peers
without substance use disorders (Johnson, Brems, & Bruke, 2002). Research confirms
this view, indicating SUD individuals as having “substantial impairments” in quality of
life as compared to their peers without substance use disorders, particularly in the area of
mental health (Buchholz, Krol, Rist, Nieuwkerk, & Schippers, 2008). The higher rate of
impairments as compared to their peers includes higher levels of depression, psychosis,
anxiety, and impulsivity (Nace, Davis, & Gaspari, 1991). It is likely that these
symptoms, whether directly or indirectly associated with the personality disorder,
combined with substance use, perpetuates the cycle of addiction associated with SUD,
therefore creating a cycle of increasing need to use substances in order to remain
functional, also coupled with guilt about the usage (Jolmson, Brems, & Burke, 2002).
The guilt about usage contributes to problems with self-evaluation and self
representation, specifically with the presence of low self-esteem and self-condemnation,
likely exacerbating personality disorder symptoms (Fieldman, Woolfolk, & Allen, 1995).
Drug of choice. Drug of choice also is a way to understand the substance use
disordered population. Groups of users can be classified according to drug o f choice.
Some researchers have suggested that drug of choice is related to personality style, other
comorbid psychiatric problems, or availability (Bremner, Southwick, Darnell, &
Charney, 1996; Dervaux et al., 2001; Mueser, Bellack, & Blanchard 1992).

While characteristics from conduct disorder symptoms to novelty seeking have
been associated with both alcohol and drug dependence, certain combinations of
personality characteristics have been linked to particular substance use disorders (Grekin,
Sher, & Wood, 2006). For example, extraversion and low openness to new experiences
are related to alcohol use disorders, while low conscientiousness is related to drug use
disorders (Grekin, Sher, & Wood, 2006). Additionally, novelty seeking has been related
to type of substance used as well as motivation for using the substance. Adams et al.
(2003) specifically outlined the differences between low and high novelty seeking
individuals. For example, in low novelty seeking individuals, especially those using
substances to avoid emotions or negative life experiences, there is a likelihood of sedative
use, with preferred substances tending to be alcohol and marijuana. However, for high
novelty seeking individuals, especially those using substances to obtain positive rewards
such as a pleasurable experience, there is a likelihood of stimulant use, with a wider
range of preferred substances. Furthermore, in terms of specific substances used,
individuals with high novelty seeking and/or antisocial personality traits also are more
likely to use substances which are considered socially deviant, such as illegal drugs or
intravenous drugs (Chakroun, Johnson, & Swendsen, 2010).
There is evidence to suggest that use of particular substances is associated with
certain psychiatric problems. Specifically, a self-medication hypothesis is believed to
explain substance use and subsequent SUD (Khantzian, 1985). For example, alcohol has
been proposed as more commonly used among individuals who experience problems
with anxiety or depression (Bedi, & Halikas, 1985; DiSalver, 1987). Narcotics are used
more commonly among individuals with tendencies to exhibit rageful and aggressive
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behaviors, and cocaine for individuals wanting relief from feelings of depression,
hyperactivity, or hypomania (Khantzian, 1985). Type of substance also has been linked
to relief of particular symptoms of PTSD, with alcohol used most often to overcome
arousal symptoms, drugs used more often for avoidance and numbing of the symptoms,
and a combination of drugs and alcohol to cope with intrusive thoughts, flashbacks, or
nightmares (Ouimette, & Brown, 2003).

Overview of Substance Abuse Treatment
Treatment for substance use disorders differs greatly depending on the treatment
philosophy incorporated, whether it is inpatient versus outpatient, the degree of
involvement of significant others in treatment, and other factors such as co-occurring
disorders. The most common treatment approaches include cognitive-behavioral
treatments, cognitive therapy, behavior-focused treatment, motivational interventions, 12step approaches, stage-based methods, and relapse prevention approaches delivered via
outpatient, inpatient, residential, or court-mandated programs (DiClemente, 2005). Many
treatment programs use combinations of several of the above mentioned treatments, for
example, using motivational interviewing techniques within the overall treatment
modality o f a 12-step program.
Although treatments vary, one common factor emerging in the literature is that
patients can successfully overcome substance use disorders with treatment; in other
words, treatment works (Roth & Fonagy, 2005). However, an all too common factor
among the treatment modalities is the problem of treatment dropout. In a national
statewide comparison of treatment completion rates, 59% completed treatment, leaving
41% categorized as early terminators due to dropout (Stark, 1992). Estimates of dropout

rates vary according to type of treatment program, (e.g., treatment at free will versus
commitment through court system), with mandated treatment having lower dropout rates
than at-will treatment (Agosti, Nunes, Ocepeck-Welikson, Phil, 1996; Doumas, Blasey,
Thacker, 2005; Stark, 1992). However, although mandated treatments are likely to have
lower dropout rates, there is evidence to suggest resistance to treatment is lower among
participants in at-will treatment programs, thereby suggesting a greater long-term success
for at-will treatments (Shearer & Ogan, 2002). Another important problem with
treatment dropout, other than the loss of potential recovery to the patient, is the front-end
cost to each program for initiating treatment. These costs entail medical exams, and other
resources used to initiate treatment, such as treatment planning, psychological
assessments, and other routine screenings. A better understanding of what makes for
successful treatment could, in turn, influence programs’ ability to retain patients or
decrease resistance to treatment. This could cut costs to the program as well as provide
better service to the patient, which would facilitate overall better outcomes for both the
program and the patient.

Treatm ent Outcomes
Interpersonal and personality characteristics are important in substance abuse
treatment because of their impact on treatment participation and subsequent outcomes,
and a significant portion of research has focused on assessing treatment outcomes.
Outcomes in the literature are assessed in different ways, including treatment adherence,
participation, and retention; treatment completion; and long-term follow-up of treatment
completers. Previous research has drawn conclusions about treatment outcomes based on
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factors such as demographic, psychosocial, or interpersonal factors, and response to
treatment based on personality “types” as defined by psychological tests profiles.
Demographic Characteristics
Demographic characteristics have been linked to treatment outcomes. Common
correlates of treatment retention examined in the literature include factors such as age,
race, gender, and marital status (Stark, 1992). Research indicates worse outcomes for
younger patients than for older ones. For example, research conducted by Joe, Chasain,
Marsh, and Simpson (1990) found older addicts had lower rates of relapse, and Stephens
and Cottrell (1972) found that patients aged 30 and younger have higher rates of relapse
after treatment than patients aged 31 and older (McCaul, Svikis, & Moore 2001).
In addition to age, race has been shown to be a delineating factor among patients
in regard to outcomes. However, the research findings related to race are not consistent.
For example, several studies indicate African Americans and Hispanics are more likely
than Caucasians to exhibit early treatment dropout and overall noncompletion of
treatment (Agosti, Nunes, & Ocepeck-Welikson, 1996; King & Candaa, 2004; McCaul,
Svikis, & Moore 2001; Milligan, Nich, & Carroll, 2004). Yet, other studies produce
dissimilar results, as in the study conducted by Gordon et al. (2001), which identified
Caucasians as being most associated with unsuccessful detoxification treatment.
Additionally African Americans and Hispanics exhibit more favorable treatment
outcomes than Caucasians (Niv, Pham, & Hser, 2009). Yet, even with these conflicting
results, other studies report no differences in regard to race or ethnicity (Grella, Anglin,
& Wugalter, 1995; Kleinman et al., 1992).
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Similar to race, the role of gender has yielded mixed findings in relationship to
treatment outcomes. While some studies (e.g., King and Canada, 2004; Soyka &
Schmidt, 2009), have shown females are more likely to terminate treatment early, other
studies (e.g., Toneatto, Sobell, & Sobell, 1992) have shown better overall outcomes for
females. Still, other evidence suggests males have better outcomes than females
(McCaul, et al., 2001).
The conflicting results for both race and gender are likely a reflection of
methodology. Specifically, it appears that the methodology, with variations of outcome
criteria, inherently creates differences in outcome reports. For example, for race and
gender, it may be that the time of assessment for outcome data may impact these reports,
with outcomes varying from detoxification, to treatment completion, and finally to post
treatment long-term follow ups.
Additional demographic factors also have been linked to outcomes. Social
support networks, particularly a healthy marriage and/or family relationships, full-time
employment, stable housing, and a living environment free of the drug culture, have
been related to prevention of post-treatment relapse (Joe, Chasain, Marsh, and Simpson,
1990; McCaul, et al., 2001). Still, other factors affecting treatment outcomes have been
noted, for example, there is limited evidence suggesting that as education level decreases,
the likelihood of early treatment dropout increases, and that more years of education are
associated with better treatment outcomes (King, & Canada, 2004; McCaul, et al., 2001).
Psychosocial Factors
Other personal characteristics of patients have been related to positive treatment
response and outcomes. Specifically, dynamic patient characteristics are associated with

treatment participation and produce more positive outcomes, with factors such as
motivation, participation in treatment, and history of substance abuse being better
predictors of treatment retention than demographic variables (Haaga, McCrady & Lebow,
2006; Justus, Burling, & Weingardt, 2006; Stark, 1992). There also is evidence
suggesting that changes taking place while participating in treatment, such as a change in
reduction of levels o f hostility and aggression from the beginning to end of treatment, are
the best overall predictors of substance abuse recovery (Putt, Dowd, & McCormick,
2001). However, some researchers suggest that attitudes, such as patient expectancies,
readiness to change, and severity of the substance abuse disorder, are the three most
important patient variables to predict treatment responses specifically, more positive
treatment outcomes are associated with a patient’s positive and accurate expectancies, a
motivation to change, and less severe SUD (Haaga, McCrady, & Lebow, 2006).
At first glance, the different findings related to psychosocial factors and outcomes
appears incongruent. However, of the factors associated with positive outcomes, there is
evidence that different factors appear to be associated with outcome based on the length
of time of follow-up after treatment. For example, pretreatment severity of alcohol and
drug use is the best predictor o f treatment outcome at three months follow up and lower
levels of hostility and aggression are best predictors of 12 month follow ups (Putt, Dowd,
& McCormick, 2001). As a result, it is likely that the seemingly incongruent findings
may be a reflection of differing methodologies used in the studies.
Research on psychosocial variables also furthers understanding of negative outcomes.
Poor adherence to treatment is associated with severe psychiatric impairment, comorbid
personality disorders, cognitive impairment, poor social support, isolation, side effects of

medication, attitudes and beliefs, understanding of illness, and access to
treatment/financial issues; additionally, illicit drug use and global assessment of
functioning scores of 50 or less also are associated with poorer compliance and treatment
response (Herbeck et al., 2005). Though there are many psychosocial variables that
negatively impact treatment outcomes, evidence indicates that pre-treatment psychiatric
problems are the single best predictor, with more severe psychiatric problems associated
with worse treatment outcomes (McLellan, Luborsky, O’Brien, & Barr, 1986).
Personality Inventories
Objective personality measures have been used to identify personality “types”
associated with treatment outcomes. One of the earliest studies to investigate the
relationship between type and outcome used the Minnesota Multiphasic Personality
Inventory (MMPI; Hathaway & McKinley, 1940), to predict treatment drop out (Craig,
1984). Results indicated that patients scoring high on the depression (D) scale were more
likely to leave treatment early than individuals with normal scores on this scale. Another
early study found that treatment for individuals diagnosed with Borderline Personality
Disorder based on the MMPI had shorter, usually less successful, treatments, likely due
to acting out from anxiety associated with treatment (Inman, Bascue, & Skoloda, 1985).
Years later, with the MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kreammer,
1989), elevated scores on scale seven, which is designed to measure the presence of
maladaptive behaviors or thoughts such as fears, phobias, anxiety, or self-doubt, and
scale eight, which is designed to measure one’s feelings of alienation from others, being
misunderstood, or experiencing discomfort in social situations, were linked to non
completion of substance abuse treatment (Groth-Mamat, 2003; Marshall, & Roiger,
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1996). Additionally, high scores on the Negative Treatment Indicator (TRT) scale on the
MMPI-2, which measures distrust for helping professionals and resistance to change, also
predict poor treatment adherence as well as final outcome (Gilmore, Lash, Foster, &
Blosser, 2001; Groth-Mamat, 2003).
Factors Related to Treatment Program
Program related factors also influence treatment outcomes. Programs with higher
clinical staff to patient ratios and programs with higher funding have lower attrition rates
than programs with staff shortages and limited funding. Additionally, programs
structured in a way that allows patients to receive quick individualized attention in small
friendly groups tend to have greater treatment retention than programs which do not
allow patients to receive such benefits (Stark, 1992). Adequately trained staff members
also are associated with positive outcomes (Haaga, McCrady, & Lebow, 2006). Positive
expectancies and a strong working alliance with the treatment provider are associated
with more positive outcomes (Haaga, McCrady, & Lebow, 2006). Also, studies show
that more time spent in treatment is associated with more positive treatment outcomes
(Inman, Bascue, & Skoloda, 1985).
Type of Intervention
The type of intervention used impacts outcomes. For example, action-oriented
interventions such as cognitive therapy, which assumes the individual is ready from the
beginning of treatment to change the thoughts, beliefs, and expectations about substance
abuse, have low success rates (DiClemente, 2005), while treatments geared toward
increasing patients’ motivation through sequential steps are most successful (Connors,
Donovan, & DiClemente, 2001).
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Combinations of Factors
Most recently, the integration of known factors about patient characteristics and
treatment outcomes has been the benchmark for successful treatment. Specifically, the
latest focus for both treatment and research has been on successful matching o f treatment
type to patient characteristics. For example, it was hypothesized that patients with
varying pretreatment variables would respond uniquely to differing treatment types, in
other words, an interaction between patient characteristics and treatment occurs; research
has supported the matching hypothesis (DiClemente, 2005). A large trial of psychosocial
treatments for addiction attempted to replicate the smaller studies’ findings in the wellknown Project MATCH (Project MATCH Research Group, 1997). Results indicated
only minimal support for the concept of matching treatments to patients with certain
characteristics. For example, this study found that patients with higher levels of anger
had better outcomes when targeted with a motivational interviewing approach versus
CBT or 12-step approaches, while patients with a longer history of drinking fared better
with 12-step approaches and Alcoholic Anonymous attendance (Project MATCH
Research Group, 1997).
The concept of matching treatments with patients’ characteristics as seen in the
MATCH study used a static conceptualization of treatment matching, which means that
only one characteristic of a patient was used to indicate the type of treatment
hypothesized to work better (Project MATCH Research Group, 1997). This view directly
contradicts the more widely accepted premise that substance use disorder treatment is a
dynamic process, ever-changing as individuals increase in motivation and move towards
the action stage of recovery (DiClemente, 2005). Overall, when evaluating the MATCH
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.results and the current idea of a stage of change treatment philosophy, there is support for
a more dynamic approach to matching treatments based on shifting decisional
considerations, as well as coping skills, and psychosocial factors (DiClemente &
Prochaska, 1998; Prochaska, DiClemente, Velicer, & Rossi, 1993). Overall, the
matching philosophy is an area of research that requires more study and development
(Haaga, McCrady, & Lebow, 2006).

Summary of Treatment Outcome Literature and Conclusions
While previous studies of treatment outcomes provide a strong base for
understanding what works in SUD treatment based on differing factors, there also are
problems with the research. For one, the results often are not replicated, as each study
finds new outcomes based on the variables being examined. Additionally, some of the
factors associated with particular outcomes appear to be moderated by other factors. For
example, length of time following discharge affects which variables contribute most to
outcomes. This finding draws questions to other studies’ outcomes in that there is a
possibility that the outcome findings also are reflective of the methodology, and perhaps
other outcome indicators would change according to the type of measurement used. Due
to the diversity within the SUD population and the varying factors associated with SUD
treatment, a combination approach may be the most promising in terms of understanding
outcomes. However, in the limited body of research studying matching effects, even
these outcomes are not generalizable, as only a small group of variables have been
studied (Project MATCH Research Group, 1997).
Due to inconsistencies in the research findings, treatment planning is difficult
(Harrison & Asche, 2001). DiClemente (2005) suggests several practical suggestions for
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treatment, such as including screening for the co-occurrence of substance use disorders
and psychiatric syndromes, followed with 30-60 minutes o f discussion and/or feedback
from the practioner. The most efficient way to screen reliably for comorbidity, as well as
have a system to give feedback to the patient, is through a formal screening process based
on the results of psychological assessment.
Some commonly used inventories include the Millon Clinical Multiaxial
Inventory, Third Edition (MCMI-III, 1997), the MMPI-2, and the Personality Assessment
Inventory (PAI; Morey, 1991). The MCMI-III is a 175-item self-report instrument
requiring an eighth grade reading level. The instrument is designed to assess both Axis I
and Axis II disorders. The MMPI-2 is a 567-item self-report instrument requiring a tenth
grade reading level. The MMPI-2 is more useful than the MCMI-III in assessing
substance using populations, as it also includes an Addiction Admission Scale; however,
the reading level is often a drawback with this population, as it has one of the highest
reading levels required of similar psychological inventories.
The PAI is a 344-item self-report instrument, requiring a fourth-grade reading
level, which also has scales to assess alcohol and drug problems. The PAI, with the
lowest reading level requirements, moderate number of test items, and attention to
alcohol and drug problems, makes it an ideal choice for use with substance use disorder
populations. Other characteristics of the PAI make it an ideal choice for the SUD
population. Numerous studies support the use of the PAI as an ideal choice within the
SUD population. There is a growing base o f knowledge obtained for the SUD population
through the PAI and it has several other unique strengths as compared to the MCMI-III
and MMPI-2, all of which will be discussed in detail in the section below.
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The Personality Assessment Inventory
The Personality Assessment Inventory (PAI) is a self-administered, objective
personality measure for adults. The PAI was developed by Leslie C. Morey in 1991 and
standardized on adults 18 years of age and older. It consists of 344 items and requires a
fourth grade reading level. In most cases, the test can be completed in 40-50 minutes.
The PAI may be administered in a group format or individually.

Each question is

answered by the examinee on a Likert-type scale: totally false, slightly true, mainly true,
and very true.
Advantages of the PAI
There are many advantages to using the PAI over other similar instruments, such
as the MMPI-II, which often is considered to be the gold standard for personality
assessment. First, the minimum fourth grade reading level required for the PAI, as
compared to a minimum tenth grade reading level for the MMPI-2, provides a distinct
advantage, especially when working with populations with lower levels of education. A
second advantage of the PAI is the lower number of total test items, with 344 items on
PAI versus 567 items on the MMPI-2. Another advantage is that the PAI can be
completed in most cases within 40-50 minutes, as opposed to about 90 minutes to
complete the MMPI-2. The shorter length and lower reading level of the PAI contribute
to another advantage of the PAI, in that because o f the ease of completion, a greater
numbers of valid profiles are produced as compared to the MMPI-2. (LePage & Mogge,
2001). Another advantage of the PAI is that it can be administered by any clinician
trained in administering self-report inventories. This advantage is helpful in clinical or
research situations, in which there are differing levels of skill and training among
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practitioners. Finally, another advantage over other inventories is that the PAI is more
comprehensive in the assessment of psychopathology, particularly related to severe
personality dysfunction, problems with alcohol or drugs, interpersonal issues, and
treatment acceptance (Karlin et al., 2005). These advantages make the PAI a first choice
for many clinicians and particularly those working with the multi-faceted SUD
population.
Not only is the PAI a strong instrument in terms o f clinical utility, it has excellent
psychometric properties. The PAI was developed based on a construct-validation
framework, which emphasizes rational and quantitative methods o f scale development
(Morey, 1991). It emphasizes scale homogeneity, external correlates, scale stability, and
selecting items based on multiple discriminative criteria (Schinka, 1995). Morey reports
that internal consistency alphas for the normative population is .81, for a college sample
it is .82, and for a clinical sample, .86 (Morey, n.d.). Test-retest reliability across all three
samples was .83, after an interval of three to four weeks.
The PAI demonstrated reliability in many different types of populations. The
original clinical sample for standardization included patients from a wide variety of
settings, specifically, 35% from outpatient psychiatric settings, 25% inpatient psychiatric
settings, 15% substance abuse settings, 12% correctional settings, and 2% medical
settings; however, only 5% of the total patients were involuntary commitments (Boone,
1998). Based on the small percentage of involuntary commitments, Boone (1998)
identified the need to study a severe inpatient sample to test reliability with involuntary
participants. Subsequent research designed to evaluate the reliability of the PAI in more
seriously disturbed psychiatric inpatients found large and acceptable full-scale
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reliabilities, averaging .82, with lower but acceptable subscale reliabilities, averaging .66
(Boone, 1998). Further research by Boyle and Lennon (1994) supported the earlier
research findings, further indicating that the clinical scales are internally consistent with
more severe clinical samples. Additionally, when comparing the internal consistency
reliability of the PAI full scales to other inventories, such as the MMPI-2 clinical scales,
the PAI full scales consistently demonstrated higher internal consistency reliability
(Boone, 1998).
There are many explanations as to why the PAI full scale score has higher internal
consistency than the MMPI-2 clinical scales. The most probable reason becomes clearer
with further investigation of the PAI. The PAI produces 22 non-overlapping scales.
Although the subscales provide the clinician with rich information concerning the patient,
the non-overlapping nature of the scales is the particular advantage of the PAI, because
inflation of one scale will not inflate the others. The non-overlapping scales are much
different than other test scales, such as the MMPI-2 clinical scales, which do overlap one
another (Greene, 2000; LePage & Mogge, 2001; Morey, 1991). As a result, higher
internal consistency is demonstrated with the PAI full scales, giving the clinician more
accurate information regarding the respondent.
Subscales of the PAI
The 22 scales of the PAI include: 4 validity scales, 11 clinical scales, 5 treatment
consideration scales, and 2 interpersonal scales. Ten o f the clinical scales are further
broken down into subscales for ease of interpretation. In addition to these scales, there
are 27 critical items, which require follow up questioning by the clinician.

The four validity scales, designed to measure deviations in test takers’
responding, include an Inconsistency (INC), Infrequency (INF), Negative Impression
(NIM), and Positive Impression (PIM) scale. The INC and INF scales measure response
consistency. The two dissimilation scales are the Negative Impression (NIM), sensitive
to “fake bad” responses and Positive Impression (PIM) scales, sensitive to “fake good”
responses. Additionally, there are six supplemental validity indicators. An example of a
supplemental validity indicator is the Rogers Discriminate Function (RDF), which is
derived from a weighted combination of 20 scales scores. The RDF is designed to
distinguish genuine versus false response profiles.
The eleven clinical scales assess the following: Somatic Complaints, Anxiety,
Anxiety-Related Disorders, Depression, Mania, Paranoia, Schizophrenia, Borderline
Features, Antisocial Features, Alcohol Problems, and Drug Problems. The Treatment
Consideration Scales assess constructs such as attitudes and behaviors about treatment,
death and suicide, aggressiveness, life stressors, and social support. The Interpersonal
Scales assess levels of dominance and warmth in relationships with others.
The psychometric properties of individual scales of the PAI have been widely
researched, as well as the possible relationships between patterns of scores on multiple
scales. One area of research evaluates the validity scales of the PAI, particularly the NIM
and the PIM scales. In addition, the following scales and indices have been widely
researched: RXR, TPI, ANT, AGG, VPI, ALC, and DRG. A more thorough evaluation
of this research is outlined in the next sections.
Negative impression scale. The NIM is the primary validity scale used to detect
over-reporting of psychological symptoms or malingering (Edens, Cruise, & Buffington-

Vollum, 2001). Studies of convergent validity have found correlations ranging between
.32 and .52 between the NIM and other inventories such as the Structured Interview of
Reported Symptoms by Rogers, Bagby, and Dickens (1992) (Wang, Rogers, Giles,
Diamond, Herrington-Wang, & Taylor, 1997). Overall, studies of the NIM scale have
yielded mixed findings, indicating that this scale is better at identifying attempts to feign
particular disorders over others, depending on the cut score. For example, one study
instructed naive and sophisticated feigners to feign either schizophrenia, major
depression, or generalized anxiety disorder. Results from this study concluded that for
naive and sophisticated test takers, the NIM scale is unsuccessful at recognizing feigned
generalized anxiety disorders, modestly successful for recognizing feigned depression,
and moderately successful in recognizing feigned schizophrenia (Rogers, Omduff, &
Sewell, 1993).

Another study by Rogers, Sewell, Morey, and Ustad (1996) used the

previous methodology and included a clinical comparison group which had been
diagnosed with these disorders. Rogers et al. (1996) found differing results from the
previous study, finding the NIM scale to be most successful in recognizing attempts to
feign major depression versus schizophrenia or generalized anxiety disorder.
Additionally, they identified that sophisticated feigners went virtually undetected.
Another study by Liljequist, Kinder, and Schinka (1998) examined the ability of the NIM
to identify feigned PTSD. A clinical group, a group of college students instructed to
feign PTSD, and a control group of college students were compared. The clinical group
and the students instructed to feign the disorder had significantly higher NIM scores than
the control group, with the malingering group having the highest scores.

Calhoun,

Eamst, Tucker, Kirby, and Beckham (2000) assessed the ability of individuals to
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successfully feign PTSD symptoms and found that the NIM produced modest accuracy in
detecting real PTSD versus those feigning the disorder. These findings, in addition to
Boone’s (1998) note of a large standard error of measurement, serve as a caution to
clinicians to conclude malingering or exaggerated negative impressions based only on
elevated scores. Furthermore, it is a warning against ruling out malingering in cases of
extremely low scores. Overall, these findings suggest the importance of evaluating the
NIM in context with other scales.
Positive impression scale. The Positive Impression Scale (PIM), is a validity
scale used to assess underreporting of psychological symptoms and defensiveness (Edens
et al. 2001). Morey’s validation of the PIM scale compared college students who faked
good and compared their test PIM scores to normal and clinical samples (Morey, 1991).
Morey was able to identify 81.8% of fake good profiles with a cut score o f 18 or above.
Additionally, the PIM was found to moderately correlate with the Marlowe-Crowne
Social Desirability Scale (Crowne & Marlowe, 1960) in community and clinical samples.
After Morey’s original validation, other simulation studies have confirmed the usefulness
of this scale, with a cut score of 18 or above as providing the best estimate of separating
fake good or defensive test profiles from the honest profiles (Cashel, Rogers, Sewell, &
Martini-Cannici, 1995; Fals-Stewart, 1996; Peebles & Moore, 1998;). However, seven
years after his original suggestion to use a cut off score of 18 or above, Morey and Lanier
(1998) found that a PIM cut score of 20 or above optimizes sensitivity and specificity and
is superior over the originally suggested score o f 18. Since that discovery, research
suggests the PIM has continued to provide good estimates of fake good response profiles
at a cut score set to 20 (Edens et al., 2001).

Treatment rejection scale and treatment process index. The PAI Treatment
Rejection Scale (RXR) often is analyzed to understand readiness for treatment or
treatment outcomes, because the scale was designed to measure treatment motivation, or
attitudes or attributes associated with change (Morey, 1991).

The RXR scale is

comprised of eight items related to treatment motivation, such as treatment expectations
and openness. High RXR scores are associated with individuals who are unmotivated for
treatment, while low RXR scores are associated with the opposite. Morey (1991) found
that the RXR has satisfactory reliability, with internal consistency =.72, and test-retest
reliability after 24 days =.83.
The RXR can accurately identify individuals who are motivated for treatment.
For example, in studies of patients receiving treatment, where one would expect
motivation for treatment to be present, as well as in samples comparing clinical and
community test takers, lower scores were exhibited by the clinical samples and the
sample of patients receiving treatment. This suggests that the RXR will differentiate
those participating in or wanting treatment from those uninterested or not needing
treatment (Alterman et al., 1995; Boyel & Lennon, 1994; Cherepon & Prinzhor, 1994).
Additionally, the RXR scale also has been used to predict length of treatment, completion
o f treatment, and behaviors during treatment. For example, Everson (1999) found that
the RXR scale predicted treatment length in an outpatient psychotherapy sample, with
longer treatment associated with lower RXR scores; Edens and Ruiz (2005) showed that
the RXR scale predicted treatment completion in a forensic setting, with treatment
completers having lower RXR scores than non-completers. Likewise, Karlin et al.,
(2005) found it useful in predicting outcomes with chronic pain patients, and Keeley,
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Smith, and Miller (2000) found similar results in family medicine, accurately predicting
patients willing to complete prescribed treatment versus those unwilling to complete
treatment.
Using a different approach, additional examples of predicting treatment
completion with the RXR, were demonstrated in a study conducted with chronic pain
patients (Hopwood, Creech, Clark, Meagher, & Morey, 2008). The RXR scale predicted
successful completion of treatment by using the Mean Clinical Elevation (MCE) score on
the PAI in conjunction with the RXR scale. It was determined that a significant
prediction of successful program completion was possible for patients who scored above
39T and below SOT on the RXR scale, along with lower general symptom severity as
measured on the MCE. However, this study further indicated that the MCE was not a
predictor of program completion for those patients either resistant to treatment (RXR>50)
or hyper motivated (RXR<39T), and program completion in these cases was more likely
related to external or other treatment factors (i.e., treatment completion as alternative to
incarceration) rather than a true motivation for change. This study lends new utility to
using the RXR in conjunction with the MCE for patients who are neither resistant nor
hypermotivated for treatment. This finding replicates other studies which indicate poorer
outcomes associated with greater numbers of or magnitude o f symptoms upon entering
treatment (McLellan, Luborsky, O’Brien, & Barr, 1986).
The RXR scale correlates with other behaviors and scales. For example,
Caperton, Edens, and Johnson (2004), found that the RXR scale positively correlated
with treatment noncompliance and nonaggressive infractions such as gambling, lying, or
stealing. The RXR scale has positively correlated with measures of problem

37

minimization (Hopwood, Ambwani, & Morey, 1994), while negative correlations also
have been demonstrated by Baity (2004) and Blais et al., (2003) with several measures of
treatment alliance. Finally, the RXR scale is modestly negatively correlated with the
Beck Depression Inventory, strongly negatively correlated with Wiggens’ (1966) “Poor
Morale” scale on the MMPI, and positively correlated with perceived social support
(Morey, 1991).
The Treatment Process Index (TPI), a measure of 12 scale elevations of problems
associated with treatment amenability, predicts outcomes of treatment. The raw score for
the TPI is 0-12, with one point added for each feature present. The following twelve
features are used to calculate the TPI and are presented in Table 1 (Morey, 2007).

Table 1.
Features Used to Calculate the TPI
Scales

Score

NIM or BOR or ANT or ALC or DRG

>70T

PIM or RXR

>60T

SOM or BOR-S or ANT-A or ANT-E

>70T

PAR

>70T

BOR or ANT

>70T

BOR or ANT or ALC or DRG

>70T

AGG or BOR-S or ANT-A or ANT-S

>70T

STRorNON

>70T

NONorARD-T

>70T
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Table 1. (continued)
Features Used to Calculate the TPI
Scales

Score

DOM or MAN-G or ANT-E

>70T

WRM

<30T

PAR-R

>70T

AGG-A

>70T

ANT-E

>70T

Scales = PAI Subscales; Score = T Scores on PAI Subscale

For the TPI, higher scores are associated with less amenability for treatment
(Morey, 1991). The TPI may be a more accurate predictor of treatment completions than
the RXR scale, at least in some instances, as evidenced by Hopwood, Ambwani, and
Morey’s (2007) research, which found the TPI to be the best predictor of outcomes for
therapy.

Specifically, the results indicated that for clients who are motivated for

treatment, amenability for treatment is a predictor of nonmutual therapy termination,
while for those unmotivated for treatment, the TPI is not indicative of predicting
termination. Because the TPI has been found clinically useful in predicting outcomes,
some research (i.e., Hopwood, Creech, Clark, Meagher, & Morey, 2008) suggests
evaluating the RXR and TPI in conjunction, because RXR has been found to moderate
the TPI. Other research (i.e., Hopwood, Baker, & Morey, 2008), however, does not
support this suggestion, given the contradictory findings that RXR does not moderate
effectiveness of TPI (Hopwood, Baker, & Morey, 2008). A possible explanation for the
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incongruity in previous studies is the different treatment settings in which these variables
are studied, such as inpatient versus outpatient (Hopwood, Baker, & Morey, 2008).
Because motivation for treatment often is related to other factors, such as when treatment
is an alternative to a more negative outcome (e.g., incarceration), patients attempting to
avoid the perceived negative consequence may try to appear more motivated and
amenable for treatment than those enrolled at free will. These differing motivations for
treatment are likely the difference reflected in research outcomes.
Antisocial features, aggression, and violence potential index scales. Several
other PAI indexes have been studied to understand institutional adjustment and
behaviors.

One example is a study of inmates conducted by Caperton, Edens, and

Johnson (2004) in which the Antisocial Features Scale (ANT), the Aggression Scale
(AGG), and the Violence Potential Index (VPI) were linked to the commitment of
infractions while participating in a treatment program for sex offenders. Specifically, the
ANT scale was predictive of acts of verbal and physical aggression, defiance, and
nonaggressive infractions, such as gambling, lying, and stealing, while the AGG and VPI
scales were predictive of verbal aggression and acts of defiance.

Another study

conducted by Magyar et al., (2012) demonstrated support for using the AGG scale as a
predictor of general noncompliance and aggressive behavior. Further research suggests
that disciplinary reports and staff ratings of treatment noncompliance are correlated with
the ANT and AGG scales.

(Buffington-Vollum, Edens, Johnson, & Johnson, 2002;

Sanford, 2003; Walters, Duncan, & Geyer 2003; Walters & Geyer, 2005).
Alcohol problems and drug problems scales. There are two scales on the PAI
that are useful for assessing individuals with drug and/or alcohol related problems. Both
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the Alcohol Problems (ALC) and the Drug Problems (DRG) scales are indicators of
individuals with alcohol or drug problems (Fals-Stewart, 1996; Parker, Daleiden, &
Simpson, 1999). With similar findings, a study by Kellogg, et al. (2002), found the DRG
scale was significantly correlated with the Addiction Severity Index, indicating that the
DRG scale has utility in identifying individuals with drug related problems. However,
Fals-Stewart (1996) found that most individuals who were attempting to deny a problem
or responding defensively were able to dissimulate. Thus clinicians should use caution
when interpreting the ALC and DRG scales with individuals suspected of alcohol and/or
drug problems, or who are motivated to deny such problems exist (Fals-Stewart &
Lucente, 1997). Additionally, Fals-Stewart (1996) found that nonclinical samples often
have clinically significant elevations on these scales, and when interviewed, indicate past,
not current, recreational use of drugs.

The PAI in Substance Abusing Populations
Research with the PAI conducted with substance abusers has yielded meaningftd
contributions to the substance abuse literature. The PAI has been used to explore
patients’ symptoms and other personality factors to classify patients, make associations
with treatment outcomes, and predict associations with drug of choice. For example, a
study by Schinka (1995) involving alcohol-dependent patients found seven distinct
groups of patients. These groups were: 1. Antisocial Acts, 2. Depressed, 3. Dysphoric,
4. Distressed, 5. Normal, 6. Personality disorders, and 7. Somatic concerns. Further
analysis of these types revealed associations with age, length of stay in treatment, and
numbers of previous treatments based on type. Additionally, Rosselli, Ardila, Lubomski.
Murray, and King (2001) found that the primary personality profile o f cocaine addicted

patients is a borderline or antisocial type, often with features of mania. However, this
same study also noted that in 10% of cases, the addicted patients were able to produce a
normal personality profile, supporting previous research (e.g:, Martinotti, et al., 2009)
indicating an inability to consistently identify a single typology of an addict. Other
research with this population has indicated that common personality features of
individuals engaging in drug abuse or combined drug and alcohol abuse, include
hypervigilance and suspiciousness (Schinka, Curtiss, & Mulloy, 1994). In addition,
antisocial characteristics are associated with individuals who engage in illegal drug use,
while those with fewer antisocial characteristics are more likely to limit drug use to the
spectrum of legal drugs (Schinka, Curtiss, & Mulloy, 1994).
In addition to the PAI revealing general information concerning substance
abusing individuals, specific scales also have been reviewed to provide indicators for
treatment. These scales include: STR, NON, RXR, DOM, ANT, and BOR. A more
detailed examination of these scales in regard to substance abuse treatment is outlined
below.
Stress Scale
The STR scale of the PAI is used to identify the degree to which an individual is
experiencing current stressors. Individuals with high scores on the STR scale of the PAI
indicate that they are experiencing crises and feel a lack o f power in the ability to control
events happening around them; these individuals often view themselves as dependent,
ineffective, and often are vulnerable to other psychological symptoms and/or disorders
(Morey, 2007). Several studies have used the STR scale to investigate the relationship of
stress to substance abuse treatment, with results indicating that high levels of stress are

associated with lower treatment response rates and less improvements from treatment,
and have been associated with higher rates of drug and alcohol relapse (D’Andrea &
D’Andrea, 1996; Tate, Brown, Glasner, Unrod, & McQuiad, 2006). Additionally, other
studies tapping into similar constructs as measured by the STR scale, such as selfefficacy or the belief in his or her ability to be successful, have shown that self-efficacy is
a significant variable in the ability of humans to regulate their own behaviors, specifically
for substance abuse treatment outcomes (Magura et al., 2003). In other words, one’s
belief in his or her ability to have personal power to control events around them are
associated with better outcomes. Although within a twelve-step drug and alcohol
addiction treatment program, an initial admission of powerlessness over the addiction is
part of treatment, the lack of powerlessness over the addiction should not be confused
with a lack of ability to take personal responsibility, which is more associated with one’s
self-efficacy or internal locus of control.
Nonsupport Scale
The NON scale of the PAI measures a perceived lack of social support, as well as
the availability and quality of social relationships; high scores are associated with a
perceived lack of support and possible dissatisfaction with social relationships (Morey,
2007). Previous examinations of social support in relation to drug and alcohol treatment
indicate that higher perceived levels of social support upon intake are associated with
better treatment outcomes (Dobkin, De Civita, Paraherakis, & Gill, 2002; Huselid, Self,
& Gutierres, 1991; Westreich, Heitner, Cooper, Galanter, & Gued, 1997). Specifically,
the greater the social support one believes he or she has, the more likely more days will
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be spent in treatment and there will be higher rates of treatment completion, both of
which are associated with more positive outcomes.
Treatment Rejection Scale
The RXR scale of the PAI measures an interest in a psychological or emotional,
personal change, with lower scores reflecting a high motivation for engaging in treatment
(Morey, 2007). Although the concept of motivation has been related to successful
outcomes of substance abusing populations (e.g., Conners, Donovan, & DiClemente,
2001), there also are situational specifics that influence the role motivation plays in
treatment outcomes. Moreover, the motivation to participate in treatment for substance
dependent populations is associated with initial treatment entry motivation and treatment
completion, but not been associated with overall long-term treatment outcomes (Rapp,
Siegal, & DeLiberty, 2003). Additionally, high motivation is associated with severity of
alcohol and drug use, and/or significant life stressors associated with the use of
substances, such as involvement with the court system (Breda, & Hefiinger, 2007). All
of these factors suggest that high levels of motivation are extrinsically based, not
intrinsically based. Given that substance abuse treatment is often associated with some
ambivalence, and extremely high levels of motivation for treatment may signify a lack of
ambivalence about treatment, the possibility exists that treatment participation is
associated with secondary gain rather than a true desire for personal change.
Dominance Scale
The DOM scale of the PAI measures the likelihood to be submissive,
autonomous, or controlling within interpersonal relationships (Morey, 2007). Low
scores are associated with individuals who lack confidence within interpersonal
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relationships. These individuals also are likely to have difficulty asserting themselves
and having their needs met (Morey, 2007). Average scores indicate that one is able to
adapt to different situations and both exert and relinquish control within interpersonal
relationships. High scores on this scale are associated with individuals who are
confident, forceful, and controlling. These individuals usually are domineering and have
difficulty interacting with others when others disagree or fail to treat them with respect.
Prior research indicates that a high percentage of the substance addicted
population have difficulty within interpersonal relationships. For example, Calsyn,
Roszell, and Anderson (1988) found that at least half of the addicts in their sample were
selective about friendships, often felt uncomfortable in social situations, especially with
non-users, had at least some difficulty with authority, and had an unwillingness to take
personal responsibility. Additionally, other common characteristics o f the sample
included difficulty expressing oneself within interpersonal relationship as well as
difficulty having emotional needs met. Although all of these characteristics could
potentially inhibit outcomes of treatment, the most pronounced result was that the worst
treatment outcomes were associated with those individuals who were unwilling to take
personal responsibility for problems and those individuals who had problems with
authority (Calsyn, Roszell, & Anderson, 1988).
Because most drug and alcohol treatments rely on 12-step or psychotherapy
groups as the primary form of treatment, the process of treatment and recovery depends
largely on interpersonal interactions with others. In a study by Doumas, Blasey, and
Thacker (2005), interpersonal styles described as vindictive and domineering were
positively associated with treatment attrition. The scale used in this particular study was

the Domineering and Vindictive Scales of the Inventory of Interpersonal Problems, which
also has been shown to detect Cluster B personality styles in the substance abuse
population (Doumas, Blasey, & Thacker, 2005). Therefore, this finding is consistent
with other studies of interpersonal and personality functioning, which have found that
antisocial or borderline traits, and personality characteristics common to these disorders,
also are associated with poor treatment outcomes (Booth, Cook, & Blow, 1992; Haller,
Miles, & Dawson, 2002).
Borderline Features Scale
The BOR scale on the PAI measures hallmark elements related to Axis II
personality disorders (Morey, 2007). Average scores on the BOR scale indicate that the
individual is emotionally and interpersonally stable. Moderate elevations are associated
with individuals considered moody and uncertain about certain aspects of one’s life.
High elevations on the BOR scale are associated with dissatisfaction in interpersonal
relationships, often accompanied by symptoms of feeling misunderstood, angry, anxious,
impulsive, and emotional, as well as being ambivalent about interactions with others.
These symptoms increase in frequency and magnitude as the score on the BOR scale
increases. Extremely high scores on the BOR scale suggest Borderline Personality
Disorder, while moderate and other high scores can be associated with other personality
disorders.
Research suggests both short and long-term treatment outcomes are worse for
individuals with personality disorders compared to those without them (Herbeck et al.,
2005); Moreover, problems early on with treatment compliance have been noted for
individuals with Axis II disorders, often exhibited behaviorally in not attending

appointments, not completing homework, and having interpersonal problems with other
patients (Herbeck et al., 2005). Long term, Axis II personality disorders also are
associated with higher relapse and rehospitalization rates (Pettinati, Pierce, Belden, &
Meyers, 1999). Because much of substance abuse treatment is interpersonal in nature
and patients with personality disorders have intractable difficulties in establishing and
maintaining relationships with others, these patients usually have difficulty engaging in
treatment (Lehman, 1996). In fact, a patient’s social functioning is strongly associated
with treatment compliance, in that as social functioning deteriorates, problems with
treatment compliance increase (Herbeck, Fitek, Svikis et al., 2005).
Antisocial Features Scale
The ANT scale on the PAI measures personality and behavioral features related to
antisocial personality disorder and psychopathology (Morey, 2007). Average scores on
the ANT scale indicate the individual is warm and considerate in relationships with
others. Moderate scores are associated with individuals who are self-centered,
uninhibited, and unsentimental in interpersonal relationships. High scores are associated
with individuals who are reckless, impulsive, and callous in their relationships. These
individuals may engage in antisocial acts. These characteristics become even more
evident and pronounced with increasing elevated scores on this scale.
Research indicates that a high proportion of patients being treated for substance
abuse problems also have a co-occurring Cluster B personality disorder, which are
associated with poor behavioral control and impulsivity (Taylor, 2005). Further, these
individuals often have difficulties with executive cognitive functioning, such as planning,
judgment, and impulsivity (Taylor, 2005). Research has identified that for individuals
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participating in substance abuse treatment, antisocial personality disorder or
characteristics o f the disorder are associated with shorter treatment stays, violation of
program rules, and poor participation in treatment (Fals-Stewart, & Lucente, 1997).
Summary of the PAI in Substance Abusing Populations
Although the PAI has proven a valid measure for assessment in inpatient
substance abuse settings, researchers suggest a need for future research with the PAI in
the inpatient substance abuse setting (Hopwood, Baker, & Morey, 2008; Schinka, 1995).
Justification for further research in this area has been outlined by Schinka (1995) in
suggesting that understanding interpersonal styles and underlying psychological
dysfunction identified with the PAI may be beneficial for treatment programs when
examining suitability of patients for programs. For example, his particular study used
factor analysis to demonstrate that high positive loadings on the Nonsupport, Paranoia,
Schizophrenia, and Infrequency scales, and high negative loadings on the Warmth scale,
uncover severe personality pathology or dysfunction, often displayed interpersonally with
a mistrust of others, social distancing, and interpersonal coolness (Schinka, 1995). From
this, Schinka (1995) proposes that such information can be useful to inform treatment
based on these personality variables. Additionally, there also is support for risk
assessment with the PAI in substance abuse settings as proposed by Hopwood, Baker,
and Morey (2008). Their research demonstrated that an elevated SUI scale and the SPI
(Suicide Potential Index) are correlates with individuals with a suicidal attempt in their
past. Such knowledge can inform treatment and provide clinicians with information
useful in determining precautionary safety measures for patients. In summary, the PAI is
useful in not only making predictions about patient characteristics and other treatment
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related factors, but it also can be used to provide better quality care for patients while in
substance abuse treatment. The potential for better patient care combined with the PAI’s
demonstrated strong psychometric properties makes it an ideal choice for use within the
SUD population.

Treatment Process Measure
The Treatment Process Measure (TPM) is a counselor-rated index o f a patient
participating in substance abuse treatment, and is comprised of 14 items divided into
three scales: 1. Counseling Rapport 2. Motivation 3. Self-confidence (Joe, Simpson,
Greener, & Rowan-Szal, 2004). Counseling Rapport consists of five items: (a) easy to
talk to; (b) warm and caring; (c) honest and sincere; (d) not hostile nor aggressive; and (e)
not in denial about problems. Motivation consists of four items: (a) motivation for
treatment; (b) being cooperative; (c) being responsible; and (d) keeping session
appointments. Self-confidence consists of five items: (a) being self-confident; (b) freely
expresses wishes; (c) not being depressed; (d) not being nervous or anxious; and (e) being
motivated. The three scales on the TPM are a measure of treatment engagement (Joe,
Simpson, Greener, & Rowan-Szal, 2004). According to Drieschner and Verschuur
(2010), treatment engagement is a concept associated with behaviors demonstrated by the
patient such as “dealing with the content of therapy between sessions,” openness,”
“session attendance,” and “constructive use of therapy session,” and further have
demonstrated through research that positive treatment outcomes are associated with these
behavior changes of the patient. Additionally, in a study by Joe, Simpson, and Broome
(1998) the concepts of treatment related confidence, counseling rapport, and engagement
in treatment were demonstrated as being predictors of pre-treatment motivation, which
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was found to be the most important predictor of drug abuse treatment retention and
outcomes.
The Treatment Process Measure was developed by researchers at Texas Christian
University as a shorter version of a more comprehensive assessment, The Counselor
Rating Form (Texas Christian University, Institute of Behavioral Research, n,d.). Time
for completion of the TPM is very brief; in most cases, it can be completed in 3 minutes
or less. Each statement, about the patient, is rated by the counselor on a 7 point, Likerttype scale, anchored by 1: strongly disagree, and 7: strongly agree. The Treatment
Process Measure has good psychometric properties, described in the following paragraph
The normative sample consisted of a sample o f 547 clients enrolled in an
outpatient methadone treatment clinic in Texas. The sample was 70% male, with the
average age being 38 years old, and in regard to race, 22% were Euro-American and 67%
were Hispanic. Coefficient alphas reliabilities were calculated for each scale across
three month treatment intervals. Coefficient alpha ranges for the Counseling Rapport
Scale were .79-.83, for the Motivation Scale, .84-.87, and ,77-.79 for the Self-Confidence
Scale.

Hypotheses
The literature suggests that patient characteristics can influence treatment process
and outcomes for substance abuse treatment. Additionally, the literature also suggests the
utility of the PAI with the substance addicted population (e.g., Fals-Steart, 1996;
Hopwood, Baker, & Morey, 2008; Parker, Daleiden, & Simpson, 1999; Schinka, 1995;
Schinka, Curtiss, & Mulloy, 1994; Tolisano, 1998). However, there is no research that
examines the ability of the PAI to predict patient treatment participation progress in
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substance abuse treatment settings. The objective of this study was to further
understanding of and contribute to the best practices for treatment of individuals with
substance use disorders. This study examined how personality and interpersonal factors,
as measured by the PAI, are related to treatment participation as measured by weekly
counselor ratings of patient treatment progress.
Hypothesis One
There will be a significant relationship between scores on the stress (STR) scale
of the PAI and treatment participation. Individuals with high scores on the STR scale of
the PAI indicate that they are experiencing crises and feel a lack of power in the ability to
control events happening around them; these individuals often view themselves as
dependent, ineffective, and will often times be vulnerable to other psychological
symptoms and/or disorders (Morey, 2007). Previous investigations o f stress and its
relationship to substance abuse treatment, have shown that high levels o f stress are
associated with lower treatment response rates and less improvements from treatment,
and further also have been associated with higher rates of drug and alcohol relapse
(D’Andrea, & D’Andrea, 1996; Tate, Brown, Glasner, Unrod, & McQuiad, 2006). It is
hypothesized that higher scores on the STR scale will be associated with poorer treatment
participation scores on the Treatment Process Measure.
Hypothesis Two
There will be a significant relationship between scores on the nonsupport (NON)
scale of the PAI and treatment participation. The NON scale of the PAI measures a
perceived lack of social support, as well as the availability and quality o f social
relationships, with high scores associated with a perceived lack of support and possible

dissatisfaction with social relationships (Morey, 2007). Previous examinations o f social
support in relation to drug and alcohol treatment indicate that higher perceived levels of
social support upon intake are associated with better treatment outcomes (Dobkin, De
Civita, Paraherakis, & Gill, 2002; Huselid, Self, & Gutierres, 1991; Westreich, Heitner,
Cooper, Galanter, & Gued, 1997). Specifically, the greater the social support one
believes he or she has, the more likely more days will be spent in treatment and there will
be higher rates of treatment completion, both of which are associated with more positive
outcomes. Higher scores on the NON scale will be associated with poorer treatment
participation scores on the Treatment Process Measure.
Hypothesis Three
There will be a significant relationship between scores on the treatment rejection
(RXR) scale on the PAI and treatment participation. The RXR scale o f the PAI measures
an interest in a psychological or emotional, personal change, with lower scores reflecting
a high motivation for engaging in treatment (Morey, 2007). The concept of motivation
has been related to successful outcomes of substance abusing populations (Conners,
Donovan, & DiClemente, 2001). Additionally, high motivation is associated with
severity of alcohol and drug use, and/or significant life stressors associated with the use
of substances, such as involvement with the court system (Breda, & Heflinger, 2007).
All of these factors suggest that high levels o f motivation could be extrinsically based,
not intrinsically based. Given that substance abuse treatment is often associated with
some ambivalence, and extremely high levels of motivation for treatment may signify a
lack of ambivalence about treatment, the possibility exists that extremely high levels of
treatment acceptance could be associated with secondary gain rather than a true desire for
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personal change. It is hypothesized that moderate scores on the RXR scale of the PAI
will be associated with better treatment participation scores on the Treatment Process
Measure.
Hypothesis Four
There will be a significant relationship between the dominance (DOM) scale of
the PAI and treatment participation. Because it is known that the substance abuse
population has high rates of cluster B personality styles (e.g., Barnes, 1983; Martin &
Sher, 1994), which is associated with being dominating, vindictive, and controlling, in
addition to having difficult interpersonal relationships, it is hypothesized that individuals
with high scores on the DOM scale will have poorer treatment participation scores on the
Treatment Process Measure, than those individuals with moderate or low scores on the
DOM scale.
Hypothesis Five
There will be a significant relationship between the borderline features (BOR)
scale of the PAI and treatment participation. Because much of substance abuse treatment
is interpersonal in nature, and patients with personality disorders have intractable
difficulties in establishing and maintaining relationships with others, these patients
usually have difficulty engaging in treatment (Lehman, 1996). High elevations on the
BOR scale are associated with dissatisfaction in interpersonal relationships, often
accompanied by symptoms of feeling misunderstood, angry, anxious, impulsive, and
emotional, as well as being ambivalent about interactions with others. Research suggests
both short and long-term treatment outcomes are worse for individuals with personality
disorders compared to those without them (Herbeck et al., 2005). Moreover, problems
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early on with treatment compliance have been noted for individuals with Axis II
disorders, often exhibited behaviorally in not attending appointments, not completing
homework, and having interpersonal problems with other patients (Herbeck et al., 2005).
It is hypothesized that individuals with high scores on the BOR scale will have poorer
treatment participation scores on the Treatment Process Measure, than those individuals
with low scores on the BOR scale.
Hypothesis Six
There will be a significant relationship between the antisocial features (ANT)
scale of the PAI and treatment participation. Research indicates that a high proportion of
patients being treated for substance abuse problems also have a co-occurring Cluster B
personality disorder, which are associated with poor behavioral control and impulsivity
(Taylor, 2005). Further, these individuals often have difficulties with executive cognitive
functioning, such as to planning, judgment, and impulsivity (Taylor, 2005). Research has
identified that for individuals participating in substance abuse treatment, antisocial
personality disorder or characteristics of the disorder are associated with shorter
treatment stays, violation of program rules, and poor participation in treatment (FalsStewart & Lucente, 1997). Because participation in substance abuse treatment requires
adhering to treatment program guidelines, it is hypothesized that individuals with high
scores on the ANT scale will have poorer treatment participation scores on the Treatment
Process Measure, than those individuals with low scores on the ANT scale.
Hypothesis Seven
It is hypothesized that the PAI scales (STR, NON, RXR, DOM, BOR, and ANT)
will be predictive of treatment participation as measured from the onset and at
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completion of treatment. Specifically, individuals with higher scores on each of the six
PAI scales will be expected to be predictive o f poorer treatment participation as measured
by the TPM. Previous support for use of the PAI in substance abusing populations and
the previous research which suggests certain patient characteristics are indicators of
treatment behaviors and outcomes, substantiate this hypothesis.
The PAI has proven a valid measure for assessment in inpatient substance abuse
settings, yet researchers suggest a need for future research with the PAI in the inpatient
substance abuse setting (Hopwood, Baker, & Morey, 2008; Schinka, 1995). Several
studies have used the Stress scale to investigate the relationship of stress to substance
abuse treatment, with results indicating that high levels of stress are associated with lower
treatment response rates and less improvements from treatment (D’Andrea & D’Andrea,
1996). For the Nonsupport scale, previous examinations of social support in relation to
drug and alcohol treatment indicate that higher perceived levels of social support upon
intake are associated with better treatment outcomes (Dobkin, De Civita, Paraherakis, &
Gill, 2002; Huselid, Self, & Gutierres, 1991; Westreich, Heitner, Cooper, Galanter, &
Gued, 1997). For the Treatment Rejection scale, a related yet opposing concept to
treatment rejection, motivation, has been related to successful outcomes of treatment in
substance abusing populations (Conners, Donovan, & DiClemente, 2001). For the
Dominance scale, similar concepts related to interpersonal relationships, have been
shown to be related to treatment outcomes; specifically, worse treatment outcomes are
associated with those individuals who are unwilling to take personal responsibility for
problems and those individuals who have problems with authority (Calsyn, Roszell, &
Anderson, 1988). Additionally, for the Borderline and Antisocial scales, research
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suggests both short and long-term treatment outcomes are worse for individuals with
personality disorders compared to those without them (Herbeck et al., 2005). Moreover,
problems early on with treatment compliance have been noted for individuals with Axis
II disorders, often exhibited behaviorally in not attending appointments, not completing
homework, and having interpersonal problems with other patients (Herbeck et al., 2005).
Long term, Axis II personality disorders also are associated with higher relapse and
rehospitalization rates (Pettinati, Pierce, Belden, & Meyers, 1999). Research indicates
that a high proportion of patients being treated for substance abuse problems also have a
co-occurring Cluster B personality disorder, which are associated with poor behavioral
control and impulsivity (Taylor, 2005).

CHAPTER TWO

METHOD

The purpose of this study was to assess the influence that pre-existing personality
and interpersonal variables, as measured by subscales of the PAI, have on substance
abuse treatment participation. Personality and interpersonal variables were assessed
using the Personality Assessment Inventory (Morey, 1991). Substance abuse treatment
participation was assessed weekly, using the Treatment Process Measure (TPM).
Positive treatment participation was defined by higher scores on the TPM.

Participants
The participants were inpatients at a large publically funded state hospital. This
hospital is the largest psychiatric inpatient facility in the United States, and provides short
and long-term care for patients with a wide variety of psychiatric illnesses. The facility
includes 915 licensed psychiatric beds and 418 licensed nursing home beds. The
chemical dependency units consist of separate male and female units, comprised of 40
beds each, or a total of 80 beds.
Patients admitted to SUD treatment are treated from a multidisciplinary approach.
Complete medical care and detoxification are supervised by medical doctors and other
medical professionals. Additionally, patients participate in individual and group therapy,
as well as optional family treatment and aftercare treatment or housing arrangements,
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with therapists. Psychologists are available for psychological assessment if determined to
be vital for treatment, or if the cognitive stability of a patient is in question. A unit
psychologist also supervises and oversees the treatment plans for therapy for each patient.
Additionally, patients also work in conjunction with social workers and educators to
address and overcome anticipated stressors in daily living upon discharge. For example,
patients have the opportunity to complete a GED program while in treatment. Patients
also have access to a chaplain to discuss spiritual issues that may surface during
treatment. Treatment is highly structured, and patients attend group therapy daily,
individual therapy at least once weekly, a treatment team evaluation meeting once
weekly, and participate in other various treatment groups or trainings based on an
individualized approach to the patient’s treatment needs.
The primary theoretical orientation for treatment is centered around the 12-step
approach, but an integration of empirically supported techniques and approaches are also
part of treatment. For example, patients have opportunities to participate in individual
biofeedback training sessions, stress reduction groups, art, physical activities,
psychoeducational groups such as relapse prevention, and specific group therapy,
centered on topics such as trauma, male issues, and grief. The average length of stay for
patients enrolled in SUD treatment at this facility is about one month.
Individuals committed to the chemical dependency unit are deemed by the courts
as being an imminent danger to self or others, and judged to be in need of an aggressive
approach to chemical dependency treatment beyond what is possible at other less
intensive facilities. This means that the individuals undergoing treatment at this facility
are the most severe of all patients seeking treatment for substance use disorders, and

therefore a qualifying requirement before admission for treatment is a clearly delineated
diagnosis of substance dependence. The dependency diagnosis is important to note, as
the previous review of the literature combined studies of substance use, abuse, and
dependency for continuity purposes. It is also important to note that although
comprehensive assessment will likely reveal additional psychiatric comorbidity, the
problem for treatment is initially judged to be primarily for chemical dependency versus
other psychiatric problems.
A commitment to the chemical dependency treatment unit was the criteria for
participation in this study. Additionally, the participants met the following criteria: (a)
DSM-IV-TR diagnostic criteria for at least one of the following: Alcohol Abuse, Alcohol
Dependence, Drug Abuse, Drug Dependence, Polysubstance Dependence; (b) the legal
authority and mental capacity to provide informed consent; (c) a minimum of a fourthgrade reading level in English as indicated by participant’s score on the Wide Range
Achievement Test, Fourth Edition; and (d) the ability to complete a demographic
research questionnaire in a meaningful way. Consultations with the hospital treatment
team also assisted in the determination of whether prospective participants met the
inclusion criteria. Specifically, each participant was medically and cognitively stable as
evidenced by the participants’ ability to participate in the mandatory patient
programming on the unit. Patients unable to participate in the general treatment program,
due to a need for special medical care for detoxification or other cognitive impairment
requiring assistance, were not be qualified to participate in this study until the attending
physician released the patient into the general treatment program. This criterion ensured
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that each patient was stable enough to make a choice about participation and capable of
providing informed consent. The informed consent is presented in Appendix A.
All research materials used were pre-approved by the institutional review boards
at both the affiliated university and hospital. Each participant in the study received a
consent form, explaining the nature of the study, a demographics questionnaire, and PAI.
The principle researcher met with each participant, to discuss the informed consent.
Additionally, participants were asked to read and sign the consent form prior to
completing the demographic questionnaire and the PAI. All collected data were held in
confidence, specifically, the results of the WRAT-4, PAI, TPM, or demographic form,
did not affect treatment, and was not disclosed to the treatment team at the hospital.
Participation in the study was completely voluntary. All participants were treated
in accordance with the ethical guidelines established by the American Psychological
Association (APA, 2002). All participants were guaranteed anonymity, in that each
participant was assigned a number to be used for identification, rather than their name.
The assigned number was attached to all research materials. This system ensured that
patient information obtained from the PAI, TPM, and demographic form would not be
attached to any patient name and patient names were not available to the researcher.

Instrumentation
WRAT-4
The Wide Range Achievement Test (WRAT-4; Wilkinson & Robertson, 2006) is
a clinician administered achievement test for individuals aged 5 to 94 years o f age. The
WRAT-4 contains four subtests: Word Reading, Sentence Comprehension, Spelling, and
Math Computation. Additionally, a Reading Composite Score is calculated, which is a
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combination score based on the Word Reading and Sentence Comprehension subtests,
and can be used to determine an individual’s reading grade equivalent. The WRAT-4
was standardized on a national sample of 3,021 individuals. Validity of the WRAT-4 is
considered moderate, ranging from .40 to .70, while reliability of the WRAT-4 is deemed
excellent, with corrected alpha reliability coefficients ranging from .87-.93 for age and
.83-.93 for grade level (Hoff, Swerdlik, Sabers, & Olson, 2006). The Reading Composite
reliability coefficient is .95-.96 (Hoff, Swerdlik, Sabers, & Olson, 2006). Assessment to
determine the Reading Composite Score takes about 10-15 minutes.
PAI
The Personality Assessment Inventory (PAI; Morey, 1991) is a self-administered,
objective personality measure for adults, consisting of 344 items and requires a fourth
grade reading level. The PAI is intended for individuals 18 years o f age and older. Each
question is answered by the examinee on a Likert-type scale: (F) totally false, (ST)
slightly true, (MT) mainly true, and (VT) very true. The examinee marks his or her
answers on an answer sheet which is then hand or computer scored, based on preference
of the clinician. Internal consistency alphas for the normative population is .81, for a
college sample it is .82, and for a clinical sample, .86; for all three samples, the test retest
reliability was .83, after an interval of three to four weeks (Morey, n.d.).
The instrument’s 22 scales, listed with each corresponding acronym and number
of items for that scale, are as follows: Inconsistency (ICN/10), Infrequency (INF/8),
Negative Impression (NIM/9), Positive Impression (PIM/9), Somatic Complaints
(SOM/24), Anxiety (ANX/24), Anxiety-Related Disorder (ARD/24), Depression
(DEP/24), Mania (MAN/24), Paranoia (PAR/24), Schizophrenia (SCZ/24), Borderline
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Features (BOR/24), Antisocial Features (ANT/24), Alcohol Problems (ALC/12), Drug
Problems (DRG/12), Aggression (AGG/18), Suicidal Ideation (SUI/12), Stress (STR/8),
Nonsupport (NON/8), Treatment Rejection (RXR/8), Dominance (DOM/12), Warmth
(WRM/12). Of these 22 scales, four are validity scales, eleven are clinical scales, five are
treatment scales, and two are interpersonal scales. The scores on each scale are presented
as linear T scores with a mean of 50T and a standard deviation of 10T.
The PAI also allows calculating supplemental indexes which provide additional
treatment or validity information. There are nine supplemental indexes, which include
the following: Malingering Index (MAL), Rogers Discriminant Function (RDF),
Defensiveness Index (DEF), Cashel Discriminant Function (CDF), Estimated Alcohol
and Drug Scores (ALC Est) and (DRG Est), Suicide Potential Index (SPI), Violence
Potential Index (VPI), and Treatment Process Index (TPI). This study used the STR,
NON, RXR, DOM, BOR, and ANT scales.
Treatment Process Measure
The Treatment Process Measure (TPM), see Appendix C, is a counselor-rated
index of a patient participating in substance abuse treatment, and is comprised 14 items
divided into three scales: 1. Counseling rapport 2. Motivation 3. Self-confidence (Joe,
Simpson, Greener, & Rowan-Szal, 2004). The Treatment Process Measure was
developed by researchers at Texas Christian University, as a shorter version of a more
comprehensive assessment, The Counselor Rating Form (Texas Christian University,
Institute of Behavioral Research, n.d.), Time for completion of the TPM is very brief,
and in most cases, can be completed in three minutes or less. Each statement, about the
patient, is rated by the counselor on a seven point, Likert-type scale, anchored by 1:
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strongly disagree, and 7: strongly agree. High scores are associated with better treatment
participation on ten of the items, and low scores are associated with better treatment
participation for four of the items. The Treatment Process Measure has good
psychometric properties, described in the following paragraph (Joe, Simpson, Greener, &
Rowan-Szal, 2004).
The normative sample consisted of a sample of 547 clients enrolled in an
outpatient methadone treatment clinic in Texas. The sample was 70% male, with the
average age being 38 years old, and in regard to race, 22% were Euro-American and 67%
were Hispanic. Coefficient alphas reliabilities were calculated for each scale across
three month treatment intervals. Coefficient alpha ranges for the Counseling Rapport
Scale were ,79-.83, for the Motivation Scale, .84-.87, and .77-.79 for the Self-Confidence
Scale.
Demographic Questionnaire
The demographic questionnaire, see Appendix B, was designed to elicit standard
demographic information and other information deemed important to this study.
Standard information included age, gender, ethnicity, and education level. Additionally,
frequency and history as well as type o f substances used were asked because of the
particular relevance to this study.

Procedure
The Institutional Review Boards for the affiliated university and hospital
approved the study prior to any collection of data; see Appendices D and E. Participants
were civilly committed inpatients participating in a court-ordered substance abuse
treatment program. A convenience sample from the substance abuse unit was utilized.
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Each patient upon admission to the unit, was informed by their assigned therapist o f the
opportunity to voluntarily participate in a research study. Patients interested in
participating in the study were assigned a time to meet directly with the researcher.
Each patient was treated in accordance with the “Ethical Principles of
Psychologists and Code o f Conduct” (American Psychological Association, 2002).
The principal researcher directly provided each interested participant with the informed
consent and discussed with each, administration procedures for the study. Each patient
was guaranteed anonymity, with each participant assigned a number for identification
rather than using their name. Participants were assured results would be reported on an
aggregate basis rather than for each individual.
Before any research began, the researcher in-serviced each participating therapist
on the research study and procedures to be used. Additionally, each therapist was given
the contact information of the researcher, and asked to contact the researcher with
questions or concerns during the research process. Next, the researcher created a folder
for each participant, and assigned each participant a number. This number was included
on all forms inside the folder, including the informed consent form, demographic form,
PAI, and TPM.
Once the research process began, potential participants received and signed the
informed consent form, which verified voluntary participation in the study and also
notified participants that there were minimal risks to involvement in the study. Patients
choosing to participate were informed that results of the PAI, demographic form, and
TPM would not be shared with the treatment team or affect their treatment in any way.
Additionally, participants were informed that they were free to withdraw from

participation in the study at any time, and would not suffer penalty or influence on
treatment services if they decided to withdraw. Participants also were informed that due
to the nature of certain questions on the PAI, there would be a potential for evoking
emotional distress. Participants were directed to discuss any questions or issues that
arose with their assigned individual therapist or treatment team. The informed consent
form also provided the participants with information to contact the researcher with any
questions or concerns. Each participant was informed they could contact the researcher
at the conclusion of the study to request debriefing information that would summarize the
research findings.
Once the informed consent form was signed by the participant, the principal
researcher removed the consent form from the packet of information, and placed it in a
separate folder for signed informed consent forms, thus separating the participants’
names from the research materials used. The researcher then gave participants the
WRAT, PAI and demographic form, with only an assigned number for identification, and
assessed during a single administration. Upon completion o f the WRAT, PAI and
demographic form, the principal researcher filed these instruments in folders specific to
each document. Next, the researcher wrote the participant’s name on the top tab o f the
folder, and gave the folder to the patient’s individual therapist. The folder included a
TPM for each week the patient was enrolled in treatment, as well as envelopes to seal the
TPM in upon completion, so that other therapists or patients would not have access to the
information. Each participant’s therapist then completed one of the treatment
participation rating forms on a weekly basis according to a specified day and time,
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predetermined with the unit supervising psychologist, and placed the TPM in a sealed
envelope provided by the researcher.
Data Analysis
There were several analyses used to understand the data. First, descriptive
statistics including frequency and percentages of the following demographic variables:
age, gender, ethnicity, sexual orientation, socioeconomic status, legal charge status, and
drug of choice were calculated. Next, hypotheses one through six were analyzed using
Pearson Correlations, a statistical technique used to measure the degree and direction of a
linear relationship between two variables (Gravetter & Wallnau, 2004). Also, where
appropriate, Analysis of Variance (ANOVA) was used, a statistical technique used to
compare two or more means to see if there are non-linear differences (Tabachnik &
Fidell, 2001). Hypothesis 7 was analyzed using a multiple regression analysis, a
statistical technique used to examine and predict relationships between one dependent
variable, or criterion variable, and several independent variables, or predictor variables
(Tabachnik & Fidell, 2001).

The six predictor variables in the regression analysis were

PAI subscales as follows: STR, NON, RXR, DOM, BOR, and ANT scales. All of the
predictor variables were continuous. The criterion variable was the substance abuse
treatment participation score, based on the TPM.

CHAPTER THREE

RESULTS
The purpose of this study was to examine how personality and interpersonal
variables are related to behaviors exhibited during treatment in an intensive inpatient
substance abuse treatment program. Personality and interpersonal variables were
assessed using the Personality Assessment Inventory (Morey, 1991). Substance abuse
treatment behaviors were assessed using the Treatment Process Measure (TPM), (Joe,
Simpson, Greener, & Rowan-Szal, 2004), a brief rating scale for examining various
aspects of counselor-rated treatment participation, completed weekly. Treatment
participation was assessed based on scores on the TPM. The purpose of this chapter is to
present the results of the study. First, sample characteristics, standard deviations, and
means are presented. Next, correlations between variables are provided. Finally, where
applicable, results of the ANOVA, Tukey’s HSD post hoc test, and multiple regression
analyses are reported.

Participants
Participants consisted of inpatients at a large publically funded state hospital,
hospitalized for chemical dependency treatment. The participants consisted of males
(N=61) and females (N=45) ranging in age from 18-61 years old, who were chancerycourt committed for chemical dependency treatment. Each participant was screened prior
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to data collection to ensure a minimum of a fourth grade reading level with the WRAT-4.
All participants of the study met the fourth grade reading requirements. The mean age of
the participants was 35.2 years with a standard deviation of 10.76. In terms of ethnicity,
the overall sample consisted of 75 Caucasian Americans (70.8%), 28 African Americans
(26.4%), 1 American Indian (0.9%), 1 Biracial (0.9%), and 1 that did not indicate
ethnicity (0.9%). Demographic information of the study sample is displayed in Table 2.

Table 2.
Descriptive Statistics o f the Sample
Variables

Frequency

Percentage

Gender
Males

61

57.5

Females

45

42.5

Caucasian

75

70.8

African-American

28

26.4

Ethnicity

American-Indian

1

.9

Biracial

1

.9

Other

1

.9

Heterosexual

92

86.8

Homosexual

4

3.8

Bisexual

6

5.7

Sexual Orientation

68

Table 2. (continued)

Descriptive Statistics o f the Sample
Variables

Frequency

Other

Percentage

4

3.8

Lower

40

37.7

Middle

56

52.8

5

4.7

Yes

26

24.5

No

77

72.6

Alcohol

29

27.4

Marijuana

18

17.0

Opiates

14

13.2

Crack Cocaine

16

15.1

Cocaine

10

9.4

Methamphetamines

5

4.7

Benzodiazepines

4

3.8

Hallucinogens

1

0.9

Other prescriptions

5

4.7

Socioeconomic Status

High
Current legal charges

Drug o f Choice
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Data Analysis
The TPM is composed of 14, counselor-rated items designed to measure patient
participation in substance abuse treatment (Joe, Simpson, Greener, & Rowan-Szal, 2004).
Each statement about the patient is rated by the counselor on a seven point, Likert-type
scale, anchored by 1: strongly disagree, and 7: strongly agree. Four of the items on the
TPM are reverse scored.

For each patient, a weekly TPM was completed by the

individual therapist assigned to the patient.

Of the 106 participants, 94 had six

consecutive weeks of TPM scores completed by their therapist, however, 12 o f the
participants were discharged from treatment early due to medical illness, violence on the
unit, or a quick treatment due to previous, multiple admissions on. the unit. These
discharged patients were missing TPM scores for the last one through three weeks of
treatment.

For the missing data, mean replacement for each TPM item for each

individual was used to fill in missing data points.
For hypotheses one through seven mean scores were calculated for the available
TPM ratings for each participant, and missing data points were filled in with the mean
score for each person. Next, rather than use each o f the fourteen ratings, collected over
the course of the six weeks, a mean was calculated for each of the fourteen item ratings
for each participant. These 14 means were used for the first phase o f statistical analyses.
The means and standard deviations for the fourteen TPM ratings and the six PAI
variables assessed for this project are presented in Table 3. Additional analyses were
conducted by taking out each of the participants that did not have six total weekly ratings.
Then, the mean of the first two and last two TPM ratings were calculated and data
analysis was conducted for each of the fourteen ratings for each participant. Next, the

three subscales of the TPM were analyzed. Subscale scores were calculated by using the
mean of the first two weekly ratings and the mean of the final two weekly ratings. These
first and last means were used for the next phase o f statistical analyses. The means and
standard deviations for the first and final weekly ratings for each of the three subscales on
the TPM and the six PAI variables assessed for this project are presented in Table 4.

Table 3.
Means and Standard Deviations o f the Variables
Variables

N

Mean

SD

Min

Max

\ge

106

35.18

10.76

18.00

61.00

ifears of Education

106

12.00

2.18

6.00

20.00

Easy to talk to

106

5.64

1.22

1.00

7.00

Warm and Caring

106

5.29

1.31

1.00

7.00

Honest and sincere

106

4.52

1.10

1.00

6.00

Hostile or aggressive

106

1.94

1.05

1.00

5.17

In denial about problems

106

3.26

1.49

1.00

9.33

Motivated to recovery

106

5.00

1.24

1.50

6.83

Cooperative

106

5.41

1.09

1.00

7.00

Responsible

106

5.09

1.20

1.00

7.00

Consistently keeps
session appointments

106

5.42

1.22

1.00

7.00

Self-confident

106

4.83

1.03

2.67

7.00

Freely expresses wishes

106

5.29

1.06

2.00

7.00

1PM
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Table 3. (continued)

Means and Standard Deviations o f the Variables
N

Mean

SD

Min

Max

Depressed

106

2.90

1.19

1.00

6.17

Nervous or anxious

106

3.50

1.37

1.00

7.00

Motivated

106

4.99

1.23

1.00

7.00

Borderline

106

70.90

12.80

39

104

Antisocial

106

68.44

13.95

40

106

Stress

106

68.50

13.28

37

91

Nonsupport

106

59.33

12.22

37

91

Treatment rejection

106

33.92

9.11

20

63

Dominance

106

48.04

12.55

20

78

Variables

PAI scales

TPM means and standard deviations were calculated using the average o f six consecutive weekly ratings.
Note: N = Number o f Participants; SD = Standard Deviation; Min = Minimum; Max = Maximum

Table 4.
Means and Standard Deviations o f the Variables fo r TPM Subscales
Variables

N

Mean

SD

Counseling Rapport (First)

106

25.10

4.91

Motivation (First)

106

19.46

4.48

TPM

,
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Table 4. (continued)

Means and Standard Deviations o f the Variables fo r TPM Subscales
Variables

N

Mean

SD

Self-Confidence (First)

106

22.88

4.24

Counseling Rapport (Final)

106

27.78

5.56

Motivation (Final)

106

21.83

5.15

Self-Confidence (Final)

106

26.24

4.15

TPM means and standard deviations were calculated using the mean of the
first two weekly ratings (first) and the mean of the last two weekly ratings (final).
Note: TPM= Treatment Process Measure; N = Number of Participants; SD = Standard Deviation

For Hypothesis 7 a multiple regression analysis was conducted to examine the
relationship between TPM subscale scores and the six PAI predictor variables. Also, a
change score for the TPM subscales was calculated by subtracting the score of week 6
rating from the score of the week one rating and regression analyses were conducted to
examine the relationship between the TPM subscale change scores and the PAI
predictors. For the hypothesis testing the alpha level of .05 was used to determine
significance.

Results of Hypotheses
Hypothesis One
The first hypothesis stated that scores on the stress (STR) scale o f the PAI would
be associated with treatment participation; a significant negative correlation was
predicted between scores on the Stress scale of the PAI and individual and subscale rating
scores on the Treatment Process Measure. Pearson correlations between the grand mean
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for each of the 14 TPM item ratings and the Stress scores (higher scores indicating higher
levels o f stress and inability to control events around them) were conducted to test for
linear relationships. Further analyses were conducted to determine whether higher scores
on the STR scale were related to treatment process early and/or late over the course o f
treatment. Accordingly, Pearson correlations between the mean of the first two TPM
ratings and the STR scale were conducted. Next Pearson correlations between the mean
of the final two TPM ratings and the STR scale was conducted. Finally subscales were
analyzed, again using Pearson correlations, looking at the mean of the first two and the
mean of the final two subscale TPM ratings.
Results showed no significant relationships between the STR scale and the grand
mean TPM ratings. These results do not support the hypothesis. Pearson Correlations
are presented in Table 5.

Table 5.
Pearson Correlations Between STR Scale and TPM Items (Grand Mean)
Variables

N

r

p

Easy to talk to

106

.079

.421

Warm and caring

106

.101

.303

Honest and sincere

106

.073

.457

Hostile and aggressive

106

.054

.582

In denial about problems

106

-.049

.616

Motivated to recovery

106

.106

.280

Cooperative

106

.069

.480
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Table 5. (continued)

Pearson Correlations Between STR Scale and TPM Items (Grand Mean)
Variables

N

r

p

Responsible

106

.102

.297

Consistently keeps session appointments

106

.096

.327

Self-confident

106

.037

.709

Freely expresses wishes

106

.096

.325

Depressed

106

-.031

.749

Nervous or anxious

106

.067

.494

Motivated

106

.094

.337

Note: STR = Stress Scale on PAI; TPM= Treatment Process Measure; N = Number o f Participants;
r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed five significant relationships between the STR scale and the mean
of the first two weekly TPM ratings : “honest and sincere” (r (87) = .260, p < .01), “in
denial about problems” (r (87) = -.256, p < .01), “motivated to recovery” (r (87) = .237, p
< .05), “responsible” (r (87) = .231, p < .05), and “motivated” (r (87) = .229, p < .05).
These results provide some partial support for this hypothesis. Pearson correlations are
presented in Table 6.

Table 6.
Pearson Correlations Between STR Scale and TPM Items (Mean o f First Two Weeks)
Variables

N

r

Easy to talk to

89

.128

p

.232
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Table 6. (continued)
Pearson Correlations Between STR Scale and TPM Items (Mean o f First Two Weeks)

Variables

N

r

Warm and caring

89

.185

.083

Honest and sincere

89

-.260

.014*

Hostile and aggressive

89

-.008

.942

In denial about problems

89

-.256

.016*

Motivated to recovery

89

-.237

.025*

Cooperative

89

.134

.211

Responsible

89

-.231

.029*

Consistently keeps session appointments

89

.194

.069

Self-confident

89

.031

.773

Freely expresses wishes

89

.123

.253

Depressed

89

-.156

.144

Nervous or Anxious

89

.133

.214

Motivated

89

-.229

.031*

P

Note: STR = Stress Scale on PAI; TPM = Treatment Process Measure; N = Number o f
Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <01.

Results showed no significant relationships between the STR scale and the mean
of the last two weekly TPM ratings. These results do not support the hypothesis.
Pearson correlations are presented in Table 7.
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Table 7.
Pearson Correlations Between STR Scale and TPM Items (Mean o f Last Two Weeks)

Variables

N

r

P

Easy to talk to

89

.035

.741

Warm and caring

89

.059

.586

Honest and sincere

89

.033

.757

Hostile and aggressive

89

-.079

.461

In denial about problems

89

.080

.458

Motivated to recovery

89

.087

.419

Cooperative

89

.079

.462

Responsible

89

.076

.480

Consistently keeps session appointments

89

.083

.440

Self-confident

89

-.016

.882

Freely expresses wishes

89

.040

.713

Depressed

89

.058

.589

Nervous or Anxious

89

.123

.250

Motivated

89

.114

.286

Note: STR = Stress Scale on PAI; TPM = Treatment Process Measure; N = Number o f Participants;
r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the STR scale and the mean
of the first two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 8.
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Table 8.

Pearson Correlations Between STR Scale and TPM Subscales (Mean o f First Two
Weeks)
Subscales

N

r

p

Self-confidence

89

.180

.065

Motivation

89

.149

.129

Counseling Rapport

89

.150

.124

Note: STR = Stress Scale on PAI; TPM = Treatment Process Measure; N = Number o f Participants;
r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the STR scale and the mean
of the last two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 9.

Table 9.
Pearson Correlations Between STR Scale and TPM Subscales (Mean o f Last Two Weeks)
Subscales

N

r

p

Self-confidence

89

-.038

.697

Motivation

89

.053

.587

Counseling Rapport

89

-.007

.942

Note: STR = Stress Scale on PAI; TPM = Treatment Process Measure; N = Number o f
Participants; r - Pearson Correlation Value; p = Probability; * p < .05. **p <.01.
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Hypothesis Two
The second hypothesis stated that the scores on the nonsupport (NON) scale of
the PAI would be associated with treatment participation; a significant negative
correlation was predicated between scores on the NON scale of the PAI and individual
and subscale rating scores on the Treatment Process Measure. Pearson correlations
between the grand mean for each of the 14 TPM ratings and the NON scores (higher
scores indicating a perceived lack of social support and dissatisfaction with social
relationships) were conducted to test for linear relationships. Further analyses were
conducted to determine whether higher scores on the NON scale were related to
treatment process early and/or late over the course of treatment. Accordingly, Pearson
correlations between the mean of the first two TPM ratings and the NON scale were
conducted. Next Pearson correlations between the mean of the final two TPM ratings
and the NON were conducted. Finally subscales were analyzed, again using Pearson
correlations, looking at the mean of the first two and the mean of the final two subscale
TPM ratings.
Results showed no significant relationships between the NON scale and the grand
mean TPM ratings. These results do not support the hypothesis. Pearson Correlations
are presented in Table 10.

Table 10.
Pearson Correlations Between NON Scale and TPM Items (Grand Mean)
Variables

Easy to talk to

N

r

p

106

-.104

.287
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Table 10. (continued)
Pearson Correlations Between NON Scale and TPM Items (Grand Mean)

N

r

P

Warm and caring

106

-.130

.183

Honest and sincere

106

-.153

.118

Hostile and aggressive

106

.142

.146

In denial about problems

106

-.070

.475

Motivated to recovery

106

-.093

.344

Cooperative

106

-.104

.289

Responsible

106

-.128

.192

Consistently keeps session appointments

106

-.094

.335

Self-confident

106

-.082

.405

Freely expresses wishes

106

-.043

.662

Depressed

106

.094

.336

Nervous or anxious

106

.000

.997

Motivated

106

-.126

.199

Variables

Note: NON = Nonsupport Scale on PAI; TPM= Treatment Process Measure; N = Number o f Participants; r
= Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the NON scale and the mean
of the first two weekly TPM ratings. These results do not support the hypothesis.
Pearson correlations are presented in Table 11.
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Table 11.
Pearson Correlations Between NON Scale and TPM Items (Mean o f First Two Weeks)

N

r

P

Easy to talk to

106

-.087

.420

Warm and caring

106

-.054

.616

Honest and sincere

106

.043

.688

Hostile and aggressive

106

.010

.926

In denial about problems

106

.007

.945

Motivated to recovery

106

.047

.659

Cooperative

106

.009

.936

Responsible

106

-.011

.915

Consistently keeps session appointments

106

-.035

.744

Self-confident

106

-.054

.617

Freely expresses wishes

106

-.092

.394

Depressed

106

-.015

.885

Nervous or anxious

106

-.058

.588

Motivated

106

.016

.882

Variables

Note: NON= Nonsupport Scale on PAI; TPM= Treatment Process Measure; N = Number o f Participants;
r = Pearson Correlation Value; p = Probability; * p < -05. **p <.01.

Results showed one significant relationships between the NON scale and the
mean of the last two weekly TPM ratings: “depressed” (r (87) = .220, p < .05). These
results do not support the hypothesis. Pearson correlations are presented in Table 12.
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Table 12.
Pearson Correlations Between NON Scale and TPM Items (Mean o f Last Two Weeks)

N

r

P

Easy to talk to

106

-.174

.104

Warm and caring

106

-.126

.238

Honest and sincere

106

-.141

.187

Hostile and aggressive

106

-.068

.528

In denial about problems

106

.089

.405

Motivated to recovery

106

-039

.718

Cooperative

106

-.122

.254

Responsible

106

-.126

.238

Consistently keeps session appointments

106

-.089

.406

Self-confident

106

-.151

.158

Freely expresses wishes

106

-.144

A ll

Depressed

106

.220*

.038

Nervous or anxious

106

.046

.669

Motivated

106

-.099

.355

Variables

Note: NON - Nonsupport Scale on PAI; TPM- Treatment Process Measure; N=
Number of Participants; r = Pearson Correlation Value; p '= Probability; * p< .05. **p <.01.

Results showed no significant relationships between the NON scale and the mean
o f the first two weekly TPM subscale rating. These results do not support the hypothesis.
Pearson correlations are presented in Table 13.
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Table 13.

Pearson Correlations Between NON Scale and TPM Subscales (Mean o f First Two
Weeks)
Subscales

N

r

P

Self-confidence

89

.022

.822

Motivation

89

-.038

.702

Counseling Rapport

89

-.108

.269

Note: NON = Nonsupport Scale on PAI; TPM = Treatment Process Measure; N =
Number o f Participants; r = Pearson Correlation Value; p = Probability

Results showed no significant relationships between the NON scale and the t
of the last two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 14.

Table 14.
Pearson Correlations Between NON Scale and TPM Subscales (Mean o f Last Two
Weeks)
Subscales

N

r

Self-confidence

89

-.188

.054

Motivation

89

-.120

.220

Counseling Rapport

89

-.179

.067

P

Note: NON = Nonsupport Scale on PAI; T P M - Treatment Process Measure; N = Number o f Participants;
r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.
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Hypothesis Three
The third hypothesis stated that the scores on the treatment rejection (RXR) scale
of the PAI would be associated with treatment participation; a significant correlation was
predicted between moderate scores on the RXR scale (moderate scores associated with
differing levels of motivation toward treatment, not particularly low or high) of the PAI
and individual and subscale rating scores on the Treatment Process Measure. Pearson
correlations between the grand mean for each of the 14 TPM ratings and RXR scores
were conducted to test for linear relationships. Further analyses were conducted to
determine whether moderate scores on the RXR scale were related to treatment process
early and/or late over the course of treatment. Accordingly, PearsOn correlations between
the mean of the first two TPM ratings and the RXR scale were conducted. Next Pearson
correlations between the mean of the final two TPM ratings and the RXR scale was
conducted. Finally subscales were analyzed, again using Pearson correlations, looking at
the mean of the first two and the mean of the final two subscale TPM ratings.
Results showed ten significant relationships between the RXR scale and the mean
o f the TPM ratings: “easy to talk to” (r (104) = -.347, p < .000), “warm and caring” (r
(104) = -.325,/? < .01), “honest and sincere” (r (104) = -.261, p < .01), “motivated to
recovery” (r (104) = -.330,/? <.01), “cooperative” (r (104) = -.290,p <.01), “responsible”
(r (104) = -.327,/? < .01), “consistently keeps session appointments” (r (104) = -.399,/? <
.000), “freely expresses wishes” (r (104) = -.274, p <.01), “nervous or anxious” (r (104) =
-.210, p < .05), and “motivated” (r (104) = -.343, p <.000). Specifically, for the ten
statistically significant treatment ratings and the RXR, it appears that a negative
correlation exists; higher scores on the RXR scale are associated with lower scores on
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the TPM rating of “consistently keeps appointments,” “easy to talk to,” “motivated,”
“motivated to recovery,” “responsible,” “warm and caring,” “cooperative,” “freely
expresses wishes,” “honest and sincere,” and “nervous or anxious.” Pearson Correlations
are presented in Table 15.

Table 15.
Pearson Correlations Between RXR Scale and TPM Items (Grand Mean)
Variables

N

r

Easy to talk to

106

-.347

.000**

Warm and caring

106

-.325

.001**

Honest and sincere

106

-.261

.007**

Hostile and aggressive

106

.057

.564

In denial about problems

106

.168

.085

Motivated to recovery

106

-.330

.001**

Cooperative

106

-.290

.003**

Responsible

106

-.327

.001**

Consistently keeps session appointments

106

-.399

.000**

Self-confident

106

-.120 ,

.221

Freely expresses wishes

106

-.274

.004**

Depressed

106

-.066

.503

Nervous or anxious

106

-.210

.031*

Motivated

106

-.343

.000**

P

Note: RXR = Treatment Rejection Scale on PAI; TPM = Treatment Process Measure; N = Number o f
Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.
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Treatment rejection was broken into three groups: low scorers, middle scorers,
and high scorers, each group approximately a third of the sample. Next a One-Way
ANOVA was conducted to compare group means in treatment ratings to test for non
linear differences. In the case of a significant overall model, Tukey’s HSD was used to
determine which means were significant.
Results of the One-Way ANOVA indicated two significant differences, with the
TPM variables, “consistently keeps session appointments,” and “nervous or anxious.”
The ANOVA results are presented in Table 16.

Table 16.
Analysis o f Variance (ANOVA) for RXR o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)
Variables

N

Mean

SD

Easy to talk to
Low

34

5.85

.85

Middle

27

5.90

1.12

High

45

5.32

1.44

Warm and caring
Low

34

5.52

1.00

Middle

27

5.52

1.28

High

45

4.99

1.48

Honest and sincere
Low

34

4.57

.84

F

P

2.777

.067

2.233

.112

1.843

.164
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Table 16. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

N

Mean

SD

Middle

27

4.81

1.05

High

45

4.31

1.26

Hostile and aggressive
Low

34

1.96

1.14

Middle

27

1.91

.84

High

45

1.93

1.11

In denial about problems
Low

34

3.09

1.26

Middle

27

3.13

1.43

High

45

3.46

1.68

Motivated to recovery
Low

34

5.12

.90

Middle

27

5.11

1.15

High

45

4.61

1.45

Cooperative
Low

34

5.61

.79

Middle

27

5.56

1.18

High

45

5.18

1.21

F

P

.012

.988

.716

.491

2.201

.116

1.841

.164
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Table 16. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

N

Mean

SD

Responsible
Low

34

5.29

.87

Middle

27

5.27

1.25

High

45

4.84

1.36

Consistently keeps session appointments
Low

34

5.80

.76

Middle

27

5.51

1.25

High

45

5.08

1.40

Self-confident
Low

34

4.77

1.05

Middle

27

5.01

1.02

High

45

4.77

1.04

Freely expresses wishes
Low

34

5.46

.85

Middle

27

5.44

1.20

High

45

5.06

1.11

Depressed
Low

34

2.97

1.13

Middle

27

2.78

1.10

F

P

1.761

A ll

3.706

.028*

.529

.591

1.772

.175

.188

.829
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Table 16. (continued)
Analysis o f Variance (ANOVA) for RXR o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

High

N

Mean

SD

45

2.93

1.30

Nervous or anxious
Low

34

3.99

1.23

Middle

27

3.39

1.39

High

45

3.20

1.39

Motivated
Low

34

5.26

.92

Middle

27

5.15

1.17

High

45

4.69

1.42

F

P

3.471

.035*

2.507

.086

Note: RXR = Treatment Rejection Scale on PAI; N = Number in Group; M = Mean; SD = Standard
Deviation; F = F ratio o f ANOVA; p = Probability; * p < -05.

A subsequent Tukey HSD was performed to compare each variable between
groups in order to find the variables with the greatest amount of variance. The results of
the Tukey HSD are presented in Table 17. Tukey post-hoc comparisons of the three
groups for “consistently keeps session appointments,” indicate that the low group (M=
5.80,95% C l [5.54,6.07]) and the high group (M = 5.08,95% C/[5.02, 6.01]),/? = .029
are significantly different. Comparisons between the middle group (M= 5.51, 95% C l
[4.66,5.50]) and the other two groups were not statistically significant a tp < .05. Tukey

post-hoc comparisons o f the three groups for “nervous or anxious,” indicate that the low
group { M - 3.99,95% C l [3.56,4.41]) and the high group (M= 3.20, 95% C l [2.84,
3.94]),/? = .029 are statistically significant compared to the middle group. Comparisons
between the middle group (M ~ 3.39,95% C l [2.84, 3.94]) and the other two groups were
not statistically significant at p < .05. These results provide additional information to the
Pearson correlations that indicated significant differences in RXR and TPM ratings;
however, overall, Hypothesis 3 was not supported.

Table 17.
Group Score Differences for RXR Levels on the TPM with Tukey HSD Comparison
(Grand Mean)
Item

Low
Mean [Cl]

Middle
Mean [Cl]

High
Mean [Cl]

Consistently keeps session
appointments

5.80 [5.54, 6.07]*

5.51 [5.02, 6.01]

5.08 [4.66, 5.50]*

Nervous or anxious

3.99 [3.56,4.41]*

3.39 [2.84, 3.94

3.20 [2.78,3.61]*

Note: Groups were determined based on three groups: low scorers, middle scorers, and high scorers, each
group approximately a third o f the sample. C l - Confidence Interval; numbers in brackets are 95%
confidence intervals o f the means. *p < .05

Results showed ten significant relationships between the RXR scale and the mean
of the first two weekly TPM ratings : “easy to talk to” (r (87) = -.256, p < .05), “warm
and caring” (r (87) = -.329, p < .01), “honest and sincere” (r (87) = -.310,p < .01), “in
denial about problems” (r (87) = .221, p < .05), “motivated to recovery” (r (87) = -.428,/?
< .000), “cooperative” (r (87) = -.21%, p < .01), “responsible” (r (87) = -.308,/? < .05),
“consistently keeps session appointments” (r (87) = -.459, p < .000), “freely expresses
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wishes” (r (87) = -.298,/? < .01), and “motivated” (r (87) = -.404,/? < .000). Pearson
correlations are presented in Table 18.

Table 18.
Pearson Correlations Between RXR Scale and TPM Items (Mean o f First Two Weeks)
Variables

N

r

Easy to talk to

89

-.256

.016*

Warm and caring

89

-.329

.002**

Honest and sincere

89

-.310

.003**

Hostile and aggressive

89

.056

.602

In denial about problems

89

.227

.032*

Motivated to recovery

89

-.428

.000**

Cooperative

89

-.278

.008**

Responsible

89

-.308

.003**

Consistently keeps session appointments

89

-.459

.000**

Self-confident

89

-.162

.129

Freely expresses wishes

89

-.298

.005**

Depressed

89

.026

.807

Nervous or anxious

89

-.103

.335

Motivated

89

-.404

.000**

P

Note: RXR = Treatment Rejection Scale on PAI; TPM = Treatment Process Measure; N = Number o f
Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <01.
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Treatment rejection was broken into three groups: low scorers, middle scorers,
and high scorers, each group approximately a third of the sample. Next a One-Way
ANOVA was conducted to compare group means in treatment ratings to test for non
linear differences. In the case of a significant overall model, Tukey’s HSD was used to
determine which means were significant.
Results o f the One-Way ANOVA indicated five significant differences, with the
TPM variables, “warm and caring,” “motivated to recovery,” “consistently keeps session
appointments,” and “freely expresses wishes,” and “motivated.” The ANOVA results are
presented in Table 19.

Table 19.
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f First Two Weeks)
Variables

N

Mean

SD

Easy to talk to
Low

29

5.66

1.12

Middle

33

5.55

1.24

High

27

5.06

1.42

Warm and caring
Low

29

5.29

1.16

Middle

33

5.27

1.17

High

27

4.52

1.57

Honest and sincere

F

P

1.79

.173

3.27

.043*

1.90

.156
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Table 19. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f First Two Weeks)

Variables

N

Mean

SD

Low

29

4.71

1.28

Middle

33

4.70

1.45

High

27

4.07

1.45

Hostile and aggressive
Low

29

2.22

1.61

Middle

33

2.09

1.33

High

27

2.28

1.51

In denial about problems
Low

29

3.28

1.41

Middle

33

3.80

1.68

High

27

3.74

1.65

Motivated to recovery
Low

29

4.91

1.00

Middle

33

4.67

1.39

High

27

3.83

1.44

Cooperative
Low

29

5.48

5.48

Middle

33

5.42

5.42

High

27

4.85

5.27

F

P

.130

.879

.977

.381

5.344

.006**

2.814

.066
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Table 19. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f First Two Weeks)

Variables

N

Mean

SD

Responsible
Low

29

4.90

0.91

Middle

33

5.06

1.31

High

27

4.37

1.27

Consistently keeps session appointments
Low

29

5.48

0.86

Middle

33

5.41

1.35

High

27

4.39

1.36

Self-confident
Low

29

4.45

1.25

Middle

33

4.45

1.36

High

27

4.11

1.15

Freely expresses wishes
Low

29

5.09

1.07

Middle

33

5.20

1.32

High

27

4.35

1.26

Depressed
Low

29

3.03

1.29

Middle

33

3.45

1.37

F

P

2.689

.074

7.077

.001**

.685

.507

3.996

.022*

.912

.406
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Table 19. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f First Two Weeks)

Variables

High

N

Mean

SD

27

3.07

1.42

Nervous or anxious
Low

29

3.80

1.50

Middle

33

3.74

1.50

High

27

3.13

1.09

Motivated
Low

29

4.88

1.01

Middle

33

4.94

1.26

High

27

4.02

1.41

F

P

1.989

.143

4.922

.009**

Note: RXR = Treatment Rejection Scale on PAI; N - Number in Group; M = Mean; SD = Standard
Deviation; F - F ratio of ANOVA; p = Probability; * p < .05. **p <.01.

A subsequent Tukey HSD was run to compare each variable between groups in
order to find the variables with the greatest amount of variance. The results of the Tukey
HSD are presented in Table 20. Tukey post-hoc comparisons of the three groups for
“warm and caring,” indicate that the low group (M =5.29, 95% C l [4.86, 5.73]) and the
high group (M=4.52, 95% C l [3.90,5.14]) are not significantly different a tp <.05.
Comparisons between the middle group (A/=5.27, 95% C l [4.86, 5.69]) and the low and
high groups were not significantly different at p <.05. Tukey post-hoc comparisons o f

the three groups for “motivated to recovery,” indicate that the low group (M =4.91, 95%
C l [4.53, 5.29]) and the high group (M =3.83, 95% C l [3.26, 4.40]) are significantly
different,/? =.007. Comparisons between the middle group (A/=4.67, 95% C l [4.17,
5.16]) and the high group (M =3.83, 95% C l [3.26,4.40]) are significantly different,/? =
.039. Comparisons of the low group and the middle group were not statistically
significant at/? < .05. Tukey post-hoc comparisons of the three groups for “consistently
keeps session appointments,” indicate that the low group (Af =5.48, 95% C l [5.16, 5.81])
and the high group (M =4.39, 95% C l [3.85,4.93]) are significantly different,/? =.003.
Comparisons between the middle group (A/=5.41, 95% C l [4.93, 5.89]) and the high
group are significantly different,/? = .005. Comparisons of the low group and the middle
group were not statistically significant at/? < .05. Tukey post-hoc comparisons of the
three groups for “freely expresses wishes,” indicate that the middle group (Af =5.20, 95%
C l [4.73, 5.67]) and the high group (Af =4.35, 95% C l [3.85, 4.85]) are statistically
significant,/? = .025. Comparisons between the low group (Af=5.09, 95% C l [4.68,
5.49]) to the middle and high group were not statistically significant at/? < .05. Tukey
post-hoc comparisons of the three groups for “motivated,” indicate that the low group (Af
= 4.88, 95% C l [4.49, 5.27]) and the high group (Af=4.02,95% C l [3.46,4.58]) are
statistically significant different, p = .029. Comparisons of the middle group (Af= 4.94,
95% C l [4.49, 5.39]) and high group were significantly different,/? = .014. Comparisons
between the low group and the high group were not statistically significant at/? < .05.
These results provide additional information to the Pearson correlation that indicated
significant differences in RXR and TPM ratings; however, overall, Hypothesis 3 was not
supported. Tukey’s post-hoc comparison information is presented in Table 20.
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Table 20.

Group Score Differences fo r RXR Levels on the TPM with Tukey HSD Comparison
(Mean o f first Two Weeks)
Item

Low
Mean [Cl]

Middle
Mean [Cl]

High
Mean [Cl]

Warm and caring

5.29 [4.86, 5.73]

5.27 [4.86, 5.69]

4.52 [3.90,5.14]

Motivated to recovery

4.91 [4.53, 5.29]*

4.67 [4.17, 5.16]*

3.83 [3.26,4.40]*

Consistently keeps session
Appointments

5.48 [5.16, 5.81]*

5.41 [4.93, 5.89]*

4.39 [3.85, 4.93]

Freely expresses wishes

5.09 [4.68, 5.49]

5.20 [4.73, 5.67]*

4.35 [3.85, 4.85]*

Motivated

4.88 [4.49, 5.27]

4.94 [4.49, 5.39]*

4.02 [3.46,4.58]*

Note: Groups were determined based on three groups: low scorers, middle scorers, and high scorers, each
group approximately a third o f the sample. C7= Confidence Interval; numbers in brackets are 95%
confidence intervals o f the means. *p < .05

Results showed ten significant relationships between the RXR scale and the mean
o f the last two weekly TPM ratings : “easy to talk to” (r (87) = -.352, p < .01), “warm and
caring” (r (87) = -.312,/? < .01), “honest and sincere” (r (87) = -.239,/? < .05), “motivated
to recovery” (r (87) = -.235,/? < .05), “cooperative” (r (87) = -.307,/? = .01),
“responsible” (r (87) = -.345,/? < .01), “consistently keeps session appointments” (r (87)
= -.390, p < .000), “freely expresses wishes” (r (87) = -.379, p < .000), “nervous or
anxious” (r (87) = -.232, p < .05), and “motivated” (r (87) = -.307,/?<= .01). Pearson
correlations are presented in Table 21.

97

Table 21.
Pearson Correlations Between RXR Scale and TPM Items (Mean o f Last Two Weeks)

Variables

N

r

Easy to talk to

89

-.352

.001**

Warm and caring

89

-.312

.003**

Honest and sincere

89

-.239

.024*

Hostile and aggressive

89

.104

.333

In denial about problems

89

-.026

.809

Motivated to recovery

89

-.235

.027*

Cooperative

89

-.307

.003**

Responsible

89

-.345

.001**

Consistently keeps session appointments

89

-.390

.000**

Self-confident

89

-.170

.111

Freely expresses wishes

89

-.379

.000**

Depressed

89

-.124

.246

Nervous and anxious

89

-.232

.029*

Motivated

89

-.307

.003**

P

Note: RXR = Treatment Rejection Scale on PAI; TPM= Treatment Process Measure; N = Number o f
Participants; r = Pearson Correlation Value; p - Probability; * p < .05. **p <.01.

Treatment rejection was broken into three groups: low scorers, middle scorers,
and high scorers, each group approximately a third of the sample. Next a One-Way
ANOVA was conducted to compare group means in treatment ratings to test for non-
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linear differences. In the case of a significant overall model, Tukey’s HSD was used to
determine which means were significant.
Results of the One-Way ANOVA indicated three significant differences, with the
TPM variables, “consistently keeps session appointments,” “freely expresses wishes,”
and “nervous or anxious.” The ANOVA results are presented in Table 22.

Table 22.
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f Last Two Weeks)
Variables

N

Mean

SD

Easy to talk to
Low

29

5.98

1.00

Middle

33

5.92

1.24

High

27

5.24

1.75

Warm and caring
Low

29

5.71

1.24

Middle

33

5.73

1.47

High

27

4.94

1.90

Honest and sincere
Low

29

5.19

1.40

Middle

33

5.48

1.56

High

27

4.74

1.85

Hostile and aggressive

F

P

2.626

.078

2.355

.101

1.598

.208

.046

.955
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Table 22. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f Last Two Weeks)

N

Mean

SD

Low

29

1.67

1.11

Middle

33

1.76

1.17

High

27

1.74

1.16

Variables

In denial about problems
Low

29

3.14

1.86

Middle

33

2.95

1.88

High

27

2.46

1.66

Motivated to recovery
Low

29

5.31

1.39

Middle

33

5.47

1.46

High

27

4.80

1.76

Cooperative
Low

29

5.78

1.11

Middle

33

5.67

1.32

High

27

5.07

1.66

Responsible
Low

29

5.69

1.09

Middle

33

5.64

1.40

High

27

4.85

1.81

F

P

1.035

.360

1.513

,226

2.118

.127

2.992

.055
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Table 22. (continued)
Analysis o f Variance (ANOVA) for RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f Last Two Weeks)

Variables

N

Mean

SD

Consistently keeps session appointments
Low

29

6.09

.96

Middle

33

5.73

1.31

High

27

5.07

1.93

Self-confident
Low

29

5.31

1.22

Middle

33

5.56

.90

High

27

5.11

1.36

Freely expresses wishes
Low

29

5.98

.77

Middle

33

5.64

1.23

High

27

5.07

1.45

Depressed
Low

29

2.79

1.51

Middle

33

2.73

1.65

High

27

2.28

1.59

Nervous or anxious
Low

29

4.02

1.82

Middle

33

3.45

1.78

F

P

3.575

.032*

1.131

.327

4.192

.018*

.871

.422

3.191

.046*
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Table 22. (continued)

Analysis o f Variance (ANOVA) for RXR o f Low Scorers, Middle Scorers, and High
Scorers (Mean o f Last Two Weeks)
Variables

High

N

Mean

SD

27

2.81

1.74

Motivated
Low

29

5.55

1.14

Middle

33

5.36

1.49

High

27

4.93

1.79

F

P

1.302

.277

Note: RXR = Treatment Rejection Scale on PAI; N = Number in Group; M = Mean; SD = Standard
Deviation; F = F Ratio o f ANOVA; p - Probability; * p < .05.

A subsequent Tukey HSD was run to compare each variable between groups in
order to find the variables with the greatest amount of variance. Tukey post-hoc
comparisons of the three groups for “consistently keeps session appointments,” indicate
that the low group (M=6.09,95% C l [5.73,6.45]) and the high group (M =5.07, 95% Cl
[4.31,5.84]) are significantly different, p = .026. Comparisons between the middle group
(M =5.73,95% C l [5.26, 6.19]) and the other two groups were not statistically significant
at p < .05. Tukey post-hoc comparisons of the three groups for “freely expresses
wishes,” indicate that the low group (M=5.98, 95% C l [5.69,6.28]) and the high group
(M =5.07, 95% C l [4.50, 5.65]) are statistically different, p= .014. Comparisons
between the middle group middle group ( M - 5.64, 95% C l [5.20, 6.07]) and the other
two groups were not statistically significant at p < .05. Tukey post-hoc comparisons of
the three groups for “nervous and anxious,” indicate that the low group (M = 4.02, 95%

C l [3.33,4.71]) and the high group (M = 2.81,95% C l [2.12, 3.50]) are statistically
significant,p = .035. Comparisons between the middle group (M= 3.45,95% C l [2.82,
4.09]) and the other two groups were not statistically significant at/? < .05. These results
provide additional information to the Pearson correlations that indicated significant
differences in RXR and TPM ratings, however, overall, Hypothesis 3 was not supported.
Tukey’s post-hoc comparison information is presented in Table 23.

Table 23.
Group Score Differences for RXR Levels on the TPM with Tukey HSD Comparison
(Subscale Mean o f Last Two Weeks)
Item

Low
Mean [Cl]

Middle
Mean [Cl]

High
Mean [Cl]

Consistently keeps session
Appointments

6.09 [5.73,6.45]*

5.73 [5.26,6.19]

5.07 [4.31, 5.84]

Freely expresses wishes

5.98 [5.69,6.28]*

5.64 [5.20,6.07]

5.07 [4.50, 5.65]*

Nervous or anxious

4.02 [3.33,4.71]*

3.45 [2.82,4.09]

2.81 [2.12, 3.50]*

Note: Groups were determined based on three groups: low scorers, middle scorers, and high scorers, each
group approximately a third o f the sample. C l = Confidence Interval; numbers in brackets are 95%
confidence intervals o f the means. *p < .05

Results showed two significant relationships between the RXR scale and the
mean of the first two weekly TPM subscale ratings: “motivation” (r (104) = -.342,/? <
.000), and “counseling rapport” (r (104) = -.289,/? < .01). Pearson correlations are
presented in Table 24.
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Table 24.
Pearson Correlations Between RXR Scale and TPM Subscale Items (Mean o f First Two
Weeks)

Variables

N

r

P

Self-confidence

106

-.175

.073

Motivation

106

-.342

.000**

Counseling rapport

106

-.289

.003**

Note: RXR - Treatment Rejection Scale on PAI; TPM= Treatment Process Measure; N = Number o f
Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Treatment rejection was broken into three groups; low scorers, middle scorers,
and high scorers, each group approximately a third of the sample. Next a One-Way
ANOVA was conducted to compare group means in treatment ratings to test for non
linear differences. In the case o f a significant overall model, Tukey’s HSD was used to
determine which means were significant.
Results of the One-Way ANOVA indicated one significant difference, with the
TPM subscale variable, “motivated.” The ANOVA results are presented in Table 25.

Table 25.
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Subscales, Mean o f First Two Weeks)
Variables

N

Mean

SD

Self-confidence
Low

F

.403
34

4.62

.97

p

.669
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Table 25. (continued)
Analysis o f Variance (ANOVA) fo r RXR o f Low Scorers, Middle Scorers, and High
Scorers (Subscales, Mean o f First Two Weeks)

Variables

N

Mean

SD

Middle

40

4.63

.81

High

32

4.46

.77

Motivation
Low

34

5.11

.75

Middle

40

4.98

1.24

High

42

4.46

1.21

Counseling rapport
Low

34

5.17

.92

Middle

40

5.09

1.01

High

32

4.78

1.00

F

p

3.309

.040*

1.49

.233

Note: RXR = Treatment Rejection Scale on PAI; N = Number in Group; M - Mean; SD = Standard
Deviation; F = F Ratio o f ANOVA; p = Probability; * p < .05.

A subsequent Tukey HSD was run to compare each variable between groups in
order to find the variables with the greatest amount of variance. Tukey post-hoc
comparisons of the three groups for “motivated,” indicate that the low group (M =5.11,
95% C l [4.85, 5.37]) and the high group (M = 4.46,95% C l [4.02,4.89]) are significantly
different,/? = .045. Comparisons between the middle group (M= 4.98, 95% C l [4.59,
5.38]) and the other two groups were not statistically significant at/7 < .05. These results
provide additional information to the Pearson correlations that indicated significant
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differences in RXR and TPM ratings, however, overall, Hypothesis 3 was not supported.
Tukey’s post-hoc comparison information is presented in Table 26.

Table 26.
Group Score Differences fo r RXR Levels on the TPM with Tukey HSD Comparison
(Subscale Mean o f First Two Weeks)
Item

Motivation

Low
Mean [Cl]
5.11 [4.85,5.37]*

Middle
Mean [Cl]
4.98 [4.59, 5.38]

High
Mean [Cl]
4.46 [4.02,4.89]*

Note: Groups were determined based on three groups: low scorers, middle scorers, and high scorers, each
group approximately a third o f the sample. C l = Confidence Interval; numbers in brackets are 95%
confidence intervals o f the means. *p < .05

Results showed two significant relationships between the RXR scale and the
mean of the last two weekly TPM subscale ratings: “motivation” (r (104) - -.301, p <
.01), and “counseling rapport” (r (104) = -.208, p < .05). Pearson correlations are
presented in Table 27.
Treatment rejection was broken into three groups: low scorers, middle scorers,
and high scorers, each group approximately a third of the sample. Next a One-Way
ANOVA was conducted to compare group means in treatment ratings to test for non
linear differences. In the case of a significant overall model, Tukey’s HSD was used to
determine which means were significant.
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Table 27.
Pearson Correlations Between RXR Scale and TPM Subscale Items (Mean o f Last Two

Weeks)
Variables

N

r

p

Self-confidence

106

-.102

.298

Motivation

106

-.301

.002**

Counseling Rapport

106

-.208

.033*

Note: RXR = Treatment Rejection Scale on PAT, TPM = Treatment Process Measure; N = Number o f
Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results of the One-Way ANOVA indicated no significant difference, with the
TPM subscale variables. The ANOVA results are presented in Table 28.

Table 28.
Analysis o f Variance (ANOVA) for RXR o f Low Scorers, Middle Scorers, and High
Scorers (Subscales, Mean o f Last Two Weeks)
Variables

N

Mean

SD

Self-confidence
Low

28

5.19

.84

Middle

33

5.28

.93

High

27

5.20

.94

Motivation
Low

28

5.71

.97

Middle

33

5.63

1.32

F

p

.076

.927

2.59

.081

107

Table 28. (continued)
Analysis o f Variance (ANOVA) for RXR o f Low Scorers, Middle Scorers, and High
Scorers (Subscales, Mean o f Last Two Weeks)

Variables

High

N

Mean

SD

27

4.95

1.74

Counseling rapport
Low

28

5.60

.98

Middle

33

5.68

1.23

High

27

5.34

1.39

F

P

.618

.542

Note: RXR = Treatment Rejection Scale on PAI; N ~ Number in Group; M - Mean; SD = Standard
Deviation; F = F Ratio o f ANOVA; p = Probability; * p < .05.

Hypothesis Four
The fourth hypothesis stated that the scores on the dominance (DOM) scale o f the
PAI would be associated with treatment participation; a significant relationship was
predicated between moderate scores on the DOM (moderate scores indicating an ability
to adapt to different situations with the ability to both exert and relinquish control in
interpersonal relationships) of the PAI and individual and subscale rating scores on the
Treatment Process Measure. Pearson correlations between the grand mean for each of
the 14 TPM ratings and DOM scores were conducted to test for linear relationships.
Further analyses were conducted to determine whether moderate scores on the DOM
scale were related to treatment process early and/or late over the course of treatment.
Accordingly, Pearson correlations between the mean of the first two TPM ratings and the
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DOM scale were conducted. Next, Pearson correlations between the mean of the final
two TPM ratings and the RXR scale was conducted. Finally subscales were analyzed,
again using Pearson correlations, looking at the mean of the first two and the mean of the
final two subscale TPM ratings. Next, a One-Way ANOVA was then used to compare
group means with treatment ratings, to test for non-linear relationships. Also, Pearson
correlations between the mean of the first two and the mean of the final two subscale
TPM ratings were calculated.
Results showed one significant correlation between the DOM scale and the
individual mean TPM ratings: “motivated to recovery” (r (104) = -.191, p < .05). It
appears that a negative correlation exists; higher scores on the DOM scale is associated
with lower scores on “motivated to recovery.” Pearson correlations are presented in
Table 29.

Table 29.
Pearson Correlations Between DOM Scale and TPM Items (Grand Mean)
Variables

N

r

P

Easy to talk to

106

-.156

.110

Warm and caring

106

-.176

.072

Honest and sincere

106

-.122

.214

Hostile and aggressive

106

.134

.170

In denial about problems

106

.071

A ll

Motivated to recovery

106

-.191

.049*

Cooperative

106

-.144

.142
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Table 29. (continued)
Pearson Correlations Between DOM Scale and TPM Items (Grand Mean)

Variables

N

r

p

-.143

.143

Consistently keeps session appointments

106

-.132

.177

Self-confident

106

.070

.479

Freely expresses wishes

106

-.015

.878

Depressed

106

-.066

.503

Nervous or anxious

106

-.032

.748

Motivated

106

''O
r—
4

.102

o

106

r

Responsible

Note: D O M = Dominance Scale on PAI; TPM -Treatment Process Measure; N = Number o f Participants; r
= Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Next, the DOM scores were broken into three groups: low scorers, middle scorers,
and high scorers, each group approximately one-third of the sample. A One-Way
ANOVA was then used to compare group means with treatment ratings, to test for non
linear relationships.

Results of the One-Way ANOVA indicated no significant

differences, with the TPM variables. This result does not support Hypothesis 4. Results
are presented in Table 30.
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Table 30.
Analysis o f Variance (ANOVA) for DOM o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

N

Mean

SD

Easy to talk to
Low

32

5.84

.86

Middle

34

5.59

1.37

High

40

5.52

1.33

Warm and caring
Low

32

5.48

1.12

Middle

34

5.35

1.36

High

40

5.10

1.40

Honest and sincere
Low

32

4.51

.84

Middle

34

4.53

1.33

High

40

4.52

1.09

Hostile and aggressive
Low

32

1.66

.94

Middle

34

2.04

1.11

High

40

2.06

1.07

F

P

.658

.520

.825

.441

.004

.996

1.584

.210

I ll

Table 30. (continued)
Analysis o f Variance (ANOVA) for DOM ofLow Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

N

Mean

SD

In denial about problems
Low

32

3.04

1.31

Middle

34

3.49

1.67

High

40

3.24

1.47

Motivated to recovery
Low

32

5.09

1.13

Middle

34

4.87

1.21

High

40

4.78

1.35

Cooperative
Low

32

5.55

.97

Middle

34

5.34

1.22

High

40

5.37

1.09

Responsible
Low

32

5.21

1.05

Middle

34

5.02

1.27

High

40

5.06

1.28

Consistently keeps session appointments
Low

32

5.51

1.10

Middle

34

5.48

1.11

F

P

.734

.482

.571

.567

.351

.705

.228

.796

.295

.745
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Table 30. (continued)
Analysis o f Variance (ANOVA) for DOM o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

High

N

Mean

SD

40

5.30

1.41

Self-confident
Low

32

4.71

1.13

Middle

34

4.80

1.03

High

40

4.96

.97

Freely expresses wishes
Low

32

5.19

1.04

Middle

34

5.47

1.02

High

40

5.21

1.12

Depressed
Low

32

2.99

1.10

Middle

34

3.02

1.10

High

40

2.73

1.33

Nervous or anxious
Low

32

3.74

1.39

Middle

34

3.47

1.44

High

40

3.33

1.30

Motivated
Low

32

5.15

1.07

F

P

.516

.598

.740

.479

.684

.507

.790

.457

.390

.678
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Table 30. (continued)
Analysis o f Variance (ANOVA) fo r DOM o f Low Scorers, Middle Scorers, and High
Scorers (Grand Mean)

Variables

N

Mean

SD

Middle

34

4.96

1.26

High

40

4.89

1.35

F

p

Note: D O M = Dominance Scale on PAI; N - Number in Group; M = Mean; SD = Standard Deviation; F = F ratio of
ANOVA; p = Probability; * p < .05.

Results showed no significant relationships between the DOM scale and the mean of the
first two weekly TPM ratings. These results show no support for this hypothesis. Pearson
correlations are presented in Table 31.

Table 31.
Pearson Correlations Between DOM Scale and TPM Items (Mean o f First Two
Weeks)
Variables

N

r

p

Easy to talk to

106

-.090

.110

Warm and caring

106

-.138

.072

Honest and sincere

106

-.018

.214

Hostile and aggressive

106

.110

.170

In denial about problems

106

-.014

.472

Motivated to recovery

106

-.107

.049

Cooperative

106

-.008

.142
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Table 31. (continued)
Pearson Correlations Between DOM Scale and TPM Items (Mean o f First Two
Weeks)

Variables

N

r

p

Responsible

106

.024

.143

Consistently keeps session appointments

106

-.062

.177

Self-confident

106

.125

.479

Freely expresses wishes

106

.006

.878

Depressed

106

-.050

.503

Nervous or anxious

106

-.031

.748

Motivated

106

-.110

.102

Note: D O M - Dominance Scale on PAI; TPM = Treatment Process Measure; N = Number o f Participants; r
= Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the DOM scale and the mean
of the last two weekly TPM ratings. These results show no support for this hypothesis.
Pearson correlations are presented in Table 32.

Table 32.
Pearson Correlations Between DOM Scale and TPM Items (Mean o f Last Two
Weeks)
Variables

N

r

p

Easy to talk to

106

-.140

.192

Warm and caring

106

-.122

.255
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Table 32. (continued)
Pearson Correlations Between DOM Scale and TPM Items (Mean o f Last Two
Weeks)

Variables

N

r

P

Honest and sincere

106

-.129

.229

Hostile and aggressive

106

.011

.921

In denial about problems

106

.058

.589

Motivated to recovery

106

-.177

.096

Cooperative

106

-.164

.124

Responsible

106

-.144

.177

Consistently keeps session appointments

106

-.115

.282

Self-confident

106

.040

.711

Freely expresses wishes

106

-.082

.443

Depressed

106

.006

.959

Nervous or anxious

106

.000

1.00

Motivated

106

-.070

.513

Note: DOM = Dominance Scale on PAI; T P M - Treatment Process Measure; N = Number o f Participants; r
= Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the DOM scale and the mean
of the first two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 33.
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Table 33.
Pearson Correlations Between DOM Scale and TPM Subscale Variables (Mean o f First
Two Weeks)

Self-confidence

106

.028

.775

Motivation

106

-.152

.121

Counseling Rapport

106

Note: D O M = Dominance Scale on PAI; TPM= Treatment Process Measure; N
r = Pearson Correlation Value; p = Probability; * p < .05. **p <01.

p

M
"*
o4*

r

'O

N

1

Variables

=Number o f Participants;

Results showed no significant relationships between the DOM scale and the mean
of the last two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 34.

Table 34.
Pearson Correlations Between DOM Scale and TPM Subscale Variables (Mean o f Last
Two Weeks)
Variables

N

r

Self-confidence

106

-.019

.850

Motivation

106

-.149

.126

Counseling Rapport

106

-.113

.249

P

Note: D O M = Dominance Scale on PAI; TPM= Treatment Process Measure; N = Number o f Participants; r
= Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

117

Hypothesis Five
The fifth hypothesis stated that the scores on the borderline (BOR) scale of the
PAI would be associated with treatment participation; a significant negative correlation
was predicted between scores on the Borderline scale of the PAI and individual and
subscale rating scores on the Treatment Process Measure. Pearson correlations between
the grand mean for each of the 14 TPM ratings and the BOR scores (high scores
indicating emotional instability ranging from being moody to angry and impulsive) were
conducted to test for linear relationships. Further analyses were conducted to determine
whether higher scores on the BOR scale were related to treatment process early and/or
late over the course of treatment. Accordingly, Pearson correlations between the mean of
the first two TPM ratings and the BOR scale were conducted. Next, Pearson correlations
between the mean of the final two TPM rating and the BOR scale was conducted. Finally
subscales were analyzed, again using Pearson correlations, looking at the mean of the
first two and the mean of the final two subscale TPM ratings.
Results showed no significant relationships between the BOR scale and the grand
mean TPM ratings. These reports do not support this hypothesis. Pearson correlations
are presented in Table 35.

Table 35.
Pearson Correlations Between BOR Scale and TPM Items (Grand Mean)
Variables

N

r

p

Easy to talk to

106

.017

.862

Warm and caring

106

.058

.557
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Table 35. (continued)
Pearson Correlations Between BOR Scale and TPM Items (Grand Mean)

Variables

N

r

P

Honest and sincere

106

-.071

.471

Hostile and aggressive

106

-.006

.953

In denial about problems

106

-.026

.794

Motivated to recovery

106

.067

.498

Cooperative

106

-.019

.848

Responsible

106

-.006

.948

Consistently keeps session appointments

106

.060

.543

Self-confident

106

-.066

.502

Freely expresses wishes

106

.078

.424

Depressed

106

-.004

.967

Nervous or anxious

106

.134

.171

Motivated

106

.029

.767

Note: BOR = Borderline Scale on PAI; TPM ~ Treatment Process Measure; N =Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the BOR scale and the mean
of the first two weekly TPM ratings. These results do not support this hypothesis.
Pearson correlations are presented in Table 36.
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Table 36.
Pearson Correlations Between BOR Scale and TPM Items (Mean o f First Two Weeks)

Variables

N

r

P

Easy to talk to

106

-.002

.983

Warm and caring

106

.068

.524

Honest and sincere

106

.083

.442

Hostile and aggressive

106

-.059

.583

In denial about problems

106

-.123

.251

Motivated to recovery

106

.173

.105

Cooperative

106

.061

.572

Responsible

106

.035

.747

Consistently keeps session appointments

106

.137

.201

Self-confident

106

-.001

.994

Freely expresses wishes

106

.134

.210

Depressed

106

-.090

.402

Nervous or anxious

106

.002

.982

Motivated

106

.116

.280

Note: BOR = Borderline Scale on PAI; TPM= Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p= Probability; * p < .05. **p <.01.

Results showed no significant relationships between the BOR scale and the mean
o f the last two weekly TPM ratings. These results do not support this hypothesis.
Pearson correlations are presented in Table 37.
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Table 37.
Pearson Correlations Between BOR Scale and TPM Items (Mean o f Last Two Weeks)

Variables

N

r

P

Easy to talk to

106

-.015

.891

Warm and caring

106

-.014

.893

Honest and sincere

106

-.152

.156

Hostile and aggressive

106

-.061

.567

In denial about problems

106

.091

.397

Motivated to recovery

106

-.020

.853

Cooperative

106

-.063

.560

Responsible

106

-.058

.588

Consistently keeps session appointments

106

.000

.998

Self-confident

106

-.049

.647

Freely expresses wishes

106

.001

.996

Depressed

106

.023

.834

Nervous or anxious

106

.115

.282

Motivated

106

-.041

.701

Note: BOR = Borderline Scale on PAI; TPM = Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p = Probability ; * p < .05. **p <.01.

Results showed no significant relationships between the BOR scale and the mean
of the first two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 38.
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Table 38.
Pearson Correlations Between BOR Scale and TPM Subscale Variables (Mean o f First
Two Weeks)

Variables

N

r

Self-confidence

106

.061

.537

Motivation

106

.100

.308

Counseling Rapport

106

.081

.409

P

Note: BOR = Borderline Scale on PAI; TPM = Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed no significant relationships between the BOR scale and the mean
of the last two weekly TPM subscale ratings. These results do not support the
hypothesis. Pearson correlations are presented in Table 39.

Table 39.
Pearson Correlations Between BOR Scale and TPM Subscale Variables (Mean o f Last
Two Weeks)
Variables

N

r

Self-confidence

106

-.072

.466

Motivation

106

-.044

.656

Counseling Rapport

106

-.082

.404

Note: BOR = Borderline Scale on PAI; TPM = Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

P
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Hypothesis Six
The sixth hypothesis stated that scores on the antisocial (ANT) scale of the PAI
would be associated with treatment participation; a significant negative correlation was
predicted between scores on the Antisocial scale of the PAI and individual and subscale
rating scores on the Treatment Process Measure. Pearson correlations between the grand
mean for each of the 14 TPM ratings and the ANT scores (higher scores indicating higher
levels of impulsiveness, recklessness, and callousness within interpersonal relationships)
were conducted to test for linear relationships. Further analyses were conducted to
determine whether higher scores on the ANT scale were related to treatment process
early and/or late over the course of treatment. Accordingly, Pearson correlations between
the mean of the first two TPM ratings and the ANT scale were conducted. Next Pearson
correlations between the mean of the final two TPM ratings and the ANT scale was
conducted. Finally subscales were analyzed, again using Pearson correlations, looking at
the mean of the first two and the mean of the final two subscale TPM ratings.
Results showed three significant relationships between the ANT scale and the
grand mean TPM ratings: “cooperative” (r (104) = -.226, p < .05), “consistently keeps
session appointments” (r (104) = -.194, p < .05), and “motivated” (r (104) = -.257, p <
.01). The three statistically significant correlations with the ANT scale, which indicate a
linear relationships, and the TPM items “cooperative,” “consistently keeps session
appointments,” and “motivated,” are all negative correlations with the ANT scale. These
results provide some support for Hypothesis 6. Pearson correlations are presented in
Table 40.
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Table 40.
Pearson Correlations Between ANT Scale and TPM Items (Grand Mean)

Variables

r

P

Easy to talk to

106

-.159

.103

Warm and caring

106

-.181

.064

Honest and sincere

106

-.132

.176

Hostile and aggressive

106

.140

.153

In denial about problems

106

.091

.353

Motivated to recovery

106

-.187

.055

Cooperative

106

-.226

.020*

Responsible

106

-.182

.062

Consistently keeps session appointments

106

-.194

.047*

Self-confident

106

-.036

.717

Freely expresses wishes

106

-.104

.287

Depressed

106

-.023

.811

Nervous or anxious

106

.046

.641

Motivated

106

-.257

.008*

Note: ANT = Antisocial Scale on PAI; TPM = Treatment Process Measure; N = Number
o f Participants; r -Pearson Correlation Value; p - Probability; * p < .05. **p <.01.

Results showed one significant relationship between the ANT scale and the mean
of the first two weekly TPM ratings: “easy to talk to” (r (87) = -.219,p < .05). These
results do not offer much support for this hypothesis. Pearson correlations are presented
in Table 41.

124

Table 41.
Pearson Correlations Between ANT Scale and TPM Items (Mean o f First Two Weeks)

N

r

Easy to talk to

106

-.219

.040*

Warm and caring

106

-.206

.053

Honest and sincere

106

-.151

.157

Hostile and aggressive

106

.093

.384

In denial about problems

106

.012

.910

Motivated to recovery

106

-.134

.209

Cooperative

106

-.109

.307

Responsible

106

-.137

.199

Consistently keeps session appointments

106

-.130

.225

Self-confident

106

-.007

.949

Freely expresses wishes

106

-.126

.238

Depressed

106

-.020

.849

Nervous or anxious

106

-.067

.534

Motivated

106

-.196

.065

Variables

P

Note: A N T - Antisocial Scale on PAI; TPM= Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed four significant relationships between the ANT scale and the
mean of the last two weekly TPM ratings : “cooperative” (r (87) = -.258,/? < .01),
“consistently keeps session appointments” (r (87) = -.253, p < .01), “freely expresses
wishes” (r (87) = -.251, p < .01), and “motivated” (r (87) = -.252, p < .01). These results
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show partial support for this hypothesis. Significant Pearson correlations are presented in
Table 42.

Table 42.
Pearson Correlations Between ANT Scale and TPM Items (Mean o f Last Two Weeks)
N

r

P

Easy to talk to

106

-.183

.085

Warm and caring

106

-.174

.104

Honest and sincere

106

-.162

.130

Hostile and aggressive

106

.030

.779

In denial about problems

106

.028

.798

Motivated to recovery

106

-.202

.058

Cooperative

106

-.258

.015*

Responsible

106

-.190

.075

Consistently keeps session appointments

106

-.253

.017*

Self-confident

106

-.155

.148

Freely expresses wishes

106

-.251

.017*

Depressed

106

-.052

.631

Nervous or anxious

106

-.001

.991

Motivated

106

-.252

.017*

Variables

Note: ANT= Antisocial Scale on PAI; TPM= Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed one significant relationships between the ANT scale and the mean
o f the first two weekly TPM subscale ratings; “counseling rapport” (r (104) = -.212, p <
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.05). These results do not offer much support for this hypothesis. Pearson correlations
are presented in Table 43.

Table 43.
Pearson Correlations Between ANT Scale and TPM Subscale Variables (Mean o f First
Two Weeks)
Variables

N

r

p

Self-confidence

106

-.043

.662

Motivation

106

-.157

.107

Counseling Rapport

106

-.212

.029*

Note: A NT= Antisocial Scale on PAI; TPM = Treatment Process Measure; N = Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p <.01.

Results showed one significant relationships between the ANT scale and the mean
of the last two weekly TPM subscale ratings “motivation” (r (104) = -.221, p < .05).
These results do not offer much support for this hypothesis. The Pearson correlations are
presented in Table 44.

Table 44.
Pearson Correlations Between ANT Scale and TPM Subscale Variables (Mean o f Last
Two Weeks)
Variables

N

r

p

Self-confidence

106

-.151

.122

Motivation

106

-.221

.023*

!
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Table 44. (continued)
Pearson Correlations Between ANT Scale and TPM Subscale Variables (Mean o f Last
Two Weeks)

Variables

N

r

P

Counseling Rapport

106

-.155

.112

Note: A N T= Antisocial Scale on PAI; TPM= Treatment Process Measure; N =Number
o f Participants; r = Pearson Correlation Value; p = Probability; * p < .05. **p < 01.

Hypothesis Seven
The seventh hypothesis stated that scores on the stress, nonsupport, treatment
rejection, dominance, borderline, and antisocial (STR, NON, RXR, DOM, BOR, and
ANT) scale of the PAI would be associated with treatment participation as measured
from the onset and at completion of treatment; specifically, individuals with higher scores
on the PAI scales will be expected to have less differences in overall treatment
participation. Multiple regression analyses were conducted to examine the relationship
between TPM subscale scores and the six PAI predictor variables. Also, a change score
for the TPM subscales was calculated by subtracting the score of week six rating from the
score of the week one rating and regression analyses were conducted to examine the
relationship between the TPM subscale change scores and the PAI predictors.
A stepwise multiple regression was conducted to examine the relationship
between the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the initial ratings (mean of first two weeks) on the
Counseling Rapport subscale of the TPM as the outcome variable. By utilizing a
stepwise regression in analyzing the data, two models were produced, and both were
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significant at p <.01; however, the second model was more comprehensive. The second
model produced an R square of .163, which was statistically significant, [F (2,103) =
10.038,/? < .000]. Treatment rejection and antisocial can account for 16.3 % of the
variance in initial Counseling Rapport subscale ratings. Treatment rejection had
significant negative regression weight (B = -.352, t = -3.81 \ , p < .000). Antisocial had
significant negative regression weight (B = -.289, t = -3.130, p < .005). Borderline,
Stress, Nonsupport, and Dominance did not enter the model. The results of the
regression analysis are shown in Tables 45 and 46. These results indicate that the best
model for predicting initial ratings on the counseling rapport subscale of the TPM is to
use treatment rejection and antisocial scores from the PAI. Results of this regression
model provide partial support for the hypothesis.

Table 45.
Analysis o f Variance (ANOVA) Table: Second Regression Model fo r Initial Counseling
Rapport Ratings
Model
2

R Square

dfl

df2

.163

2

103

F

P

10.038

.000

Note: R Square = Amount o f Variance in Initial Counseling Rapport Ratings Brought by Predictor
Variables as a Whole; d f= Degrees o f Freedom; p.= Level o f Significance

Table 46.
Coefficients for Model 2 Initial Counseling Rapport Ratings

Variables

Treatment Rejection

Unstandardized
Coefficients

-.190

Standardized
Coefficients Beta

t

-.352

-3.811

p

.000
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Table 46. (continued)

Coefficients for Model 2 Initial Counseling Rapport Ratings
Unstandardized
Coefficients

Variables

Antisocial

-.102

Standardized
Coefficients Beta

t

-.289

-3.130

P
.002

Note: p = level o f significance
C-

A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the initial ratings (mean of first two weeks) on the
Motivation subscale of the TPM as the outcome variable. By utilizing a stepwise
regression in analyzing the data, two models were produced, and both were significant at
p <.000; however, the second model was more comprehensive. The second model
produced an R square of .174, which was statistically significant, [F (2,103) = 10.819, p
< .000]. Treatment rejection arid antisocial can account for 17.4 % of the variance in
initial Motivation subscale ratings. Treatment rejection had significant negative
regression weight (B = -.395, t = -4.308,p < .01). Antisocial had significant negative
regression weight (B = -.243, t = -2.651 ,p < .005). Borderline, Stress, Nonsupport, and
Dominance did not enter the model. The results of the regression analysis are shown in
Tables 47 and 48. These results indicate that the best model for predicting initial ratings
on the Motivation subscale of the TPM is to use treatment rejection and antisocial scores
from the PAI. Results of this regression model provide partial support for the hypothesis.
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Table 47.
Analysis o f Variance (ANOVA) Table: Second Regression Model fo r Initial Motivation
Ratings

R Square

Model

.174

2

dfl

d£2

F

2

103

10.819

P
.000

Note: R Square = Amount o f Variance in Initial Motivation Ratings Brought by Predictor Variables as a
Whole; d f= Degrees o f Freedom; p= Level o f Significance

Table 48.
Coefficients fo r Model 2 Initial Motivation Ratings

Variables

Unstandardized
Coefficients B

Standardized
Coefficients Beta

t

P

Treatment Rejection

-.194

-.395

-4.308

.000

Antisocial

-.078

-.243

-2.651

.009

Note: p = level o f significance

A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the initial ratings (mean of first two weeks) on the SelfConfidence subscale of the TPM as the outcome variable. None of the six predictor
variables entered the model. Results o f this analysis do not provide support for the
hypothesis.
A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
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NON, RXR, and DOM, with the final ratings (mean of last two weeks) on the Counseling
Rapport subscale of the TPM as the outcome variable. By utilizing a stepwise regression
in analyzing the data, two models were produced, and both were significant at p <.05;
however, the second model was more comprehensive. The second model produced an R
square of .111, which was statistically significant, [F (2, 103) = 6.413,/? < .005].
Treatment rejection and borderline can account for 11.1 % of the variance in final
Counseling Rapport subscale ratings. Treatment rejection had significant negative
regression weight (B = -.405, t = -3.471,/? < .001). Borderline had significant negative
regression weight (B - -.326, t = -2.799, p < .01). Antisocial, Stress, Nonsupport, and
Dominance did not enter the model. The results of the regression analysis are shown in
Tables 49 and 50. These results indicate that the best model for predicting initial ratings
on the Counseling Rapport subscale o f the TPM is to use RXR and BOR scores from the
PAI. Results of this regression model provide partial support for the hypothesis.

Table 49.
Analysis o f Variance (ANOVA) Table: Second Regression Model for Final Counseling
Rapport Ratings
Model
2

R Square
.111

dfl

df2

F

2

103

6.413

Note: R Square = Amount o f Variance in Final Counseling Rapport Ratings Brought by
Predictor Variables as a Whole; d f= Degrees o f Freedom; p = Level o f Significance

P
.002
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Table 50.

Coefficients fo r Model 2 Final Counseling Rapport Ratings

Variables

Unstandardized
Coefficients B

Standardized
Coefficients Beta

t

P

Treatment Rejection

-.247

-.405

-3.471

.001

Borderline

-.142

-.326

-2.799

.006

Note: p = level o f significance

A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the final ratings (mean of last two weeks) on the Motivation
subscale of the TPM as the outcome variable. By utilizing a stepwise regression in
analyzing the data, two models were produced, and both were significant at p <.005;
however, the second model was more comprehensive. The second model produced an R
square of .176, which was statistically significant, \F (2, 103) = 11.036,/? < .000].
Treatment rejection and antisocial can account for 17.6 % of the variance in final
Motivation subscale ratings. Treatment rejection had significant negative regression
weight (B = -.366, t = -3.995,p < .000). Antisocial had significant negative regression
weight (B = -.301, t = -3.283,p < .001). Borderline, Stress, Nonsupport, and Dominance
did not enter the model. The results o f the regression analysis are shown in Tables 51
and 52. These results indicate that the best model for predicting final ratings on the
Motivation subscale of the TPM is to use RXR and ANT scores from the PAI. Results of
this regression model provide partial support for the hypothesis.
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Table 51.
Analysis o f Variance (ANOVA) Table: Second Regression Model fo r Final Motivation
Ratings

R Square

Model
2

.176

dfl

df2

F

2

103

11.036

P
.000

Note: R Square = Amount o f Variance in Final Motivation Ratings Brought by Predictor Variables as a
Whole; d f - Degrees o f Freedom; p = Level o f Significance

Table 52.
Coefficients fo r Model 2 Final Motivation Ratings

Variables

Unstandardized
Coefficients B

Standardized
Coefficients Beta

t

P

Treatment Rejection

-.207

-.366

-3.995

.000

Antisocial

-.111

-.301

-2.283

.001

Note: p - level o f significance

A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the final ratings (mean of last two weeks) on the SelfConfidence subscale of the TPM as the outcome variable. None of the six predictor
variables entered the model. Results of this analysis do not provide support for the
hypothesis.
A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the difference scores between the final and initial scores on

the Counseling Rapport subscale of the TPM as the outcome variable. By utilizing a
stepwise regression in analyzing the data, two models were produced, and both were
significant at p <.05; however, the second model was more comprehensive. The second
model produced an R square of .082, which was statistically significant, [F (2,103) =
4.593,/? < .05]. Borderline and antisocial can account for 8.2 % of the variance in the
difference scores on the Counseling Rapport subscale ratings. Borderline had significant
negative regression weight (B = -.366, t = -3.995,p < .000). Antisocial had significant
positive regression weight (B = .222, t = 1.994,p < .05). Treatment Rejection, Stress,
Nonsupport, and Dominance did not enter the model. The results of the regression
analysis are shown in Tables 53 and 54. These results indicate that the best model for
predicting change score ratings on the Counseling Rapport subscale of the TPM is to use
ANT and BOR scores from the PAI. Results of this regression model provide partial
support for the hypothesis.
Table 53.
Analysis o f Variance (ANOVA) Table: Second Regression Model fo r Change Scores fo r
Counseling Rapport Ratings (Last Week Minus First Week Scores)
Model
2

R Square

dfl

d£2

F

P

.082

2

103

4.593

.012

Note: R Square = Amount o f Variance in Change Scores for Counseling Rapport Ratings Brought by
Predictor Variables as a Whole; df~ Degrees o f Freedom; p = Level o f Significance
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Table 54.

Coefficients for Model 2 Change Scores fo r Counseling Rapport Ratings (Last Week
Minus First Week Scores)

Variables

Unstandardized
Coefficients B

Standardized
Coefficients Beta

t

P

Borderline

-.103

-.333

-2.992

.003

Antisocial

-.063

-.222

-1.994

.049

Note: p = level o f significance

A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the difference scores between the final and initial scores on
the Motivation subscale of the TPM as the outcome variable. By utilizing a stepwise
regression in analyzing the data, one model were produced, and was significant at p <.05.
The model produced an R square of .037, which was statistically significant, [ F ( l, 104)
= 3.949, p < .05]. Borderline can account for 3.7 % o f the variance in the difference
scores on the Motivation subscale ratings. Borderline had significant negative regression
weight (B = -.191, t = -1.987,/? < .05). Antisocial, Treatment Rejection, Stress,
Nonsupport, and Dominance did not enter the model. The results of the regression
analysis are shown in Tables 55 and 56. These results indicate that the best model for
predicting change score ratings on the Motivation subscale o f the TPM is to use BOR
scores from the PAI. Results of this regression model provide partial support for the
hypothesis.
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Table 55.
Analysis o f Variance (ANOVA) Table: Regression Model fo r Change Scores fo r
Motivation Ratings (Last Week Minus First Week Scores)

Model

R Square

1

.037

dfl

df2

F

1

104

3.949

P
.050

Note: R Square = Amount o f Variance in Change Scores for Motivation Ratings Brought
by Predictor Variables as a Whole; d f= Degrees o f Freedom; p= Level o f Significance

Table 56.
Coefficients fo r Regression Model with Change Scores fo r Motivation Ratings (Last
Week Minus First Week Scores)

Variable

Unstandardized
Coefficients B

Borderline

-.053

Standardized
Coefficients Beta

t

-.191

-1.987

P
.050

Note: p = level of significance

A stepwise multiple regression was conducted to examine the relationship
between with the following PAI subscale scores as predictor variables: BOR, ANT, STR,
NON, RXR, and DOM, with the difference scores between the final and initial scores on
the Self-Confidence subscale of the TPM as the outcome variable. By utilizing a
stepwise regression in analyzing the data, one model were produced, and was significant
at p <.05. The model produced an R square of .052, which was statistically significant,
[F (1,104) = 5.730, p < .05]. Stress can account for 5.2% o f the variance in the
difference scores on the Self-Confidence subscale ratings. Stress had significant negative
regression weight (B = -.229, t - -2.394, p < .05). Borderline, Antisocial, Treatment
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Rejection, Nonsupport, and Dominance did not enter the model. The results of the
regression analysis are shown in Tables 57 and 58. These results indicate that the best
model for predicting change score ratings on the Self-Confidence subscale of the TPM is
to use STR scores from the PAI. Results of this regression model provide partial support
for the hypothesis.
Table 57.
Analysis o f Variance (ANOVA) Table: Second Regression Modelfo r Change Scores fo r
Self-Confidence Ratings (Last Week Minus First Week Scores)
Model
1

R Square
.052

dfl

df2

F

1

104

5.730

P
.018

Note: R Square = Amount o f Variance in Change Scores for Self-Confidence Ratings Brought by Predictor
Variables as a Whole; d f - Degrees o f Freedom; p= Level o f Significance

Table 58.
Coefficients fo r Model 2 Change Scores for Self-Confidence Ratings (Last Week Minus
First Week Scores)

Variables

Unstandardized
Coefficients B

Stress

Note: p = level o f significance

-.070

Standardized
Coefficients Beta

t

-.229

-2.394

P
.018

CHAPTER FOUR

DISCUSSION
Findings and Implications
The purpose of this study was to assess the influence that pre-existing personality
and interpersonal variables, as measured by subscales of the PAI, have on substance
abuse treatment participation. Personality and interpersonal variables were assessed
using the Personality Assessment Inventory (Morey, 1991). Substance abuse treatment
participation was assessed weekly from admission to discharge, for each patient, using
the Treatment Process Measure (TPM). Demographics were also a measure of interest.
Positive treatment participation was defined as high treatment participation scores.
Although the literature suggested the utility of the Personality Assessment
Inventory (PAI), (Morey, 1991), with the substance addicted population (e.g., Fals-Steart,
1996; Hopwood, Baker, & Morey, 2008; Parker, Daleiden, & Simpson, 1999; Schinka,
1995; Schinka, Curtiss, & Mulloy, 1994; Tolisano, 1998), there was no research that
examined the relationship of scores on the PAI with patient treatment participation in
substance abuse treatment settings. After a thorough review of the current literature
regarding the PAI and substance abuse treatment, seven hypotheses were derived for
investigation within the current study.
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Hypothesis 1 stated higher scores on the STR scale (higher scores indicating
higher levels of stress and inability to control events around them) would be associated
with significantly lower scores on the Treatment Process Measure. Although literature
suggested high scores on the STR scale of the PAI were associated with lower treatment
response rates and less improvements from treatment, and further were also associated
with higher rates of drug and alcohol relapse (D’Andrea, & D’Andrea, 1996; Tate,
Brown, Glasner, Unrod, & McQuiad, 2006), this study yielded mixed findings with
partial support for the hypothesis. The support for this hypothesis was in the analysis
conducted which used the first two weeks of treatment ratings. This analysis indicated
that higher scores on the STR scale were associated with lower scores on TPM ratings of
the following: (a) honest and sincere; (b) in denial about problems; (c) motivated to
recovery; (d) responsible; and (e) motivated. In other words, high levels of stress were
associated with a decreased observance of honesty, motivation for recovery,
responsibility, general motivation, and less denial about problems, at least initially, for
the first two weeks o f treatment.
Overall, there was partial support for Hypothesis 1 with this study. A possible
reason that the current study did not show greater support for this hypothesis could be
due to the treatment program itself. In other words, although the individuals were be
initially experiencing high perceived rates of stress, given the comprehensive structure of
this particular treatment program, with an interdisciplinary treatment focus, individuals
perhaps began to immediately feel a stress reduction, having a team o f individuals begin
to assist them in getting their life back on track; Individuals received services ranging
from medical and dental evaluations, to help for completion of high school education,

140

and housing placement options upon discharge from the program. Perhaps the reduction
in stress allowed individuals to focus on treatment and more effectively participate.
Hypothesis 2 stated higher scores on the NON scale (higher scores indicating a
perceived lack o f social support and dissatisfaction with social relationships) would be
associated with significantly lower scores on the Treatment Process Measure. Although
literature suggested higher perceived levels o f social support upon intake were associated
with better treatment participation and outcomes (Dobkin, De Civita, Paraherakis, & Gill,
2002; Huselid, Self, & Gutierres, 1991; Westreich, Heitner, Cooper, Galanter, & Gued,
1997), this study did not yield similar findings. Hypothesis 2 was not supported.
Again, perhaps the seemingly contradictory findings could be due to the treatment
program itself. Perhaps the comprehensive structure of this particular treatment program,
with an interdisciplinary treatment focus, allowed individuals with a perceived lack of
social support to immediately begin to feel connected to others within the group
treatment dynamics. Also, since this program emphasized family support and healing
through visitation and family therapy, perhaps this emphasis allowed many individuals to
immediately begin to reconnect with a social network, primarily the family, for which
they had previously been disconnected during their time spent living in addiction.
Perhaps this re-connectedness to a lost social support system is what was reflected in
improvements in treatment. In other words, although initially, the patient may have had a
high perceived lack of social support, treatment may have done a good job of aiding in
facilitating increased social support, which allowed the person to better focus on
treatment and ultimately have positive treatment participation.

Hypothesis 3 stated moderate scores on the RXR scale (moderate scores
associated with differing levels of motivation toward treatment), as opposed to low or
high scores, would be associated with significantly higher scores on the Treatment
Process Measure. The literature did not specifically address treatment rejection, but
rather focused on a similar concept, treatment motivation. Previous research suggested
initial treatment motivation was related to treatment completion, but not associated with
overall long-term treatment outcomes, such as relapse (Rapp, Siegal, & DeLiberty, 2003).
High motivation was also shown to be associated with severity of alcohol and drug use,
and/or significant life stressors associated with the use of substances, such as
involvement with the court system (Breda, & Heflinger, 2007). Further, high levels of
motivation may be extrinsically based rather than intrinsically based. Additionally,
substance abuse treatment was often associated with some ambivalence, and extremely
high levels of motivation for treatment may signify a lack of ambivalence about
treatment, therefore, the possibility existed that treatment participation, for individuals
with high motivation, was associated with secondary gain rather than a true desire for
personal change. It is plausible given these findings that moderate scores on the RXR
scale were more likely associated with those individuals ambivalent about treatment, yet
contemplating change, and therefore scoring higher scores for treatment participation.
However, this finding was not demonstrated in the current study, as Hypothesis 3 was not
supported.
Yet, there were other interesting findings when investigating Hypothesis 3,
specifically linear relationships, evidenced in that higher scores on the RXR scale were
associated with lower scores on TPM ratings of the following: (a) consistently keeps
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appointments; (b) easy to talk to; (c) motivated; (d) motivated to recovery; (e)
responsible; (f) warm and caring; (g) cooperative; (h) freely expresses wishes; (i) honest
and sincere; and (j) nervous or anxious. In other words, the more likely one was to reject
treatment, as evidenced by the RXR score, the more likely the patient would not keep
appointments, be easy to talk to, be motivated, be motivated to recovery, be responsible,
be warm and caring, be cooperative, freely express wishes, be honest or sincere, and
would not be nervous or anxious. For the first two weeks of TPM ratings, higher scores
on the RXR scale were associated with lower scores on TPM ratings of the following: (a)
easy to talk to; (b) warm and caring; (e) honest and sincere; (d) in denial about problems;
(e) motivated to recovery; (f) cooperative; (g) responsible; (h) consistently keeps session
appointments; (i) freely expresses wishes; and (j) motivated. In other words, the more
likely one was to reject treatment, as evidenced by the RXR score, the more likely the
patient would not be easy to talk to, be warm and caring, be honest and sincere, would be
in denial about problems, would not be motivated to recovery, cooperative, responsible,
and would not consistently keep session appointments. For the last two weeks of TPM
ratings, higher scores on the RXR scale were associated with lower scores on TPM
ratings of the following: (a) easy to talk to; (b) warm and caring; (c) honest and sincere;
(d) motivated; (e) cooperative; (f) responsible; (g) consistently keeps session
appointments; (h) freely express wishes; (i) nervous and anxious; and (j) motivated. In
other words, the more likely one was to reject treatment, as evidenced by the RXR score,
the more likely the patient would not be easy to talk to, be warm and caring, be honest
and sincere, motivated, cooperative, responsible, consistently keep session appointments,
freely express wishes, be nervous and anxious, and motivated. If an individual was not
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caring about treatment or outright rejecting treatment, it could be perhaps sensible to
conclude a lack of these previous behaviors, but the present study also gave solid
evidence of the relationship between these behaviors and the RXR scale. O f these
statistically significant findings, surprisingly, however, the low and high scorers o f the
RXR indicated significant differences for the nervous or anxious and the consistently
keeps session appointments variables on the TPM. There was no support for the
moderate scores of the RXR being associated with higher TPM ratings.
In attempting to understand these uncanny results, several ideas were postulated.
Perhaps the high treatment rejection scores associated with consistently keeps session
appointments was related to an underlying personality pattern, such as antisocial, in that
the person was rejecting of treatment, yet outwardly behaving in a way that benefited him
or herself. For these individuals, regularly attending the session appointments may have
been a strategy to complete treatment quicker, or in essence, serve the time and get out.
Also for the high treatment rejection scores in relation to the high TPM rating of anxiety,
perhaps treatment was rejected due to high levels o f anxiety or nervousness. Perhaps, the
low treatment rejection scores, associated with consistently keeping session
appointments, identified the small segment o f the treatment population which had moved
beyond the ambivalence regarding treatment, and was fully committed to engaging in the
treatment process, thereby attending appointments in the hope of gaining tools to
recovery. Additionally, the high levels of anxiety associated with low treatment rejection
may have been associated with fears related to the prospect o f change.
Hypothesis 4 stated high scores on the DOM scale (moderate scores indicating an
ability to adapt to different situations and both exert and relinquish control in

interpersonal relationships) would have statistically poorer treatment participation scores
on the Treatment Process Measure, than those individuals with moderate or low scores on
the DOM scale. Previous research indicated the worst treatment outcomes were
associated with those individuals who were unwilling to take personal responsibility for
problems and those individuals who had problems with authority (Calsyn, Roszell, &
Anderson, 1988). Additionally, because most drug and alcohol treatments relied on 12step or psychotherapy groups as the primary form o f treatment, the process of treatment
and recovery depended largely on interpersonal interactions with others. In a study by
Doumas, Blasey, and Thacker (2005), it was found that interpersonal styles, described as
vindictive and domineering, were positively associated with treatment attrition.
However, in the current study, it did not appear that high scores on the DOM score were
associated with poorer treatment participation, because Hypothesis 4 was not supported.
Perhaps these results were again due to specific differences within the treatment program.
In other words, it is possible that the individuals with high scores, which indicated that
they were dominant and needed control within interpersonal relationships were able to
use these qualities in a productive way within this program. This program used peer
group leaders, and it would be interesting to determine if the individuals which scored
high on the DOM score, were the ones who in this treatment program ultimately became
the group leaders. Also, it would be interesting to compare between program types to
see if this results still occurs, with comparisons occurring between treatment programs
using peer group leaders and those who do not use peer leadership.
Hypothesis 5 stated a significant relationship would exist between high scores on
the BOR (high scores indicating emotional instability ranging from being moody to angry

and impulsive) of the PAI and low rating scores on the Treatment Process Measure.
Previous research suggested both short and long-term treatment outcomes were worse for
individuals with personality disorders compared to those without them (Herbeck et al.,
2005). Moreover, problems early on with treatment compliance were noted for
individuals with Axis II disorders, often exhibited behaviorally in not attending
appointments, not completing homework, and having interpersonal problems with other
patients (Herbeck et al., 2005). Long term, Axis II personality disorders also were
associated with higher relapse and re-hospitalization rates (Pettinati, Pierce, Belden, &
Meyers, 1999). Because much of substance abuse treatment is interpersonal in nature,
and patients with personality disorders have intractable difficulties in establishing and
maintaining relationships with others, these patients usually have difficulty engaging in
treatment (Lehman, 1996). In fact, a patient’s social functioning was strongly associated
with treatment compliance, in that as social functioning deteriorated, problems with
treatment compliance increased (Herbeck, Fitek, Svikis et al., 2005). Although
personality disorders were associated with poorer treatment ratings, this study did not
yield similar findings, as Hypothesis 5 was not supported. Perhaps these findings were
again due to specific program strengths in managing certain personality styles.
Specifically, perhaps this program provided enough structure and boundaries so that the
instability was contained, while also modeling and offering outlets for appropriate
emotional expression, thereby allowing the individuals to effectively focus on treatment.
Again it would be interesting to look at differences in this finding with other less
structured treatment programs.

Hypothesis 6 stated a significant relationship would exist the ANT scale (higher
scores indicating higher levels of impulsiveness, recklessness, and callousness within
interpersonal relationships) of the PAI and lower rating scores on the Treatment Process
Measure. Research indicated that a high proportion of patients being treated for
substance abuse problems also had a co-occurring Cluster B personality disorder, which
was associated with poor behavioral control and impulsivity (Taylor, 2005). Further,
these individuals often had difficulties with executive cognitive functioning, such as
planning, judgment, and impulsivity (Taylor, 2005). Research identified that for
individuals participating in substance abuse treatment, antisocial personality disorder or
characteristics of the disorder were associated with shorter treatment stays, violation of
program rules, and poor participation in treatment (Fals-Stewart, & Lucente, 1997).
Hypothesis 6 was slightly supported, in that three TPM ratings were statistically
significant for treatment participation scores.
The three statistically significant ratings which were associated with higher TPM
scores, were: (a) cooperative; (b) consistently keeps session appointments; and (c)
motivated. Each of these variables was shown to have a negative linear relationship with
higher scores on the ANT scale. In other words, it appeared that these three variables
were in fact associated with antisocial personality characteristics and poorer treatment
participation, specifically, in cooperativeness, consistently with keeping session
appointments and motivation. Additionally, when evaluating the first two weeks o f TPM
ratings, higher, scores on the ANT were significantly associated with higher TPM ratings
on the following: (a) easy to talk to. This variable was shown to have a negative linear
relationship with higher scores on the ANT. Also, when evaluating the last two weeks of
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TPM ratings, higher scores on the ANT were significantly associated with higher TPM
ratings on the following: (a) cooperative; (b) consistently keeps session appointments; (c)
freely expresses wishes; and (d) motivated. In other words, a negative linear relationship
existed between these variables and the ANT scale.
When evaluating the subscales, one significant difference emerged for the first
mean of subscales and the final mean of subscales. For the first two weeks of treatment
it appeared that the Counseling Rapport subscale was significantly related to the ANT
scale, in that higher scores on the ANT scale were associated with poorer scores on initial
Counseling Rapport. Additionally, for the last two weeks of treatment, it appeared that
the Motivation subscale was significantly related to the ANT scale, in that higher scores
on the ANT scale were associated with poorer scores on final Motivation. These results
may infer that although the counseling relationship or rapport may improve, it is possibly
as a function of the personality disorder, in that the patient is geared toward making the
relationship work as a means to completing the program, while at the end o f treatment,
motivation for treatment declines. In other words, although the person wants to
outwardly do what it takes to complete the program by building rapport, internally the
person is not motivated for true change.
These finding from the current study provided additional support for previous
research, which indicated persons with antisocial characteristics have poorer treatment
participation and often violate program rules. An implication of this finding for treatment
programs was a consideration and/or awareness that those patients scoring high on the
ANT scale may not be suitable for treatment. Additionally, if decisions for treatment
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placement must be made within a limited availability of treatment spaces, individuals
with high scores on the ANT would be the less suitable candidate for treatment.
Hypothesis 7 stated that there would be a significant relationship between the PAI
scales (STR, NON, RXR, DOM, BOR, and ANT) and treatment participation. It was
hypothesized that the PAI scales (STR, NON, RXR, DOM, BOR, and ANT) would be
predictive of treatment participation as measured from the onset and at completion of
treatment; specifically, individuals with higher scores on the PAI scales were expected to
have less differences in overall treatment participation. The PAI has proven a valid
measure for assessment in inpatient substance abuse settings, yet researchers suggested a
need for future research with the PAI in the inpatient substance abuse setting (Hopwood,
Baker, & Morey, 2008; Schinka, 1995). In particular, high scores on these specified
scales or on measures of similar constructs were shown to be associated with worse
outcomes, specifically lower treatment response rates and less overall improvements
from treatment, higher relapse and higher hospitalization rates (Calsyn, Roszell, &
Anderson, 1988; D’Andrea & D’Andrea, 1996; Dobkin, De Civita, Paraherakis, & Gill,
2002; Herbeck et al., 2005; Huselid, Self, & Gutierres, 1991; Pettinati, Pierce, Belden, &
Meyers, 1999; Westreich, Heitner, Cooper, Galanter, & Gued, 1997).
For the Counseling Rapport subscale, the PAI scales that appeared to predict
treatment participation were the Treatment Rejection and Antisocial scales for initial
treatment response, and for the final treatment ratings the Treatment Rejection and
Borderline scales appeared to predict treatment participation. This study lehded support
for using the RXR scale o f the PAI to predict treatment; specifically, high scores on the
RXR scale were predictive of poorer treatment participation both at the beginning and at

the end of treatment. Additionally this study showed support for using the Antisocial
scale to predict poorer treatment participation at the beginning of treatment, and the
Borderline scale to predict poorer treatment participation towards the end of treatment.
This finding was not surprising, in that it was likely a function of each personality
disorder. Particularly for individuals with high Antisocial scores, initially the individual
may have appeared resistant to treatment, but over time the motivation to comply with
treatment served a selfish purpose toward being released from the program. For
individuals with high Borderline scores, it may take being in an environment and
developing some interpersonal relationships within the treatment program before the
dynamics of the personality disorder such as emotional lability and instability within
interpersonal relationships begins to emerge. In summary, it appeared that Counseling
Rapport can be predicted by the Treatment Rejection Scale at the beginning and end of
treatment. Further, Counseling Rapport at the beginning of treatment can be predicted by
the Antisocial scale and at the end of treatment with the Borderline scale.
This project does not find any support for using the PAI scales examined in this
study to predict treatment participation related to the Self-Confidence subscale in
treatment. For the Motivation subscale, this study lended support to using the Treatment
Rejection and Antisocial PAI scales for initial and final treatment response. In other
words, The RXR scale and ANT scale were predictive of poorer motivation in treatment.
When evaluating changes over time in treatment, this study showed support that
the Antisocial and Borderline scale were predictive of poorer treatment participation
related to Counseling Rapport. There was also support for using the Borderline scale to
predict poorer treatment participation for Motivation and for using the Stress scale to

predict poorer treatment participation in terms of Self-Confidence over the course o f
treatment. For the outcomes predicted by the Borderline scale, this was likely a function
o f the personality disorder, in that since treatment is interpersonal in nature, it was likely
that the inherent difficulties with interpersonal relationships associated with Cluster B
personality disorders was being displayed here. Also for the Antisocial scale being
related to poorer Counseling Rapport, this was also consistent with the typical
characteristics of interpersonal difficulties associated with the personality disorder.
Lastly, for the Stress scale, since it is a measure of the perceived difficulties being
experienced at the current time, it is likely that this also affected one’s ability to have
confidence in their own skills needed to effectively participate in treatment, or it could be
said that the person had limited leftover resources for fully participating in treatment due
to all of the other difficulties being experienced.
In summary, the RXR, ANT, and BOR scales were most predictive of treatment
participation, in that higher scores were associated with poorer treatment participation,
and were most consistently found in the regression models. This was an interesting
finding, as there is not yet a body of literature to support use of the Treatment Rejection
scale at predicting treatment participation and also lended support to show that traits
associated with Cluster B personality disorders may not fare as well in traditional
substance abuse treatment approaches. These findings could be evidence to support
screening of patients prior to treatment to determine if the potential participant is open to
or rejecting of treatment and also to screen for high levels o f Cluster B personality
disorders, shown to have difficulty with treatment participation. Also, these findings can
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serve as inspiration to seek new strategies for engaging certain participants in treatment,
particularly those who are rejecting of treatment or those with personality disorders.
Limitations of the Current Study
There were several limitations to consider in the present study. First, the
participants were inpatients, court ordered for substance abuse treatment. In other words,
all of the participants were forced to participate in the treatment program. These
individuals may have believed that participating and showing “good” behaviors in
treatment would lessen the amount of time hospitalized. This may have prevented
individuals from frilly engaging in the treatment process o f actually examining and
changing behaviors.
A second limitation was the number and type of participants. Although there
were 106 participants, the sample was predominately Caucasian and from only one state
in the southern part of the United States. Future research could look at differences
according to greater ethnic diversity. Additionally, it is possible that the findings o f this
particular study varied from previous reporting’s o f this paper, as a direct reflection o f the
severity of the population being studied rather than a problem with methodology.
Third, although the study used a Likert-type scale for rating the participants on
treatment participation, and therapists were trained prior to beginning the study, a
standard protocol was not followed. There was likely subjective variation in the way
treatment participation was evaluated according to each individual therapist.
A fourth limitation was related to the TPM, itself. Although in the current
literature, the TPM was found to be the best scale for rating treatment participation, it is
possible that these fourteen treatment related items are not sensitive enough to pick up on
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the differences in how individuals receive and respond to treatment. Additionally, the
TPM is a counselor-rated scale. It is possible that counselors were not able to identify
covert treatment related processes, such as those related to internal processes o f the stages
of change.
Fifth, a possible limitation could have been the counselors’ social desirability bias
in relation to providing treatment for the participants. It is possible that the individual
counselors wanted to rate all participants as showing improvements over the course of
treatment, due to the idea of how poor response to treatment could be interpreted as a
reflection of competency or lack thereof the counselor.
Suggestions for Future Research
Based on the limitations considered, a revised replication of this study would be
warranted. Ideas for improvement in this study would be to use a more diverse
population, in terms of ethnicity as well as incorporate individuals who are not forced to
attend treatment to see if the results as evidenced in this study are similar. Also,
replicating the study with a different, more objective way to rate treatment participation
would be interesting. As mentioned earlier, it would also be useful to integrate
counselor’s objective behavior ratings of each participant and participants’ own internal
treatment related processes to see how those are similar or dissimilar.
Additionally, the nonsignificant results suggest several other interesting research
ideas regarding the utility of the Personality Assessment Inventory in relating to
treatment participation. Perhaps an interesting investigation would be to examine how
individuals vary between types of treatment programs, comparing programs with a
comprehensive approach to treatment like the current one, as compared to a program

strictly focused on substance abuse treatment. Also, it would be interesting to see how
individuals score on the PAI scales as pre- and posttests following treatment, to indicate
if the treatment program has effectively treated or lessened the identified problems as
identified by the PAI. Specifically, perhaps an interesting investigation would be to
examine how individuals with high STR scores vary in treatment participation between
programs, comparing programs with a comprehensive approach to treatment like the
current one, as compared to a program strictly focused on substance abuse treatment.
The STR scale could be used as a post-test following treatment. High treatment
participation scores with lower post-test scores could indicate that the substance abuse
treatment was also effective in reducing one’s overall stress level. Another interesting
investigation would be to examine the relationship between scores on the RXR scale and
where the individual falls on the stages of change continuum as hypothesized by
Prochaska and DiClemente (1993) to see if high and low scores of RXR are associated
with specific stages of change. Future research could create additional ways to measure
treatment participation and further, an integration between counselor’s objective behavior
ratings of each participant and participants’ own internal treatment related processes.
Overall, although there was not strong support for the hypotheses as theorized,
this fact is also not surprising. The substance abuse literature was mixed in its findings,
and since there are so many other variables within this study that could have influenced
these results, it is difficult to know if these hypotheses were not supported because the
relationships did not exist, or if there were other variables confounding the results.
Further investigation of the PAI is needed to better understand how its scales are related
to substance abuse treatment participation.

APPENDIX A

CONSENT FORM
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HUMAN SUBJECTS CONSENT FORM
You are being asked to participate in a research study between Louisiana Tech University
and Mississippi State Hospital (MSH). This study is part of a dissertation project being
completed by Annese Hutchins. Ms. Hutchins is enrolled at Louisiana Tech University,
in Ruston, Louisiana, and also recently completed her psychology internship at MSH, in
Whitfield, Mississippi. You were identified as a potential subject by the psychology
staff.
This study involves an assessment phase, which will gather information about you, your
issues, and concerns. This phase takes about an hour and involves you answering two
questionnaires. After the initial assessment phase today, you are not required to fill out
any future paperwork, nor will you be contacted by the researcher. However, your
assigned individual therapist will be asked to rate your progress in treatment on a weekly
basis, and this information will be given to the researcher.
Your participation in this study is completely voluntary. All information collected will
remain confidential. Information obtained from the answers you provide will be used for
research purposes only; this information will not be used to evaluate you for treatment, it
will not be shared with the staff of MSH, nor will it impact your treatment at MSH. At
any time during participation, you may withdraw, and you will not suffer penalty, and
your withdrawal from this study will have no impact on your treatment at MSH. You
will be guaranteed anonymity in this study, as your name will not be attached to any of
the questionnaires you or your therapist will complete, rather you will be assigned an
identification number by the researcher to be used for identification purposes. Also, in
summarizing the findings of this study, the results will be based on group analysis rather
than your individual results.
The following is a brief description of the research project in which you are being asked
to participate. Please read this information before signing the statement below.
TITLE: Predicting substance abuse treatment process and outcomes with the Personality
Assessment Inventory: An investigation of how personality and interpersonal factors
affect treatment
PURPOSE: To investigate personality, demographic, and relationship factors that may
be related to substance abuse treatment outcomes. These factors may contribute to the
formulation of treatments, designed to address individuals in substance abuse treatment,
within the context of specific factors unique to each individual.
PROCEDURES: One-time completion of the survey packet by participants and weekly
completion of the weekly rating forms by each participant’s individual therapist.
INSTRUMENTS: The Personality Assessment Inventory (PAI), Treatment Process
Measure (TPM), and a Demographic Form.
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RISKS/ALTERNATIVE TREATMENTS: Some of the questions asked on the PAI and
the demographic form may be personal and sensitive in nature. Therefore it is possible
that you may experience some discomfort in responding to such questions. If you have
emotions, questions, or issues that arise from items on the inventories, you are
encouraged to discuss these with your assigned individual therapist. There are no
alternative treatments. Louisiana Tech University is not able to offer financial
compensation nor to absorb costs of medical treatment associated with injury or
participation in this research.
BENEFITS/COMPENSATION: The major benefit for participating in this research
study is that you are helping advance the field for substance abuse treatment. Answers
you provide may help those providing treatment find better ways to treat chemical
dependency, and improve treatment programs. Your participation is voluntary and you
will not receive any monetary payment or reward for choosing to participate.
CONTACT INFORMATION: If you have any questions about any aspect of this
research, participants’ rights, or related matters, you can direct your questions to the
following individuals:
The Institutional Research Review Board Chair at Mississippi State Hospital:
Dr. Shazia Frothingham (601)351-8315
The principal experimenters at Louisiana Tech University:
Dr. Donna Thomas (318) 257-4040
Dr. Tony Young (318) 257-4315
Dr. Jeffrey J. Walczyk (318) 257-3004
Annese Hutchins, M.Ed., LPC (601) 519-1559
The Human Subjects Committee of Louisiana Tech University also may be contacted if a
problem cannot be discussed with the experimenters:
Dr. Les Guice (318) 257-3056
Dr. Mary Livingston (318) 257-4315 or (318) 257-2292

I ____________ ___________
,attest with my signature below, that I have
read and understood the above description of the study, “Predicting substance abuse
treatment process and outcomes with the Personality Assessment Inventory: An
investigation of how personality and interpersonal factors affect treatment”, its purposes
and methods, and volunteer to participate in the study. I understand that my participation
in this research is strictly voluntary and my participation or refusal to participate in this
study will not affect my relationship with Louisiana Tech University, Mississippi State
Hospital, or my treatment at MSH. I understand this form does not deny me of any rights
and responsibilities I have as a patient at Mississippi State Hospital. Instead, it explains
an additional agreement to participate in a specific study being conducted at Mississippi
State Hospital. Further, I understand that I may withdraw at any time or refuse to answer
any questions without penalty, and withdrawal will not affect my treatment at Mississippi
State Hospital. Upon completion of this study, I understand that the results will be freely
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available to me upon my request. I understand that the results of my questionnaires will
be completely anonymous and confidential, accessible to only the principal investigators,
myself, or a legally appointed representative appointed only by me. From this point on, I
understand that I will be assigned a number which will be used instead of my name to
identify any information provided about myself. All information collected will be kept in
a locked file cabinet, only accessible to the researchers involved in conducting this study.
I have not requested to waive, nor do I waive any of my rights related to participating in
this study.

You will be offered a copy of this consent form to keep.

Signature of Participant

Date

Signature of Investigator

Date

Witness

Date
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BRIEF SURVEY OF DEMOGRAPHIC DEFORMATION
Instructions: Please fill in or circle the answer that best describes you.
(1.) Age:________

(2.) Gender:

Male

(3.) With which ethnic group do you most identify? (please circle one):
African American/Black (non-Hispanic)
Asian/Asian American/Pacific Islander
Biracial/Multiracial
Caucasian/European American/White (non-Hispanic)
Hispanic/Latino/Latina
Middle Eastern/Arab
Native American/American Indian/Alaska Native
South Asian/Asian Indian
Other (please specify):__________________

.

(4.) With which group do you most identify? (please circle one)
Heterosexual
Homosexual
Bisexual
Other (please specify):__________________________
(5.) What is your current relationship status? (please circle one)
Single, never married
In a relationship, not living with partner
Living with partner
Married
Separated
Divorced
Widowed

Female
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(6.) Which would describe your current socioeconomic status?
Lower class
Middle class
Upper class
(7.) What is your highest education level?
No diploma; If no diploma, please specify highest grade level completed:

_______

High school diploma/GED
Associate Degree/Vocational Training
Bachelor Degree
Master Degree
Doctorate Degree
(8.) What was the AGE you first used: Alcohol? _____ _years
years

Drugs?

(9.) What was the AGE you first noticed usage was a problem:
Alcohol?
years
Drugs?
years
(10.) Do you have a family histoiy of alcoholism?
(11.) Do you have a family history of drug abuse?

YES
YES

NO
NO

(12.) What is your main drug of
choice?_____________________________________________
(13.) How many times have you attempted to quit alcohol or
substances?________________
(14.) How many times, including currently, have you been admitted for substance
abuse treatment?
Inpatient__________ _
Outpatient___________
(15.) Do you have a family history of mental disorders (for example, depression,
bipolar disorder, personality disorders, PTSD, ADHD, etc.) other than drug abuse?
YES
NO
(16.) Have you ever been diagnosed with one or more mental health disorders (for
example, depression, bipolar disorder, PTSD, ADHD, etc.)?
YES
NO
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(17.) How many times have you been treated for mental health issues other than
substance abuse treatment (for example depression, bipolar disorder, personality
disorders, PTSD, ADHD, etc.)?
Inpatient
Outpatient
______
(18.) Do you have a history of taking medications for mental illness?
(19.) Are you currently taking medications for a mental illness?

YES
YES

NO
NO

(20.) Do you have a history of taking medications for a chronic physical illness, such
as diabetes, arthritis, high blood pressure?
YES
NO
(21.) Are you currently taking medications for a physical illness?
(22.) How often do you think about injuring yourself?
Never
Occasionally
Frequently

YES

NO

Constantly

(23.) How many times have you actually injured yourself\ or placed yourself in
harm’s way, with the intent to die, even if you changed your mind before any
serious self-harm was inflicted. (For example, you took pills but did not die, pulled
the trigger but gun didn’t fire, cut wrists but decided to call 911 for help, overdosed
but was discovered by friends or family and rushed to emergency room).
# of times:___________
(24.) Are you currently (or expect in the near future to be) involved in legal
proceedings, such as child custody, child abuse/neglect charges, domestic violence,
divorce, or other civil or criminal charges? YES
NO
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TREATMENT PROCESS MEASURE
(To be completed by counselor each week)
Counselor: This form will be used to track your patient’s progress during treatment.
This form is for research purposes only, and will be given to the principle researcher
upon your completion. Please keep these ratings confidential. Upon completion o f this
form, please place it in the envelope provided to you, and seal the envelope to ensure
confidentiality. Next, place the individual envelope in the larger envelope provided to
you, with all o f the weekly TPM forms. The researcher will collect the large envelope
containing the completedforms from you each week o f the research. Thank you again
fo r your participation.
DIRECTIONS: Please indicate how much you DISAGREE or AGREE with each item,
based on your interactions with this patient durine the last week, by circling the number
that corresponds to your answer.
l=Disagree

4=Not Sure,

7=Agree
Strongly
Strongly____________ _______________________________
Easy to talk to
1
2
4
3

5

6

7

Warm and caring

1

2

3

4

5

6

7

Honest and sincere

1

2

3

4

5

6

7

Hostile or aggressive

1

2

3

4

5

6

7

In denial about problems

1

2

3

4

5

6

7

Motivated to recovery

1

2

3

4

5

6

7

Cooperative

1

2

3

4

5

6

7

Responsible

1

2

3

4

5

6

7

Consistently keeps
session appointments
Self-confident

1

2

3

4

5

6

7

1

2

3

4

5

6

7

Freely expresses wishes

1

2

3

4

5

6

7

Depressed

1

2

3

4

5

6

7

Nervous or anxious

1

2

3

4

5

6

7

Motivated

1

2

3

4

5

6

7

Copyright2004 TCU Institute o f Behavioral Research, Fort Worth, Texas. All rights reserved.
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M is s is s ip p i S t a t e H o s p it a l
P.O. Box 157-A, W h itf ie ld , MS 39193

(601)351-8000

w w w .m s h .s ta te .m s .u s

James G. Chastain, Director

Shazia M. Frothingham, PhD.
Chair
Institutional Review Board
Building 51
Mississippi State Hospital
Whitfield, MS 39193

Telephone: (601) 351-8010
Telecopier (601) 351-8086
Electronic email: sfiothingham@msh.state.ms.us

September 21,2011
Annese Baum Hutchins, M.E4, LPC
Department of Psychology and Behavioral Sciences
Louisiana Tech University
Ruston, LA 71272
Dear Ms. Baum-Hutchins:
On September 15,2011, the Mississippi State Hospital Institutional Review Board approved
your submitted research protocol “Predicting substance abuse treatment process and
outcomes with the Personality Assessment Inventory: An investigation of how personality
and interpersonal factors affect treatment” pending revisions. You have completed required
revisions and may begin data collection.
Please sign the enclosed confidentiality and data use agreement and send to me. Also, please
keep the Board updated on the progress o f your research and inform me prior to any changes in
procedures. All ongoing research will be reviewed at least annually. Please said me information
o f any papers, publications or presentations that result from this research.

Sincerely,

Shazia M. Frothingham, Ph.D.
Chair of MSH Institutional Review Board
Mississippi State Hospital
Whitfield, MS 39193

A F a c il it y o f t h e M ississippi D e pa r t m e n t o f M e n t a l H ealth
A c c r e d it e d by t h e J o in t C o m m is sio n o n A c c r e d it a t io n o f H e a l t h c a r e O r g a n iz a tio n s
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LOUISIANA TECH
U N I V E R S I T Y
MEMORANDUM

OFFICE OF UNIVERSITY RESEARCH

TO:

Dr. Donna Thomas, Dr. Tony Young, DrJeffrey Walczyk
and Ms. Annese Hutchins

FROM:

BarbaraTalbot, University Research

SUBJECT:

HUMAN USE COMMITTEE REVIEW

DATE:

November 1,2011

In order to facilitate your project, an EXPEDITED REVIEW has been done for your proposed study
entitled:
“Predicting Substance Abuse Treatment Process and Outcomes with the
Personality Assessment Inventory: An Investigation of How Personality and Interpersonal Factors
Affect Treatment”
HUC 902

The proposed study’s revised procedures were found to provide reasonable and adequate safeguards
against possible risks involving human subjects. The information to be collected may be personal in
nature or implication. Therefore, diligent care needs to be taken to protect the privacy of the participants
and to assure that the data are kept confidential. Informed consent is a critical part of the research
process. The subjects must be informed that their participation is voluntary. It is important that consent
materials be presented in a language understandable to every participant If you have participants in your
study whose first language is not English, be sure that informed consent materials are adequately
explained or translated. Since your reviewed project appears to do no damage to the participants, the
Human Use Committee grants approval of the involvement of human subjects as outlined.

ThisapprovalwasfinalizedonNovember1,2011andthisproject
willneedtoreceiveacontinuationrenewbytheIRBiftheproject,includingdataanalysis,continues
beyondNovember1, 201ZAny discrepancies in procedure or changes that have been made including
Projects should be renewed annually.

approved changes should be noted in the review application. Projects involving NIH funds require annual
education training to be documented. For more information regarding this, contact die Office of
University Research.
You are requested to maintain written records of your procedures, data collected, and subjects involved.
These records will need to be available upon request during the conduct of 1he study and retained by the
university fra- three years after die conclusion of the study. If changes occur in recruiting of subjects,
informed consent process or in your research protocol, or if unanticipated problems should arise it is the
Researchers responsibility to notify die Office of Research or IRB in writing. The project should be
discontinued until modifications can be reviewed and approved.
If you have any questions, please contact Dr. Mary Livingston at 257-4315.

A MEMBER OF THE UMVERSITYOF LOUISIANA SYSTEM

P.O. BOX 3092 • RUSTON, LA 71272 • TELEPHONE (318) 257-5075 • FAX <31® 257-5079
AN EQUAL O m jR T U N m " UNIVERSITY
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